>HW653248.1 JP 2014523747-A/1085: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCTTC
>HW653247.1 JP 2014523747-A/1084: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW653246.1 JP 2014523747-A/1083: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGCGTC
>HW653245.1 JP 2014523747-A/1082: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCTTC
>HW653244.1 JP 2014523747-A/1081: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGAGTC
>HW653243.1 JP 2014523747-A/1080: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW653242.1 JP 2014523747-A/1079: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW653241.1 JP 2014523747-A/1078: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCAACGTG
>HW653240.1 JP 2014523747-A/1077: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAAGGTC
>HW653239.1 JP 2014523747-A/1076: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCTGTGTC
>HW653238.1 JP 2014523747-A/1075: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAAAGTC
>HW653237.1 JP 2014523747-A/1074: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGTGTC
>HW653236.1 JP 2014523747-A/1073: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACGTC
>HW653235.1 JP 2014523747-A/1072: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACGTC
>HW653234.1 JP 2014523747-A/1071: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAAAGTC
>HW653233.1 JP 2014523747-A/1070: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GCCAGTGTC
>HW653232.1 JP 2014523747-A/1069: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCAAGGTC
>HW653231.1 JP 2014523747-A/1068: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAAAGGC
>HW653230.1 JP 2014523747-A/1067: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTTTGTC
>HW653229.1 JP 2014523747-A/1066: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AACATGGTC
>HW653228.1 JP 2014523747-A/1065: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAAAGGC
>HW653227.1 JP 2014523747-A/1064: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATAGTG
>HW653226.1 JP 2014523747-A/1063: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCCTGGTC
>HW653225.1 JP 2014523747-A/1062: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATTGTA
>HW653224.1 JP 2014523747-A/1061: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGTCTC
>HW653223.1 JP 2014523747-A/1060: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCCTGGTC
>HW653222.1 JP 2014523747-A/1059: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CCCAGCGGC
>HW653221.1 JP 2014523747-A/1058: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAACATC
>HW653220.1 JP 2014523747-A/1057: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTG
>HW653219.1 JP 2014523747-A/1056: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGAGTC
>HW653218.1 JP 2014523747-A/1055: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCTGCGTC
>HW653217.1 JP 2014523747-A/1054: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAATGTC
>HW653216.1 JP 2014523747-A/1053: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAATGTC
>HW653215.1 JP 2014523747-A/1052: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCCACGTC
>HW653214.1 JP 2014523747-A/1051: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGATC
>HW653213.1 JP 2014523747-A/1050: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCAGAGTC
>HW653212.1 JP 2014523747-A/1049: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGCATC
>HW653211.1 JP 2014523747-A/1048: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGTAGCGTG
>HW653210.1 JP 2014523747-A/1047: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGG
>HW653209.1 JP 2014523747-A/1046: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACTTC
>HW653208.1 JP 2014523747-A/1045: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TTCAGCGTC
>HW653207.1 JP 2014523747-A/1044: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCAGTGTC
>HW653206.1 JP 2014523747-A/1043: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGAGTG
>HW653205.1 JP 2014523747-A/1042: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATCTTC
>HW653204.1 JP 2014523747-A/1041: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTG
>HW653203.1 JP 2014523747-A/1040: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGAGTC
>HW653202.1 JP 2014523747-A/1039: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCCGC
>HW653201.1 JP 2014523747-A/1038: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGGAGAGTC
>HW653200.1 JP 2014523747-A/1037: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AACAGGGTC
>HW653199.1 JP 2014523747-A/1036: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGGGTC
>HW653198.1 JP 2014523747-A/1035: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AACAGGGTC
>HW653197.1 JP 2014523747-A/1034: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGTAGCGCC
>HW653196.1 JP 2014523747-A/1033: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCCACGTC
>HW653195.1 JP 2014523747-A/1032: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCACCGTC
>HW653194.1 JP 2014523747-A/1031: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW653193.1 JP 2014523747-A/1030: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW653192.1 JP 2014523747-A/1029: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW653191.1 JP 2014523747-A/1028: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW653190.1 JP 2014523747-A/1027: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGC
>HW653189.1 JP 2014523747-A/1026: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGC
>HW653188.1 JP 2014523747-A/1025: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGCGTC
>HW653187.1 JP 2014523747-A/1024: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW653186.1 JP 2014523747-A/1023: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATCGTC
>HW653185.1 JP 2014523747-A/1022: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCATC
>HW653184.1 JP 2014523747-A/1021: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGAGTC
>HW653183.1 JP 2014523747-A/1020: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTC
>HW653182.1 JP 2014523747-A/1019: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGCGTC
>HW653181.1 JP 2014523747-A/1018: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGCGTC
>HW653180.1 JP 2014523747-A/1017: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTC
>HW653179.1 JP 2014523747-A/1016: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTC
>HW653178.1 JP 2014523747-A/1015: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTC
>HW653177.1 JP 2014523747-A/1014: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW653176.1 JP 2014523747-A/1013: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTC
>HW653175.1 JP 2014523747-A/1012: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW653174.1 JP 2014523747-A/1011: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW653173.1 JP 2014523747-A/1010: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW653172.1 JP 2014523747-A/1009: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW653171.1 JP 2014523747-A/1008: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW653170.1 JP 2014523747-A/1007: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW653169.1 JP 2014523747-A/1006: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGA
>HW653168.1 JP 2014523747-A/1005: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCGGGGTC
>HW653167.1 JP 2014523747-A/1004: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCAGAGTC
>HW653166.1 JP 2014523747-A/1003: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCAGC
>HW653165.1 JP 2014523747-A/1002: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCCTG
>HW653164.1 JP 2014523747-A/1001: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AACAGAGTC
>HW653163.1 JP 2014523747-A/1000: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ACCAGTGTC
>HW653162.1 JP 2014523747-A/999: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCCTG
>HW653161.1 JP 2014523747-A/998: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGGAGCTTC
>HW653160.1 JP 2014523747-A/997: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCAGC
>HW653159.1 JP 2014523747-A/996: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTG
>HW653158.1 JP 2014523747-A/995: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTC
>HW653157.1 JP 2014523747-A/994: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGAGTC
>HW653156.1 JP 2014523747-A/993: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGAGTC
>HW653155.1 JP 2014523747-A/992: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGC
>HW653154.1 JP 2014523747-A/991: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTT
>HW653153.1 JP 2014523747-A/990: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTC
>HW653152.1 JP 2014523747-A/989: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTG
>HW653151.1 JP 2014523747-A/988: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCAGCGTC
>HW653150.1 JP 2014523747-A/987: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCTTC
>HW653149.1 JP 2014523747-A/986: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCTTC
>HW653148.1 JP 2014523747-A/985: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGC
>HW653147.1 JP 2014523747-A/984: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGCC
>HW653146.1 JP 2014523747-A/983: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTG
>HW653145.1 JP 2014523747-A/982: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW653144.1 JP 2014523747-A/981: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGTCTC
>HW653143.1 JP 2014523747-A/980: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATTGTT
>HW653142.1 JP 2014523747-A/979: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGTAAAGTC
>HW653141.1 JP 2014523747-A/978: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATAGTT
>HW653140.1 JP 2014523747-A/977: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGCTTC
>HW653139.1 JP 2014523747-A/976: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGAGTC
>HW653138.1 JP 2014523747-A/975: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGTAGCGTT
>HW653137.1 JP 2014523747-A/974: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAATGTC
>HW653136.1 JP 2014523747-A/973: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCTCC
>HW653135.1 JP 2014523747-A/972: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAAAGTC
>HW653134.1 JP 2014523747-A/971: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATGGTC
>HW653133.1 JP 2014523747-A/970: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACATC
>HW653132.1 JP 2014523747-A/969: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCAGTGTC
>HW653131.1 JP 2014523747-A/968: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCAGAGTC
>HW653130.1 JP 2014523747-A/967: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCAGC
>HW653129.1 JP 2014523747-A/966: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCAGC
>HW653128.1 JP 2014523747-A/965: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATTGTC
>HW653127.1 JP 2014523747-A/964: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGCGGC
>HW653126.1 JP 2014523747-A/963: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACATC
>HW653125.1 JP 2014523747-A/962: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACTTC
>HW653124.1 JP 2014523747-A/961: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCACCGTG
>HW653123.1 JP 2014523747-A/960: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATTGTC
>HW653122.1 JP 2014523747-A/959: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCACGGTC
>HW653121.1 JP 2014523747-A/958: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTG
>HW653120.1 JP 2014523747-A/957: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACTTC
>HW653119.1 JP 2014523747-A/956: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATAGTC
>HW653118.1 JP 2014523747-A/955: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGAAACGTC
>HW653117.1 JP 2014523747-A/954: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACGTC
>HW653116.1 JP 2014523747-A/953: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW653115.1 JP 2014523747-A/952: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGC
>HW653114.1 JP 2014523747-A/951: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCACCGTC
>HW653113.1 JP 2014523747-A/950: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACGTC
>HW653112.1 JP 2014523747-A/949: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGC
>HW653111.1 JP 2014523747-A/948: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGTGTC
>HW653110.1 JP 2014523747-A/947: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGTGGCGTC
>HW653109.1 JP 2014523747-A/946: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGTGTC
>HW653108.1 JP 2014523747-A/945: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGAGTC
>HW653107.1 JP 2014523747-A/944: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AACAGCTTC
>HW653106.1 JP 2014523747-A/943: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGT
>HW653105.1 JP 2014523747-A/942: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCATA
>HW653104.1 JP 2014523747-A/941: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCATA
>HW809689.1 JP 2014533111-A/130: Sequences and their use for detection of Salmonella
GGGCACCTT
>HW809687.1 JP 2014533111-A/128: Sequences and their use for detection of Salmonella
GCGGTCCGT
>HW809678.1 JP 2014533111-A/119: Sequences and their use for detection of Salmonella
AAGGTGCCC
>HW809676.1 JP 2014533111-A/117: Sequences and their use for detection of Salmonella
ACGGACCGC
>HW797188.1 JP 2014239680-A/58: A Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby
CACCACGTC
>HW653103.1 JP 2014523747-A/940: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGTGTC
>HW653102.1 JP 2014523747-A/939: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGAG
>HW653101.1 JP 2014523747-A/938: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGAGTC
>HW653100.1 JP 2014523747-A/937: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGTAGCGGC
>HW653099.1 JP 2014523747-A/936: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AACAGCTTC
>HW653098.1 JP 2014523747-A/935: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAAAGTC
>HW653097.1 JP 2014523747-A/934: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGGGTC
>HW653096.1 JP 2014523747-A/933: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AACAGCTTC
>HW653095.1 JP 2014523747-A/932: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCATA
>HW653094.1 JP 2014523747-A/931: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTT
>HW653093.1 JP 2014523747-A/930: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGCGGC
>HW653092.1 JP 2014523747-A/929: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCACCTTC
>HW653091.1 JP 2014523747-A/928: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGCGTT
>HW653090.1 JP 2014523747-A/927: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TCCAGCGTC
>HW653089.1 JP 2014523747-A/926: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGAGTC
>HW653088.1 JP 2014523747-A/925: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACTTC
>HW653087.1 JP 2014523747-A/924: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGGGTC
>HW653086.1 JP 2014523747-A/923: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGGGTC
>HW653085.1 JP 2014523747-A/922: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACGTC
>HW653084.1 JP 2014523747-A/921: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATCGTC
>HW653083.1 JP 2014523747-A/920: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCTTC
>HW652715.1 JP 2014523747-A/552: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGT
>HW652714.1 JP 2014523747-A/551: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652713.1 JP 2014523747-A/550: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652712.1 JP 2014523747-A/549: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652711.1 JP 2014523747-A/548: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGT
>HW652710.1 JP 2014523747-A/547: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652709.1 JP 2014523747-A/546: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652708.1 JP 2014523747-A/545: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652707.1 JP 2014523747-A/544: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGT
>HW652706.1 JP 2014523747-A/543: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGG
>HW652705.1 JP 2014523747-A/542: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGT
>HW652704.1 JP 2014523747-A/541: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGG
>HW652703.1 JP 2014523747-A/540: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652702.1 JP 2014523747-A/539: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652701.1 JP 2014523747-A/538: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGT
>HW652700.1 JP 2014523747-A/537: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGG
>HW652699.1 JP 2014523747-A/536: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGG
>HW652698.1 JP 2014523747-A/535: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652697.1 JP 2014523747-A/534: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652696.1 JP 2014523747-A/533: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652695.1 JP 2014523747-A/532: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGG
>HW652694.1 JP 2014523747-A/531: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGG
>HW652693.1 JP 2014523747-A/530: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGG
>HW652692.1 JP 2014523747-A/529: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGG
>HW652691.1 JP 2014523747-A/528: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGG
>HW652690.1 JP 2014523747-A/527: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGG
>HW652689.1 JP 2014523747-A/526: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGAT
>HW652688.1 JP 2014523747-A/525: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGGTGAGGT
>HW652687.1 JP 2014523747-A/524: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CAGTGAGGC
>HW652686.1 JP 2014523747-A/523: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CAGTGAGGC
>HW652685.1 JP 2014523747-A/522: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGTTGA
>HW652684.1 JP 2014523747-A/521: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTGTGAGAA
>HW652683.1 JP 2014523747-A/520: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652682.1 JP 2014523747-A/519: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652681.1 JP 2014523747-A/518: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652680.1 JP 2014523747-A/517: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652679.1 JP 2014523747-A/516: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652678.1 JP 2014523747-A/515: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652677.1 JP 2014523747-A/514: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652676.1 JP 2014523747-A/513: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652675.1 JP 2014523747-A/512: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652674.1 JP 2014523747-A/511: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652673.1 JP 2014523747-A/510: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652672.1 JP 2014523747-A/509: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652671.1 JP 2014523747-A/508: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652670.1 JP 2014523747-A/507: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652669.1 JP 2014523747-A/506: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652668.1 JP 2014523747-A/505: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652667.1 JP 2014523747-A/504: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652666.1 JP 2014523747-A/503: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652665.1 JP 2014523747-A/502: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652664.1 JP 2014523747-A/501: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652663.1 JP 2014523747-A/500: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652662.1 JP 2014523747-A/499: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652661.1 JP 2014523747-A/498: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652660.1 JP 2014523747-A/497: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652659.1 JP 2014523747-A/496: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652658.1 JP 2014523747-A/495: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652657.1 JP 2014523747-A/494: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652656.1 JP 2014523747-A/493: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGTA
>HW652655.1 JP 2014523747-A/492: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652654.1 JP 2014523747-A/491: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CAGTGAGGA
>HW652653.1 JP 2014523747-A/490: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGGTGAGGA
>HW652652.1 JP 2014523747-A/489: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTGTGAGGA
>HW652651.1 JP 2014523747-A/488: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTGTGAGGA
>HW652650.1 JP 2014523747-A/487: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTGTGAGGA
>HW652649.1 JP 2014523747-A/486: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTGTGAGGA
>HW652648.1 JP 2014523747-A/485: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTGTGAGGA
>HW652647.1 JP 2014523747-A/484: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652646.1 JP 2014523747-A/483: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGG
>HW652645.1 JP 2014523747-A/482: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGAA
>HW652644.1 JP 2014523747-A/481: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTGTGAGGA
>HW652643.1 JP 2014523747-A/480: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652642.1 JP 2014523747-A/479: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGT
>HW652641.1 JP 2014523747-A/478: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGT
>HW652640.1 JP 2014523747-A/477: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652639.1 JP 2014523747-A/476: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652638.1 JP 2014523747-A/475: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGC
>HW652637.1 JP 2014523747-A/474: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGT
>HW652636.1 JP 2014523747-A/473: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TAGTGAGGA
>HW652635.1 JP 2014523747-A/472: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GATTGAGGA
>HW652634.1 JP 2014523747-A/471: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CAGTGAGGA
>HW652633.1 JP 2014523747-A/470: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGGTGAGGA
>HW652632.1 JP 2014523747-A/469: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGT
>HW652631.1 JP 2014523747-A/468: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAAAA
>HW652630.1 JP 2014523747-A/467: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGATGG
>HW652629.1 JP 2014523747-A/466: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGTGCA
>HW652628.1 JP 2014523747-A/465: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGGGAGGG
>HW652627.1 JP 2014523747-A/464: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGGGAAGA
>HW652626.1 JP 2014523747-A/463: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAGTGGGGA
>HW652625.1 JP 2014523747-A/462: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTGTGAGGT
>HW652624.1 JP 2014523747-A/461: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CAGTGAGCA
>HW652623.1 JP 2014523747-A/460: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652622.1 JP 2014523747-A/459: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652621.1 JP 2014523747-A/458: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAAGA
>HW652620.1 JP 2014523747-A/457: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAGTGAGGA
>HW652619.1 JP 2014523747-A/456: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGTCTC
>HW652618.1 JP 2014523747-A/455: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGTAAAGTC
>HW652617.1 JP 2014523747-A/454: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATAGTT
>HW652616.1 JP 2014523747-A/453: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGCTTC
>HW652615.1 JP 2014523747-A/452: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGCGGC
>HW652614.1 JP 2014523747-A/451: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGAGTC
>HW652613.1 JP 2014523747-A/450: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCAGTGTC
>HW652612.1 JP 2014523747-A/449: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCAGAGTC
>HW652611.1 JP 2014523747-A/448: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGTAGCGTT
>HW652610.1 JP 2014523747-A/447: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATTGTC
>HW652609.1 JP 2014523747-A/446: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATTGTC
>HW652608.1 JP 2014523747-A/445: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATGGTC
>HW652607.1 JP 2014523747-A/444: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATAGTC
>HW652606.1 JP 2014523747-A/443: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTG
>HW652605.1 JP 2014523747-A/442: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCTCC
>HW652604.1 JP 2014523747-A/441: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCAGC
>HW652603.1 JP 2014523747-A/440: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCAGC
>HW652602.1 JP 2014523747-A/439: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCACGGTC
>HW652601.1 JP 2014523747-A/438: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCACCGTG
>HW652600.1 JP 2014523747-A/437: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAATGTC
>HW652599.1 JP 2014523747-A/436: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACTTC
>HW652598.1 JP 2014523747-A/435: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACTTC
>HW652597.1 JP 2014523747-A/434: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACATC
>HW652596.1 JP 2014523747-A/433: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACATC
>HW652595.1 JP 2014523747-A/432: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAAAGTC
>HW652594.1 JP 2014523747-A/431: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGAAACGTC
>HW652593.1 JP 2014523747-A/430: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW652592.1 JP 2014523747-A/429: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGC
>HW652591.1 JP 2014523747-A/428: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGC
>HW652590.1 JP 2014523747-A/427: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCACCGTC
>HW652589.1 JP 2014523747-A/426: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACGTC
>HW652588.1 JP 2014523747-A/425: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACGTC
>HW652587.1 JP 2014523747-A/424: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGTGTC
>HW652586.1 JP 2014523747-A/423: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGGGTC
>HW652585.1 JP 2014523747-A/422: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGCGTT
>HW652584.1 JP 2014523747-A/421: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TGCAGCGGC
>HW652583.1 JP 2014523747-A/420: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TCCAGCGTC
>HW652582.1 JP 2014523747-A/419: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCAGAGTC
>HW652581.1 JP 2014523747-A/418: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGTGGCGTC
>HW652580.1 JP 2014523747-A/417: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGTAGCGGC
>HW652579.1 JP 2014523747-A/416: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGTGTC
>HW652578.1 JP 2014523747-A/415: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGTGTC
>HW652577.1 JP 2014523747-A/414: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGGGTC
>HW652576.1 JP 2014523747-A/413: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGGGTC
>HW652575.1 JP 2014523747-A/412: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGAGTC
>HW652574.1 JP 2014523747-A/411: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCTGAGTC
>HW652573.1 JP 2014523747-A/410: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTT
>HW652572.1 JP 2014523747-A/409: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGGT
>HW652571.1 JP 2014523747-A/408: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGAG
>HW652570.1 JP 2014523747-A/407: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCATA
>HW652569.1 JP 2014523747-A/406: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCATA
>HW652568.1 JP 2014523747-A/405: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCATA
>HW652567.1 JP 2014523747-A/404: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCACCTTC
>HW652566.1 JP 2014523747-A/403: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACTTC
>HW652565.1 JP 2014523747-A/402: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAAAGTC
>HW652564.1 JP 2014523747-A/401: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AACAGCTTC
>HW652563.1 JP 2014523747-A/400: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AACAGCTTC
>HW652562.1 JP 2014523747-A/399: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AACAGCTTC
>HW652561.1 JP 2014523747-A/398: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGGAGCGTC
>HW652560.1 JP 2014523747-A/397: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATCGTC
>HW652559.1 JP 2014523747-A/396: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATCGTC
>HW652558.1 JP 2014523747-A/395: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCATCGTC
>HW652557.1 JP 2014523747-A/394: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW652556.1 JP 2014523747-A/393: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW652555.1 JP 2014523747-A/392: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW652554.1 JP 2014523747-A/391: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW652553.1 JP 2014523747-A/390: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW652552.1 JP 2014523747-A/389: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGTGTC
>HW652551.1 JP 2014523747-A/388: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGGGTC
>HW652550.1 JP 2014523747-A/387: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCTTC
>HW652549.1 JP 2014523747-A/386: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCTTC
>HW652548.1 JP 2014523747-A/385: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCTTC
>HW652547.1 JP 2014523747-A/384: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTG
>HW652546.1 JP 2014523747-A/383: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGAC
>HW652545.1 JP 2014523747-A/382: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCCTC
>HW652544.1 JP 2014523747-A/381: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCCTC
>HW652543.1 JP 2014523747-A/380: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCATC
>HW652542.1 JP 2014523747-A/379: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGAGTC
>HW652541.1 JP 2014523747-A/378: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGAGTC
>HW652540.1 JP 2014523747-A/377: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCACCGTC
>HW652539.1 JP 2014523747-A/376: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACGTC
>HW652538.1 JP 2014523747-A/375: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACGTC
>HW652537.1 JP 2014523747-A/374: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAACGTC
>HW652536.1 JP 2014523747-A/373: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGAAGCGTC
>HW652535.1 JP 2014523747-A/372: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW652534.1 JP 2014523747-A/371: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW652533.1 JP 2014523747-A/370: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW652532.1 JP 2014523747-A/369: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW652531.1 JP 2014523747-A/368: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW652530.1 JP 2014523747-A/367: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW652529.1 JP 2014523747-A/366: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW652528.1 JP 2014523747-A/365: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW652527.1 JP 2014523747-A/364: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTT
>HW652526.1 JP 2014523747-A/363: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCCTC
>HW652525.1 JP 2014523747-A/362: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW652524.1 JP 2014523747-A/361: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGCAGCGTC
>HW632459.1 JP 2014176307-A/15893: The Use of Terminaters of Saccharomyces cerevisiae
GCGTGGGCG
>DI486595.1 KR 1020140135259-A/47: Antibodies that neutralize RSV, MPV and PVM and uses thereof
GGGAACAGC
>DI486584.1 KR 1020140135259-A/27: Antibodies that neutralize RSV, MPV and PVM and uses thereof
GCTAACGAC
>DI486576.1 KR 1020140135259-A/11: Antibodies that neutralize RSV, MPV and PVM and uses thereof
GATAACAAC
>DI432915.1 KR 1020140106124-A/4: Composition of prevention or treatment for intracellular pathogenic bacteria infection
TGTATTTGA
>DI432914.1 KR 1020140106124-A/3: Composition of prevention or treatment for intracellular pathogenic bacteria infection
TGTAGGTGA
>DI432913.1 KR 1020140106124-A/2: Composition of prevention or treatment for intracellular pathogenic bacteria infection
TTCCCTTTT
>DI432912.1 KR 1020140106124-A/1: Composition of prevention or treatment for intracellular pathogenic bacteria infection
TTCCCTTAA
>HW832761.1 JP 2015053935-A/217: The detection and use of genetic polymorphism of Monkeys CYP2C and CYP2D genes
GGGGCGGGC
>HW648633.1 WO 2014175284-A/5: DNA binding proteins using PPR motifs and use thereof
TCTATCACT
>DI485880.1 KR 1020140125455-A/19: HUMANIZED ANTIBODY AGAINST AMYLOID BETA
GGTGACTAC
>HW647743.1 WO 2014157429-A/15: A method for producing a protein
GAGNNNACV
>DI485246.1 KR 1020140130713-A/429: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGATTTCT
>DI485238.1 KR 1020140130713-A/413: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGTTTCT
>DI485230.1 KR 1020140130713-A/397: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGTTTCT
>DI485222.1 KR 1020140130713-A/381: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGCGTCT
>DI485214.1 KR 1020140130713-A/365: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGCGTCT
>DI485206.1 KR 1020140130713-A/349: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGCGTCT
>DI485198.1 KR 1020140130713-A/333: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGCGTCT
>DI485190.1 KR 1020140130713-A/317: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGCGTCT
>DI485182.1 KR 1020140130713-A/301: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGCGTCT
>DI485174.1 KR 1020140130713-A/285: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGTTTCT
>DI485166.1 KR 1020140130713-A/269: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGATTTCT
>DI485158.1 KR 1020140130713-A/253: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGATTTCT
>DI485150.1 KR 1020140130713-A/237: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGCGTCT
>DI485142.1 KR 1020140130713-A/221: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGCGTCT
>DI485134.1 KR 1020140130713-A/205: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGTTTCT
>DI485126.1 KR 1020140130713-A/189: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGTTTCT
>DI485118.1 KR 1020140130713-A/173: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGTTTCT
>DI485110.1 KR 1020140130713-A/157: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
TTGGGTTCT
>DI485102.1 KR 1020140130713-A/141: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGCGTCT
>DI485094.1 KR 1020140130713-A/125: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGCGTCT
>DI485086.1 KR 1020140130713-A/109: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGCGTCT
>DI485078.1 KR 1020140130713-A/93: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGTTTCT
>DI485070.1 KR 1020140130713-A/77: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGTTTCT
>DI485062.1 KR 1020140130713-A/61: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGATTTCT
>DI485054.1 KR 1020140130713-A/45: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGATTTCT
>DI485046.1 KR 1020140130713-A/29: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
AAGGTTTCT
>DI485038.1 KR 1020140130713-A/13: ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF
GGTGCATCC
>DI484984.1 KR 1020140130709-A/365: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GGTGCATCC
>DI484976.1 KR 1020140130709-A/349: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GGTACATCC
>DI484968.1 KR 1020140130709-A/333: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GGTGCATCC
>DI484960.1 KR 1020140130709-A/317: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GGTGCATCC
>DI484952.1 KR 1020140130709-A/301: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GATGCATCC
>DI484944.1 KR 1020140130709-A/285: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GCTGCATCC
>DI484936.1 KR 1020140130709-A/269: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GCTGCATCC
>DI484928.1 KR 1020140130709-A/253: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
TCTGCATCC
>DI484920.1 KR 1020140130709-A/237: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
TCTGCATCC
>DI484912.1 KR 1020140130709-A/221: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GCTGCATCC
>DI484904.1 KR 1020140130709-A/205: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GCTGCGTCC
>DI484896.1 KR 1020140130709-A/189: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GCTGCATCC
>DI484888.1 KR 1020140130709-A/173: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GGTGTTTCC
>DI484880.1 KR 1020140130709-A/157: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
ACTGCATCC
>DI484872.1 KR 1020140130709-A/141: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GCTGCTTCC
>DI484864.1 KR 1020140130709-A/125: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
AAGGCGTCT
>DI484856.1 KR 1020140130709-A/109: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GCTGCATCC
>DI484848.1 KR 1020140130709-A/93: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
AGGGCGTCT
>DI484840.1 KR 1020140130709-A/77: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
AAGGCGTCT
>DI484832.1 KR 1020140130709-A/61: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
AAGGCGTCT
>DI484824.1 KR 1020140130709-A/45: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
TGGGCATCT
>DI484816.1 KR 1020140130709-A/29: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
TGGACATCT
>DI484808.1 KR 1020140130709-A/13: HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
GGTACATCC
>DI448795.1 KR 1020140091770-A/45: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
GATGTACCC
>DI448793.1 KR 1020140091770-A/43: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
ACAATGAGT
>DI448788.1 KR 1020140091770-A/38: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
AGAACTGGG
>DI448787.1 KR 1020140091770-A/37: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
CAAACCAGA
>DI448786.1 KR 1020140091770-A/36: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
CCGTTGGTC
>DI448785.1 KR 1020140091770-A/35: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
GAGAGTTGG
>JD593546.1 Sequence 47 from Patent WO2015027154
GATGCATCC
>JD593528.1 Sequence 29 from Patent WO2015027154
AAGGCGTCT
>JD593512.1 Sequence 13 from Patent WO2015027154
GCTGCATCC
>JD591186.1 Sequence 7 from Patent EP2820132
SNCACGTCR
>JD591181.1 Sequence 2 from Patent EP2820132
GDGAGAGAG
>JD589038.1 Sequence 213 from Patent WO2015017576
GGTGCATCC
>JD588974.1 Sequence 149 from Patent WO2015017576
GGGGCAAGT
>JD588918.1 Sequence 93 from Patent WO2015017576
GCTGCATCC
>JD588902.1 Sequence 77 from Patent WO2015017576
GATGCATCC
>JD588886.1 Sequence 61 from Patent WO2015017576
GATGCTTCC
>JD588870.1 Sequence 45 from Patent WO2015017576
GAGACATCC
>JD588854.1 Sequence 29 from Patent WO2015017576
GCTGCATCC
>JD588838.1 Sequence 13 from Patent WO2015017576
TGGGCATCT
>JD584401.1 Sequence 2 from Patent EP2829614
ACTACCTCA
>JD571014.1 Sequence 23 from Patent WO2015031626
ACCACATCC
>JD570985.1 Sequence 31 from Patent WO2015031614
ACCACATCC
>JD570977.1 Sequence 23 from Patent WO2015031614
CGTGCATCC
>JD567936.1 Sequence 115 from Patent WO2015007787
CGACCTCAG
>JD018850.1 Sequence 10 from Patent WO2014164466
ACGTCCTGC
>JD018849.1 Sequence 9 from Patent WO2014164466
GCAGGACGT
>JC997269.1 Sequence 8 from Patent WO2014020062
GGTTCGTCC
>JC988858.1 Sequence 19 from Patent EP2792746
TCGCTATTC
>JC985875.1 Sequence 33 from Patent EP2692353
CTTGAAGAC
>JC985874.1 Sequence 32 from Patent EP2692353
CTGGAGGAT
>JC985873.1 Sequence 31 from Patent EP2692353
TTGGCAGAT
>JC985872.1 Sequence 30 from Patent EP2692353
TTGGCTGAT
>JC985871.1 Sequence 29 from Patent EP2692353
TTAGGAGAT
>JC985870.1 Sequence 28 from Patent EP2692353
TTATCCGAT
>JC981039.1 Sequence 10 from Patent EP2809148
GCTTCTTCT
>JC963572.1 Sequence 36 from Patent WO2014167282
TTCNNNGAA
>JC963561.1 Sequence 25 from Patent WO2014167282
CTGGAATGT
>JC962040.1 Sequence 84 from Patent WO2014018512
CCACCATGG
>JC962038.1 Sequence 82 from Patent WO2014018512
CCACCATGG
>HW612977.1 WO 2014126254-A/3: Membrane bound type protein expression vector
CGGGTAAAT
>HW612976.1 WO 2014126254-A/2: Membrane bound type protein expression vector
GACGTAAGT
>HW612975.1 WO 2014126254-A/1: Membrane bound type protein expression vector
CAGGTAAGT
>HW612480.1 WO 2014129270-A/21: human antiCD3e antibody
AGGGATGAT
>HW612048.1 JP 2014141501-A/23: HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF
TGGGCATCT
>HW612040.1 JP 2014141501-A/15: HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF
CAGGATTCC
>HW612034.1 JP 2014141501-A/9: HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF
GACAATGAT
>DI398067.1 KR 1020140033037-A/3: ANTIBODIES DIRECTED AGAINST ICOS AND USES THEREOF
TTTGATTAC
>DI380293.1 KR 1020130136381-A/63: Method for controling total protein expression by changing the 3'' region nucleotide sequence
GAGGAGGAG
>DI378659.1 KR 1020140064399-A/4: SINGLE STRANDED DNA APTAMERS SPECIFICALLY BINDING TO SALMONELLA TYPHIMURIUM AND PRODUCTION METHOD THEREOF
GGAGGTCTG
>DI378658.1 KR 1020140064399-A/3: SINGLE STRANDED DNA APTAMERS SPECIFICALLY BINDING TO SALMONELLA TYPHIMURIUM AND PRODUCTION METHOD THEREOF
GTCTGTAGG
>DI393646.1 KR 1020140015455-A/145: APTAMERS FOR CLOSTRIDIUM DIFFICILE DIAGNOSTICS
NAAANGNNN
>DI393626.1 KR 1020140015455-A/125: APTAMERS FOR CLOSTRIDIUM DIFFICILE DIAGNOSTICS
NANNNANNA
>DI408285.1 KR 1020140059256-A/2: METHODS FOR TAGGING DNA-ENCODED LIBRARIES
GCAGCACCC
>DI408062.1 KR 1020140041951-A/15: HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF
AAGGTTTCT
>DI406517.1 KR 1020140044924-A/6: Hepatitis b virus-derived cis-regulatory element and use thereof
CGACAAGGC
>DI406333.1 KR 1020140048303-A/13: Novel anti-CXCR4 antibody and its use for the detection and diagnosis of cancer
AAAGTTTCC
>DI391470.1 KR 1020140006013-A/589: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
GATGCATCC
>DI391371.1 KR 1020140006013-A/85: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TGGGCATCT
>DI391360.1 KR 1020140006013-A/61: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TGGGCCTCT
>DI391317.1 KR 1020140012075-A/589: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
GATGCATCC
>DI391218.1 KR 1020140012075-A/85: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TGGGCATCT
>DI391207.1 KR 1020140012075-A/61: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TGGGCCTCT
>DI405906.1 KR 1020140041876-A/109: FC-FREE ANTIBODIES COMPRISING TWO FAB FRAGMENTS AND METHODS OF USE
TTTGACTAC
>DI391080.1 KR 1020140005998-A/35: NANOPARTICLE COMPOSITIONS, FORMULATIONS THEREOF, AND USES THEREFOR
GGGTTAGGG
>DI391079.1 KR 1020140005998-A/34: NANOPARTICLE COMPOSITIONS, FORMULATIONS THEREOF, AND USES THEREFOR
GAGTATGAG
>DI391073.1 KR 1020140005998-A/27: NANOPARTICLE COMPOSITIONS, FORMULATIONS THEREOF, AND USES THEREFOR
TTAGGGTTA
>DI391072.1 KR 1020140005998-A/26: NANOPARTICLE COMPOSITIONS, FORMULATIONS THEREOF, AND USES THEREFOR
GTTAGGGTT
>DI391048.1 KR 1020140003572-A/35: NANOPARTICLE COMPOSITIONS
GGGTTAGGG
>DI391047.1 KR 1020140003572-A/34: NANOPARTICLE COMPOSITIONS
GAGTATGAG
>DI391041.1 KR 1020140003572-A/27: NANOPARTICLE COMPOSITIONS
TTAGGGTTA
>DI391040.1 KR 1020140003572-A/26: NANOPARTICLE COMPOSITIONS
GTTAGGGTT
>DI405522.1 KR 1020140041856-A/109: BISPECIFIC ANTIBODIES SPECIFIC FOR T-CELL ACTIVATING ANTIGENS AND A TUMOR ANTIGEN AND METHODS OF USE
TTTGACTAC
>DI405318.1 KR 1020140034310-A/238: BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
TTCGACTAC
>DI405237.1 KR 1020140034310-A/74: BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
TTTGACTAC
>DI405022.1 KR 1020140047127-A/13: Use of the antibody I-3859 for the detection and diagnosis of cancer
TGGGCATCC
>DI389026.1 KR 1020140009264-A/168: HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
TGGGCATCT
>DI389016.1 KR 1020140009264-A/141: HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
ACTGCATTC
>DI388998.1 KR 1020140009264-A/101: HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
GCTACATCC
>DI388981.1 KR 1020140009264-A/61: HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
ACTGCATCC
>DI388911.1 KR 1020140009258-A/59: IMMUNE REGULATORY OLIGONUCLEOTIDE(IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE
TGACGTTCA
>DI388910.1 KR 1020140009258-A/58: IMMUNE REGULATORY OLIGONUCLEOTIDE(IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE
GACGTTCTT
>DI388908.1 KR 1020140009258-A/55: IMMUNE REGULATORY OLIGONUCLEOTIDE(IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE
TGACGTTCT
>DI388700.1 KR 1020140001229-A/7: Recombinant expression vector elements(rEVEs) for enhancing expression of recombinant proteins in host cells
AATATATTT
>DI388696.1 KR 1020140001229-A/3: Recombinant expression vector elements(rEVEs) for enhancing expression of recombinant proteins in host cells
AATAAAYAA
>DI388609.1 KR 1020130132842-A/229: HUMAN ANTIBODIES TO HUMAN TNF-LIKE LIGAND 1A (TL1A)
TCTACATCC
>DI388599.1 KR 1020130132842-A/209: HUMAN ANTIBODIES TO HUMAN TNF-LIKE LIGAND 1A (TL1A)
AAGGCGTCT
>DI388573.1 KR 1020130132842-A/149: HUMAN ANTIBODIES TO HUMAN TNF-LIKE LIGAND 1A (TL1A)
TTGGGCTCT
>DI388554.1 KR 1020130132842-A/109: HUMAN ANTIBODIES TO HUMAN TNF-LIKE LIGAND 1A (TL1A)
CTGGGTTCT
>DI388532.1 KR 1020130132842-A/61: HUMAN ANTIBODIES TO HUMAN TNF-LIKE LIGAND 1A (TL1A)
AAGATTTCT
>DI388517.1 KR 1020130132842-A/29: HUMAN ANTIBODIES TO HUMAN TNF-LIKE LIGAND 1A (TL1A)
GCGGCGTCT
>DI402835.1 KR 1020140037218-A/157: ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF
GTTGCAGCC
>DI402828.1 KR 1020140037218-A/141: ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF
AAGGTTTCT
>DI402820.1 KR 1020140037218-A/125: ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF
ACTGCATCC
>DI402813.1 KR 1020140037218-A/109: ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF
CCTGCATCC
>DI402805.1 KR 1020140037218-A/93: ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF
ACTACTTCC
>DI387819.1 KR 1020140009174-A/15: Antibodies for the treatment of HIV
TGGGCATCC
>DI402245.1 KR 1020140041698-A/58: Anti-CXCR4 antibody with effector functions and its use for treatment of cancer
TGGGCCTCT
>DI402220.1 KR 1020140041698-A/33: Anti-CXCR4 antibody with effector functions and its use for treatment of cancer
TGGGCATCC
>DI387142.1 KR 1020140014067-A/343: ANTI-CD48 ANTIBODIES AND USES THEREOF
GCTGCTTCC
>DI387123.1 KR 1020140014067-A/243: ANTI-CD48 ANTIBODIES AND USES THEREOF
TTGGTTTCT
>DI387113.1 KR 1020140014067-A/223: ANTI-CD48 ANTIBODIES AND USES THEREOF
AAGATTTCT
>DI387092.1 KR 1020140014067-A/173: ANTI-CD48 ANTIBODIES AND USES THEREOF
GCGGCATCC
>DI387085.1 KR 1020140014067-A/157: ANTI-CD48 ANTIBODIES AND USES THEREOF
GGTTCATCC
>DI386119.1 KR 1020130136968-A/14: SAFE AND FUNCTIONAL HUMANIZED ANTI BETA-AMYLOID ANTIBODY
GGTGACTAC
>DI400601.1 KR 1020140042819-A/250: ANTI-CGRP COMPOSITIONS AND USE THEREOF
GGCGACATC
>DI400664.1 KR 1020140048136-A/250: USE OF ANTI-CGRP ANTIBODIES AND ANTIBODY FRAGMENTS TO PREVENT OR INHIBIT PHOTOPHOBIA OR LIGHT AVERSION IN SUBJECTS IN NEED THEREOF, ESPECIALLY MIGRAINE SUFFERERS
GGCGACATC
>DI399785.1 KR 1020140027405-A/2: POLYCISTRONIC EXPRESSION SYSTEM FOR BACTERIA
TAATCCATG
>HW608199.1 JP 2014513929-A/145: APTAMERS FOR C. DIFFICILE DIAGNOSTICS
NAAANGNNN
>HW608179.1 JP 2014513929-A/125: APTAMERS FOR C. DIFFICILE DIAGNOSTICS
NANNNANNA
>HW588179.1 JP 2013116116-A/117: Identification of Clonal Cells by Repeats in T-Cell Receptor V/D/J Genes
GTAGAGATG
>HW588175.1 JP 2013116116-A/113: Identification of Clonal Cells by Repeats in T-Cell Receptor V/D/J Genes
GTGGATACA
>HW588146.1 JP 2013116116-A/84: Identification of Clonal Cells by Repeats in T-Cell Receptor V/D/J Genes
GGTATAACC
>HW588142.1 JP 2013116116-A/80: Identification of Clonal Cells by Repeats in T-Cell Receptor V/D/J Genes
GGTACAACT
>HW601070.1 JP 2013532976-A/55: NOVEL AGONISTS OF TOLL-LIKE RECEPTOR 3 AND METHODS OF THEIR USE
TGTNNNNNN
>HW601069.1 JP 2013532976-A/54: NOVEL AGONISTS OF TOLL-LIKE RECEPTOR 3 AND METHODS OF THEIR USE
CCCACACCC
>HW600232.1 JP 2013533222-A/6: Novel anti-cMet antibody
AGGGCTTCT
>HW599444.1 JP 2013528608-A/182: Antibodies to Human GDF8
GCTGCATCC
>HW599436.1 JP 2013528608-A/174: Antibodies to Human GDF8
ACTACATCC
>HW599425.1 JP 2013528608-A/163: Antibodies to Human GDF8
AAGATTTCT
>HW599421.1 JP 2013528608-A/159: Antibodies to Human GDF8
TTGGGTTCT
>HW599413.1 JP 2013528608-A/151: Antibodies to Human GDF8
GCTGCATCC
>HW599405.1 JP 2013528608-A/143: Antibodies to Human GDF8
GGTGCATCC
>HW599397.1 JP 2013528608-A/135: Antibodies to Human GDF8
TTGGGTTCT
>HW599389.1 JP 2013528608-A/127: Antibodies to Human GDF8
GGTGCATCC
>HW599381.1 JP 2013528608-A/119: Antibodies to Human GDF8
GGTGCATCC
>HW599373.1 JP 2013528608-A/111: Antibodies to Human GDF8
GGTGCATCC
>HW599365.1 JP 2013528608-A/103: Antibodies to Human GDF8
GGTGCATCC
>HW599357.1 JP 2013528608-A/95: Antibodies to Human GDF8
GCTACATCC
>HW599349.1 JP 2013528608-A/87: Antibodies to Human GDF8
GGTGCATCC
>HW599341.1 JP 2013528608-A/79: Antibodies to Human GDF8
GCTGCATCC
>HW599333.1 JP 2013528608-A/71: Antibodies to Human GDF8
GTTGCATCC
>HW599325.1 JP 2013528608-A/63: Antibodies to Human GDF8
CGGATGTCC
>HW599317.1 JP 2013528608-A/55: Antibodies to Human GDF8
GCTGCATCC
>HW599309.1 JP 2013528608-A/47: Antibodies to Human GDF8
GCTGCATCC
>HW599301.1 JP 2013528608-A/39: Antibodies to Human GDF8
GCTGCATCC
>HW599293.1 JP 2013528608-A/31: Antibodies to Human GDF8
GCTGCATCC
>HW599285.1 JP 2013528608-A/23: Antibodies to Human GDF8
GCTGCATCC
>HW599277.1 JP 2013528608-A/15: Antibodies to Human GDF8
GCTGCATCC
>HW599269.1 JP 2013528608-A/7: Antibodies to Human GDF8
GGTGTATCC
>HW599052.1 JP 2013530154-A/53: OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
CAGGCAGGC
>HW599046.1 JP 2013530154-A/47: OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
GCAGCAGCA
>HW599042.1 JP 2013530154-A/43: OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
AGCAGCAGC
>HW599038.1 JP 2013530154-A/39: OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
CAGCAGCAG
>HW597550.1 JP 2013521803-A/2: Enterobacter sp. 638 and Methods of Use Thereof
TTATCCACA
>HW593145.1 JP 2013163678-A/21: CALICHEAMICIN DERIVATIVE-CARRIER CONJUGATES
GCCGCCACC
>HW581878.1 JP 2014511843-A/3: Antibodies directed against ICOS and uses thereof
TTTGATTAC
>HW580554.1 JP 2014511180-A/41: DELIVERY OF PROTEINS USING ADENO-ASSOCIATED VIRUS (AAV) VECTORS
GCCGCCATG
>HW580283.1 JP 2014511361-A/367: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TTGGGTTTT
>HW580271.1 JP 2014511361-A/355: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
GGTGCATCC
>HW580259.1 JP 2014511361-A/343: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
AAGGTTTCT
>HW580247.1 JP 2014511361-A/331: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
AAGGTTTCT
>HW580235.1 JP 2014511361-A/319: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
AAGGTTTCT
>HW580223.1 JP 2014511361-A/307: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
GGTGCATCC
>HW580211.1 JP 2014511361-A/295: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
GATGCATCC
>HW580199.1 JP 2014511361-A/283: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
GGTGCATCC
>HW580187.1 JP 2014511361-A/271: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
GGTGCATCC
>HW580175.1 JP 2014511361-A/259: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TTGGGTTTT
>HW580163.1 JP 2014511361-A/247: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
GGTGCATCC
>HW580151.1 JP 2014511361-A/235: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
AAGGCGTCT
>HW580139.1 JP 2014511361-A/223: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
AAGGCGTCT
>HW580127.1 JP 2014511361-A/211: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
AAGGCGTCT
>HW580115.1 JP 2014511361-A/199: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
AAGGCGTCT
>HW580103.1 JP 2014511361-A/187: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
GGTGCATCC
>HW580091.1 JP 2014511361-A/175: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
AAGGCGTCT
>HW580079.1 JP 2014511361-A/163: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
AAGGTTTCT
>HW580067.1 JP 2014511361-A/151: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TTGGGTTCT
>HW580055.1 JP 2014511361-A/139: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TTGGGTTTT
>HW580043.1 JP 2014511361-A/127: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TTGGGTTTT
>HW580031.1 JP 2014511361-A/115: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TTGGGTTCT
>HW580019.1 JP 2014511361-A/103: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TTGGGTTCT
>HW580007.1 JP 2014511361-A/91: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TTGGGTTCT
>HW579995.1 JP 2014511361-A/79: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
AAGGTTTCT
>HW579983.1 JP 2014511361-A/67: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
GCTGCATCC
>HW579971.1 JP 2014511361-A/55: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
GCTGCATCC
>HW579959.1 JP 2014511361-A/43: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TGGGCATCT
>HW579947.1 JP 2014511361-A/31: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
TGGGCCTCT
>HW579935.1 JP 2014511361-A/19: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
AAGGCGTCT
>HW579923.1 JP 2014511361-A/7: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
GGTGCATCC
>HW579909.1 JP 2014511173-A/12: Biologically active nucleotide molecules for selectively killing off cells, use thereof, and application kit
GTCCTTCAA
>HW577813.1 JP 2014113155-A/37: Novel antibodies inhibiting c-Met dimerization, and uses thereof
ACCACATCC
>HW577792.1 JP 2014113155-A/16: Novel antibodies inhibiting c-Met dimerization, and uses thereof
GCTGCAACA
>HW577787.1 JP 2014113155-A/11: Novel antibodies inhibiting c-Met dimerization, and uses thereof
CGTGCATCC
>HW577773.1 JP 2014113154-A/37: Novel antibodies inhibiting c-Met dimerization, and uses thereof
ACCACATCC
>HW577752.1 JP 2014113154-A/16: Novel antibodies inhibiting c-Met dimerization, and uses thereof
GCTGCAACA
>HW577747.1 JP 2014113154-A/11: Novel antibodies inhibiting c-Met dimerization, and uses thereof
CGTGCATCC
>HW577733.1 JP 2014113153-A/37: Novel antibodies inhibiting c-Met dimerization, and uses thereof
ACCACATCC
>HW577712.1 JP 2014113153-A/16: Novel antibodies inhibiting c-Met dimerization, and uses thereof
GCTGCAACA
>HW577707.1 JP 2014113153-A/11: Novel antibodies inhibiting c-Met dimerization, and uses thereof
CGTGCATCC
>HW576677.1 JP 2014103948-A/3: A method for specifically amplifying a target DNA
ACAAGCCCG
>HW576676.1 JP 2014103948-A/2: A method for specifically amplifying a target DNA
CAGACAAGC
>JC736335.1 Sequence 51 from Patent EP2708600
GGGCCCGGG
>JC741864.1 Sequence 45 from Patent WO2014078306
AAGATTTCT
>JC741848.1 Sequence 29 from Patent WO2014078306
AAGATTTCT
>JC741832.1 Sequence 13 from Patent WO2014078306
AAGATTTCT
>JC741992.1 Sequence 173 from Patent WO2014078306
AAGATTTCT
>JC741976.1 Sequence 157 from Patent WO2014078306
AAGATTTCT
>JC741960.1 Sequence 141 from Patent WO2014078306
AAGATTTCT
>JC741944.1 Sequence 125 from Patent WO2014078306
AAGATTTCT
>JC741928.1 Sequence 109 from Patent WO2014078306
AAGATTTCT
>JC741912.1 Sequence 93 from Patent WO2014078306
AAGATTTCT
>JC741896.1 Sequence 77 from Patent WO2014078306
AAGATTTCT
>JC741880.1 Sequence 61 from Patent WO2014078306
AAGATTTCT
>JC558868.1 Sequence 408 from Patent WO2014031712
GCTGCATCC
>JC558852.1 Sequence 392 from Patent WO2014031712
GCTGCATCC
>JC558825.1 Sequence 365 from Patent WO2014031712
GCTGCATCC
>JC558809.1 Sequence 349 from Patent WO2014031712
ACTACATCC
>JC558793.1 Sequence 333 from Patent WO2014031712
AAGGCGTCT
>JC558777.1 Sequence 317 from Patent WO2014031712
GCTGCATCC
>JC558761.1 Sequence 301 from Patent WO2014031712
GGTGCATCC
>JC558745.1 Sequence 285 from Patent WO2014031712
GCTGCATCC
>JC558729.1 Sequence 269 from Patent WO2014031712
GCTGCATCC
>JC558713.1 Sequence 253 from Patent WO2014031712
TCTGCATCC
>JC558697.1 Sequence 237 from Patent WO2014031712
GCTGCATCC
>JC558681.1 Sequence 221 from Patent WO2014031712
GCTGCATCC
>JC558665.1 Sequence 205 from Patent WO2014031712
GCTGCATCC
>JC558649.1 Sequence 189 from Patent WO2014031712
GCTGCATCC
>JC558633.1 Sequence 173 from Patent WO2014031712
ACTGCATCC
>JC558617.1 Sequence 157 from Patent WO2014031712
GCTGCATCC
>JC558601.1 Sequence 141 from Patent WO2014031712
GCTGCATCC
>JC558585.1 Sequence 125 from Patent WO2014031712
GCTGCATCC
>JC558569.1 Sequence 109 from Patent WO2014031712
GCTGCATCC
>JC558553.1 Sequence 93 from Patent WO2014031712
TGGGCATCT
>JC558537.1 Sequence 77 from Patent WO2014031712
AGTGCATCC
>JC558521.1 Sequence 61 from Patent WO2014031712
GCTGCATCC
>JC558505.1 Sequence 45 from Patent WO2014031712
GCTGCATCC
>JC558489.1 Sequence 29 from Patent WO2014031712
TGGGCATCT
>JC558473.1 Sequence 13 from Patent WO2014031712
AAGGCGTCT
>JC570546.1 Sequence 14 from Patent WO2014128185
GGCATTAGC
>JC570540.1 Sequence 8 from Patent WO2014128185
TATACCTCC
>JC569645.1 Sequence 8 from Patent WO2014072534
TGATGATAA
>JC569644.1 Sequence 7 from Patent WO2014072534
GCCGCCATG
>JC580108.1 Sequence 26 from Patent WO2014030066
GAGCTGGTG
>JC584169.1 Sequence 33 from Patent EP2736538
TGGAAGCTA
>JC584165.1 Sequence 29 from Patent EP2736538
CCAGCTGGA
>JC579871.1 Sequence 20 from Patent WO2014130945
ATCGTGCTA
>JC579870.1 Sequence 19 from Patent WO2014130945
ATCGTGCTA
>JC579867.1 Sequence 16 from Patent WO2014130945
ATCGTGCTA
>JC579866.1 Sequence 15 from Patent WO2014130945
ATCGTGCTA
>JC579863.1 Sequence 12 from Patent WO2014130945
ATCTTGCTA
>JC579862.1 Sequence 11 from Patent WO2014130945
ATCTTGCTA
>JC601813.1 Sequence 79 from Patent WO2014068139
TGGGCTTCC
>JC601785.1 Sequence 51 from Patent WO2014068139
TGGGCATCC
>JC601750.1 Sequence 16 from Patent WO2014068139
TGGGCATCC
>JC614082.1 Sequence 81 from Patent WO2014059260
TGTGCTCTG
>JC614080.1 Sequence 79 from Patent WO2014059260
GTGTAGACT
>JC614077.1 Sequence 76 from Patent WO2014059260
CAGAKGAGG
>JC614076.1 Sequence 75 from Patent WO2014059260
AGGAGGATG
>JC614072.1 Sequence 71 from Patent WO2014059260
CTGTAGTTC
>JC609252.1 Sequence 78 from Patent WO2014131712
TTCGACTAC
>JC607197.1 Sequence 344 from Patent WO2014131711
TTCGACTAC
>JC607091.1 Sequence 238 from Patent WO2014131711
TTCGACTAC
>JC606927.1 Sequence 74 from Patent WO2014131711
TTTGACTAC
>JC578453.1 Sequence 4 from Patent WO2014074620
ACGCGTATG
>JC578452.1 Sequence 3 from Patent WO2014074620
GGCCGGCCA
>JC604433.1 Sequence 80 from Patent EP2694686
CACNNNGTG
>JC604399.1 Sequence 46 from Patent EP2694686
GACCGGAGT
>JC604384.1 Sequence 31 from Patent EP2694686
GACCGGAGT
>JC604382.1 Sequence 29 from Patent EP2694686
GACCGGAGT
>JC604380.1 Sequence 27 from Patent EP2694686
GACCGGAGT
>JC538211.1 Sequence 4 from Patent EP2700719
TTGCCCAGG
>JC503186.1 Sequence 28 from Patent WO2014108829
GCTGCATCC
>JC486309.1 Sequence 8 from Patent WO2014026770
MAGGTRAGT
>JC505458.1 Sequence 2 from Patent EP2748357
GCAGCACCC
>JC518813.1 Sequence 374 from Patent EP2742951
AGAGTGACG
>JC529953.1 Sequence 138 from Patent EP2699078
GTGAGTCAT
>JC509639.1 Sequence 253 from Patent WO2014039461
GATGCATCC
>JC509615.1 Sequence 229 from Patent WO2014039461
GATGCATCC
>JC509591.1 Sequence 205 from Patent WO2014039461
GTTGCATCC
>JC509567.1 Sequence 181 from Patent WO2014039461
GCTGCATCC
>JC509543.1 Sequence 157 from Patent WO2014039461
TTGGGTTCT
>JC509519.1 Sequence 133 from Patent WO2014039461
AGTGCCTCC
>JC509495.1 Sequence 109 from Patent WO2014039461
GCTGCATCC
>JC509471.1 Sequence 85 from Patent WO2014039461
TTGGGTTCT
>JC509447.1 Sequence 61 from Patent WO2014039461
GCTGTATCC
>JC509423.1 Sequence 37 from Patent WO2014039461
GCTGCATCC
>JC509399.1 Sequence 13 from Patent WO2014039461
GCTGCATCC
>JC477199.1 Sequence 36 from Patent EP2739737
TNTCTGNTA
>JC477186.1 Sequence 23 from Patent EP2739737
KTTGRTTCY
>JC476332.1 Sequence 29 from Patent WO2014027118
TGTATAATA
>JC490926.1 Sequence 280 from Patent EP2709662
GGGGACATC
>JC490906.1 Sequence 260 from Patent EP2709662
GGGGACATC
>JC490896.1 Sequence 250 from Patent EP2709662
GGCGACATC
>JC490886.1 Sequence 240 from Patent EP2709662
GGGGACATC
>JC490876.1 Sequence 230 from Patent EP2709662
GGGGACATC
>JC490866.1 Sequence 220 from Patent EP2709662
GGGGACATC
>JC490846.1 Sequence 200 from Patent EP2709662
GGGGACATC
>JC490836.1 Sequence 190 from Patent EP2709662
GGGGACATC
>JC490826.1 Sequence 180 from Patent EP2709662
GGGGACATC
>JC490816.1 Sequence 170 from Patent EP2709662
GGGGACATC
>JC490806.1 Sequence 160 from Patent EP2709662
GGGGACATC
>JC490796.1 Sequence 150 from Patent EP2709662
GGGGACATC
>JC490435.1 Sequence 382 from Patent EP2769992
GCTACATCC
>JC490419.1 Sequence 366 from Patent EP2769992
AAGGCGTCT
>JC490403.1 Sequence 350 from Patent EP2769992
GCTACATCC
>JC490387.1 Sequence 334 from Patent EP2769992
GCTACATCC
>JC490856.1 Sequence 210 from Patent EP2709662
GGGGACATC
>JC508914.1 Sequence 67 from Patent WO2014083047
AGTTTATTC
>JC490371.1 Sequence 318 from Patent EP2769992
AAGGCGTCT
>JC490355.1 Sequence 302 from Patent EP2769992
GCTACATCC
>JC490339.1 Sequence 286 from Patent EP2769992
GCTACATCC
>JC490323.1 Sequence 270 from Patent EP2769992
GCTACATCC
>JC490307.1 Sequence 254 from Patent EP2769992
GCTGCATCC
>JC490291.1 Sequence 238 from Patent EP2769992
GCTTCATCC
>JC490275.1 Sequence 222 from Patent EP2769992
GCTGCATCC
>JC490259.1 Sequence 206 from Patent EP2769992
GGTGCATCC
>JC490243.1 Sequence 190 from Patent EP2769992
ACTGCTTCC
>JC490227.1 Sequence 174 from Patent EP2769992
GGTGCATCT
>JC490211.1 Sequence 158 from Patent EP2769992
GCTGCATCC
>JC490195.1 Sequence 142 from Patent EP2769992
GCTGCATCC
>JC490179.1 Sequence 126 from Patent EP2769992
GCTGCATCC
>JC490163.1 Sequence 110 from Patent EP2769992
GCTGCATCC
>JC490147.1 Sequence 94 from Patent EP2769992
GGTGCATCC
>JC490131.1 Sequence 78 from Patent EP2769992
GCTGCATCC
>JC490115.1 Sequence 62 from Patent EP2769992
GTTGCATCC
>JC490099.1 Sequence 46 from Patent EP2769992
GCTGCATCC
>JC490083.1 Sequence 30 from Patent EP2769992
GCTGCATCC
>JC490067.1 Sequence 14 from Patent EP2769992
GCTGCATCC
>JC472321.1 Sequence 42 from Patent EP2250184
GGGGCGGGG
>JC472320.1 Sequence 41 from Patent EP2250184
GCGTGGGCG
>JC518653.1 Sequence 214 from Patent EP2742951
GAGTGAGGG
>JC518652.1 Sequence 213 from Patent EP2742951
GAGTGAAGG
>JC518651.1 Sequence 212 from Patent EP2742951
GAGTGATGG
>JC518498.1 Sequence 59 from Patent EP2742951
CCACCATGG
>JC493881.1 Sequence 280 from Patent EP2710039
GGGGACATC
>JC493861.1 Sequence 260 from Patent EP2710039
GGGGACATC
>JC493851.1 Sequence 250 from Patent EP2710039
GGCGACATC
>JC493841.1 Sequence 240 from Patent EP2710039
GGGGACATC
>JC493831.1 Sequence 230 from Patent EP2710039
GGGGACATC
>JC493821.1 Sequence 220 from Patent EP2710039
GGGGACATC
>JC493811.1 Sequence 210 from Patent EP2710039
GGGGACATC
>JC493801.1 Sequence 200 from Patent EP2710039
GGGGACATC
>JC493791.1 Sequence 190 from Patent EP2710039
GGGGACATC
>JC493781.1 Sequence 180 from Patent EP2710039
GGGGACATC
>JC493771.1 Sequence 170 from Patent EP2710039
GGGGACATC
>JC493761.1 Sequence 160 from Patent EP2710039
GGGGACATC
>JC493751.1 Sequence 150 from Patent EP2710039
GGGGACATC
>HW529928.1 JP 2014087349-A/7: HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USES THEREOF
AAGGTTTCT
>HW529413.1 JP 2014087337-A/186: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GGCAACAAC
>HW529400.1 JP 2014087337-A/173: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GATGCATCC
>HW529390.1 JP 2014087337-A/163: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
AAGAATAAT
>HW529371.1 JP 2014087337-A/144: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GGTAACAAC
>HW529363.1 JP 2014087337-A/136: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
ACTACATCC
>HW529355.1 JP 2014087337-A/128: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GACGTCACT
>HW529340.1 JP 2014087337-A/113: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GCTGCATCC
>HW529326.1 JP 2014087337-A/99: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
CAAGATACG
>HW529304.1 JP 2014087337-A/77: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GGTGCATCC
>HW529296.1 JP 2014087337-A/69: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GATGTCGAT
>HW529288.1 JP 2014087337-A/61: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
CAAGATTCC
>HW529280.1 JP 2014087337-A/53: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GAGGTTTCT
>HW529272.1 JP 2014087337-A/45: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GATGGCAGT
>HW529264.1 JP 2014087337-A/37: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GATGTCAGT
>HW529256.1 JP 2014087337-A/29: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GACAATGAT
>HW529248.1 JP 2014087337-A/21: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
AAAGACACT
>HW529240.1 JP 2014087337-A/13: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GATGATAGC
>HW529232.1 JP 2014087337-A/5: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
AAGGCGTCT
>HW534242.1 JP 2014509196-A/33: OPTICALLY CONTROLLED GENE EXPRESSION SYSTEM
CTGTNACAG
>HW533152.1 JP 2014508142-A/367: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TTGGGTTTT
>HW533140.1 JP 2014508142-A/355: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
GGTGCATCC
>HW533128.1 JP 2014508142-A/343: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
AAGGTTTCT
>HW533116.1 JP 2014508142-A/331: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
AAGGTTTCT
>HW533104.1 JP 2014508142-A/319: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
AAGGTTTCT
>HW533092.1 JP 2014508142-A/307: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
GGTGCATCC
>HW533080.1 JP 2014508142-A/295: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
GATGCATCC
>HW533068.1 JP 2014508142-A/283: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
GGTGCATCC
>HW533056.1 JP 2014508142-A/271: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
GGTGCATCC
>HW533044.1 JP 2014508142-A/259: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TTGGGTTTT
>HW533032.1 JP 2014508142-A/247: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
GGTGCATCC
>HW533020.1 JP 2014508142-A/235: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
AAGGCGTCT
>HW533008.1 JP 2014508142-A/223: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
AAGGCGTCT
>HW532996.1 JP 2014508142-A/211: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
AAGGCGTCT
>HW532984.1 JP 2014508142-A/199: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
AAGGCGTCT
>HW532972.1 JP 2014508142-A/187: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
GGTGCATCC
>HW532960.1 JP 2014508142-A/175: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
AAGGCGTCT
>HW532948.1 JP 2014508142-A/163: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
AAGGTTTCT
>HW532936.1 JP 2014508142-A/151: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TTGGGTTCT
>HW532924.1 JP 2014508142-A/139: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TTGGGTTTT
>HW532912.1 JP 2014508142-A/127: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TTGGGTTTT
>HW532900.1 JP 2014508142-A/115: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TTGGGTTCT
>HW532888.1 JP 2014508142-A/103: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TTGGGTTCT
>HW532876.1 JP 2014508142-A/91: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TTGGGTTCT
>HW532864.1 JP 2014508142-A/79: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
AAGGTTTCT
>HW532852.1 JP 2014508142-A/67: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
GCTGCATCC
>HW532840.1 JP 2014508142-A/55: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
GCTGCATCC
>HW532828.1 JP 2014508142-A/43: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TGGGCATCT
>HW532816.1 JP 2014508142-A/31: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
TGGGCCTCT
>HW532804.1 JP 2014508142-A/19: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
AAGGCGTCT
>HW532792.1 JP 2014508142-A/7: PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
GGTGCATCC
>HW531646.1 WO 2014080983-A/19: The 3-way junction oligonucleotides modified by sugar and use thereof
ANCNGNAAA
>HW531633.1 WO 2014080983-A/6: The 3-way junction oligonucleotides modified by sugar and use thereof
CAGCGTGAT
>HW531632.1 WO 2014080983-A/5: The 3-way junction oligonucleotides modified by sugar and use thereof
TACCTGCGA
>HW531631.1 WO 2014080983-A/4: The 3-way junction oligonucleotides modified by sugar and use thereof
TCGCAGGTA
>HW531630.1 WO 2014080983-A/3: The 3-way junction oligonucleotides modified by sugar and use thereof
TCGCAAGTC
>HW531629.1 WO 2014080983-A/2: The 3-way junction oligonucleotides modified by sugar and use thereof
GACTTGCGA
>HW531628.1 WO 2014080983-A/1: The 3-way junction oligonucleotides modified by sugar and use thereof
ATCACGCTG
>HW531622.1 WO 2014077409-A/2: A reducing agent for side effect of Sunitinib
TTCAAGAGA
>HW530935.1 WO 2014080703-A/17: Modified proteins of galectin-9
CCGATGCCT
>BD343961.1 WO 2003060516-A/4: Screening Method
GCGGGGGCG
>BD343960.1 WO 2003060516-A/3: Screening Method
GCGTGGGCG
>BD354247.1 WO 2003068957-A/14: Method of screening for INK4 family gene expression regulator and pl9 promoter
GGATGGGTA
>BD354246.1 WO 2003068957-A/13: Method of screening for INK4 family gene expression regulator and pl9 promoter
GGGCGGGGG
>BD354245.1 WO 2003068957-A/12: Method of screening for INK4 family gene expression regulator and pl9 promoter
GGGTTTTGG
>BD354244.1 WO 2003068957-A/11: Method of screening for INK4 family gene expression regulator and pl9 promoter
GGGGCGGGG
>BD290481.1 WO 2003018803-A/5: Established adipocyte precursor, method of constructing the same and method of using the same
TTCNNNGAA
>BD290456.1 WO 2003022039-A/2: Impartment of virus-resistance by using plant protein binding to plant virus transfer protein
AGGTGCTGG
>BD373754.1 WO 2003072772-A/2: Stimuli-responsive DNA assembly
AAGGAGAAA
>BD295888.1 WO 2003033707-A/2: Enzyme gene participating in the synthesis of polyester and process for producing polyester using
GCTAAAATT
>BD295887.1 WO 2003033707-A/1: Enzyme gene participating in the synthesis of polyester and process for producing polyester using
TCTAAATTG
>BD392974.1 WO 2003089466-A/80: A novel protein and DNA encoding it
AACGGGCCC
>BD392970.1 WO 2003089466-A/76: A novel protein and DNA encoding it
TATTTGCAT
>BD392961.1 WO 2003089466-A/67: A novel protein and DNA encoding it
GTATATATA
>BD392954.1 WO 2003089466-A/60: A novel protein and DNA encoding it
GGGGTCACC
>BD392937.1 WO 2003089466-A/43: A novel protein and DNA encoding it
TGATGACGT
>BD182554.1 WO 2002092829-A/20: A method for producing a peptide
GGCCCGCGC
>BD174022.1 WO 2002064159-A/8: Remedy for tumor in hematopoietic organ
TTCCCAGAA
>BD174020.1 WO 2002064159-A/6: Remedy for tumor in hematopoietic organ
TTNCNNNAA
>BD170258.1 WO 2002036772-A/20: Novel disease-associated gene and use thereof
GCAGCCGCG
>BD170255.1 WO 2002036772-A/17: Novel disease-associated gene and use thereof
GAGGCCTAC
>BD170200.1 WO 2002036762-A/7: Process for producing peptide
GGCCCGCGC
>BD103717.1 WO 2001085733-A/10: Method of synthesis for interstrund-crosslinking agents
TGGCTGCCA
>BD096458.1 WO 2001065249-A/27: Device for correcting frame shift errors of cDNA sequence and method therefor and computer-readable medium that embodies program for carrying out said method
GNNATGGAG
>BD096457.1 WO 2001065249-A/26: Device for correcting frame shift errors of cDNA sequence and method therefor and computer-readable medium that embodies program for carrying out said method
TNNATGCTA
>BD094556.1 WO 2001032899-A/5: Method of transferring gene
GACGATATC
>BD094555.1 WO 2001032899-A/4: Method of transferring gene
GTCGATATC
>BD091511.1 WO 2001032860-A/12: Transcriptional activator
CGAGAGTAA
>BD012767.1 WO 2001013940-A/8: Agent for enhancing expression of HM1.24 antigen
TTCCCAGAA
>BD012765.1 WO 2001013940-A/6: Agent for enhancing expression of HM1.24 antigen
TTNCNNNAA
>HW521594.1 JP 2014057597-A/590: Targeted Whole Genome Amplification Method for Identification of Pathogens
TWACGATTG
>HW521583.1 JP 2014057597-A/579: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTCTTTACG
>HW521579.1 JP 2014057597-A/575: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTCAATACG
>HW521575.1 JP 2014057597-A/571: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTAACGGAA
>HW521546.1 JP 2014057597-A/542: Targeted Whole Genome Amplification Method for Identification of Pathogens
TCATTACGA
>HW521539.1 JP 2014057597-A/535: Targeted Whole Genome Amplification Method for Identification of Pathogens
TATGTAACG
>HW521535.1 JP 2014057597-A/531: Targeted Whole Genome Amplification Method for Identification of Pathogens
TAGAAGCGA
>HW521522.1 JP 2014057597-A/518: Targeted Whole Genome Amplification Method for Identification of Pathogens
TAACGGAAA
>HW521517.1 JP 2014057597-A/513: Targeted Whole Genome Amplification Method for Identification of Pathogens
TAAAGCGTT
>HW521478.1 JP 2014057597-A/474: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGTTATGAA
>HW521477.1 JP 2014057597-A/473: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGTTAATTG
>HW521474.1 JP 2014057597-A/470: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGGTTTAAT
>HW521468.1 JP 2014057597-A/464: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGATTGAAG
>HW521460.1 JP 2014057597-A/456: Targeted Whole Genome Amplification Method for Identification of Pathogens
CATATAACG
>HW521453.1 JP 2014057597-A/449: Targeted Whole Genome Amplification Method for Identification of Pathogens
CAATCGTAT
>HW521450.1 JP 2014057597-A/446: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTGTCGTT
>HW521443.1 JP 2014057597-A/439: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTACGTTA
>HW521438.1 JP 2014057597-A/434: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATGTAACGA
>HW521426.1 JP 2014057597-A/422: Targeted Whole Genome Amplification Method for Identification of Pathogens
ACGAAGCAA
>HW521424.1 JP 2014057597-A/420: Targeted Whole Genome Amplification Method for Identification of Pathogens
ACAACGATT
>HW521416.1 JP 2014057597-A/412: Targeted Whole Genome Amplification Method for Identification of Pathogens
AACGAATAA
>HW521401.1 JP 2014057597-A/397: Targeted Whole Genome Amplification Method for Identification of Pathogens
TGATGCGAA
>HW521400.1 JP 2014057597-A/396: Targeted Whole Genome Amplification Method for Identification of Pathogens
TGACGATAA
>HW521393.1 JP 2014057597-A/389: Targeted Whole Genome Amplification Method for Identification of Pathogens
TATCATCGA
>HW521389.1 JP 2014057597-A/385: Targeted Whole Genome Amplification Method for Identification of Pathogens
TAACGAAGA
>HW521385.1 JP 2014057597-A/381: Targeted Whole Genome Amplification Method for Identification of Pathogens
STTCCGCAA
>HW521383.1 JP 2014057597-A/379: Targeted Whole Genome Amplification Method for Identification of Pathogens
GTTATCGCA
>HW521382.1 JP 2014057597-A/378: Targeted Whole Genome Amplification Method for Identification of Pathogens
GTGACGAAA
>HW521380.1 JP 2014057597-A/376: Targeted Whole Genome Amplification Method for Identification of Pathogens
GTAAAACGA
>HW521378.1 JP 2014057597-A/374: Targeted Whole Genome Amplification Method for Identification of Pathogens
GGTTGAAAC
>HW521377.1 JP 2014057597-A/373: Targeted Whole Genome Amplification Method for Identification of Pathogens
GGCGGTAAA
>HW521370.1 JP 2014057597-A/366: Targeted Whole Genome Amplification Method for Identification of Pathogens
GCKGATTTA
>HW521369.1 JP 2014057597-A/365: Targeted Whole Genome Amplification Method for Identification of Pathogens
GCGTTTTGA
>HW521368.1 JP 2014057597-A/364: Targeted Whole Genome Amplification Method for Identification of Pathogens
GCGTTTAAA
>HW521367.1 JP 2014057597-A/363: Targeted Whole Genome Amplification Method for Identification of Pathogens
GCGTTAATA
>HW521366.1 JP 2014057597-A/362: Targeted Whole Genome Amplification Method for Identification of Pathogens
GCGGTATTA
>HW521365.1 JP 2014057597-A/361: Targeted Whole Genome Amplification Method for Identification of Pathogens
GCGATTTTA
>HW521364.1 JP 2014057597-A/360: Targeted Whole Genome Amplification Method for Identification of Pathogens
GCGAAAGAA
>HW521351.1 JP 2014057597-A/347: Targeted Whole Genome Amplification Method for Identification of Pathogens
GAAACGTTA
>HW521350.1 JP 2014057597-A/346: Targeted Whole Genome Amplification Method for Identification of Pathogens
GAAACGATC
>HW521337.1 JP 2014057597-A/333: Targeted Whole Genome Amplification Method for Identification of Pathogens
CTTCACGAA
>HW521332.1 JP 2014057597-A/328: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGWTAATAA
>HW521331.1 JP 2014057597-A/327: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGTTTATTA
>HW521330.1 JP 2014057597-A/326: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGTGATCAA
>HW521329.1 JP 2014057597-A/325: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGTAAATAC
>HW521328.1 JP 2014057597-A/324: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGTAAAGAA
>HW521327.1 JP 2014057597-A/323: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGGTATTGA
>HW521325.1 JP 2014057597-A/321: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGCTTTATA
>HW521324.1 JP 2014057597-A/320: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGCTAAATA
>HW521323.1 JP 2014057597-A/319: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGCCTCTTC
>HW521321.1 JP 2014057597-A/317: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGATTAAAG
>HW521320.1 JP 2014057597-A/316: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGATAATGA
>HW521319.1 JP 2014057597-A/315: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCGGTAATA
>HW521318.1 JP 2014057597-A/314: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCGCTTCA
>HW521317.1 JP 2014057597-A/313: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCAATCGGC
>HW521316.1 JP 2014057597-A/312: Targeted Whole Genome Amplification Method for Identification of Pathogens
CATCTTCCG
>HW521314.1 JP 2014057597-A/310: Targeted Whole Genome Amplification Method for Identification of Pathogens
CATCGCTTC
>HW521312.1 JP 2014057597-A/308: Targeted Whole Genome Amplification Method for Identification of Pathogens
CAGCGATTA
>HW521310.1 JP 2014057597-A/306: Targeted Whole Genome Amplification Method for Identification of Pathogens
CAATCGYTA
>HW521309.1 JP 2014057597-A/305: Targeted Whole Genome Amplification Method for Identification of Pathogens
CAATCGGTG
>HW521298.1 JP 2014057597-A/294: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTCATCGG
>HW521297.1 JP 2014057597-A/293: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTATCGTA
>HW521292.1 JP 2014057597-A/288: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTACAACG
>HW521291.1 JP 2014057597-A/287: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTAATACC
>HW521289.1 JP 2014057597-A/285: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATCTTCACG
>HW521288.1 JP 2014057597-A/284: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATCGTTAAA
>HW521287.1 JP 2014057597-A/283: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATCGTGAAG
>HW521286.1 JP 2014057597-A/282: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATCGTAATA
>HW521284.1 JP 2014057597-A/280: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATCGCACCG
>HW521283.1 JP 2014057597-A/279: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATCATGCCG
>HW521282.1 JP 2014057597-A/278: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATCAGCTAC
>HW521277.1 JP 2014057597-A/273: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATATCGTAA
>HW521276.1 JP 2014057597-A/272: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATAGCGATA
>HW521274.1 JP 2014057597-A/270: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATACGATAA
>HW521270.1 JP 2014057597-A/266: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATAACGAAG
>HW521265.1 JP 2014057597-A/261: Targeted Whole Genome Amplification Method for Identification of Pathogens
AGTTGATCG
>HW521264.1 JP 2014057597-A/260: Targeted Whole Genome Amplification Method for Identification of Pathogens
AGCTTGTTG
>HW521263.1 JP 2014057597-A/259: Targeted Whole Genome Amplification Method for Identification of Pathogens
AGCGCAATC
>HW521261.1 JP 2014057597-A/257: Targeted Whole Genome Amplification Method for Identification of Pathogens
AGCAATCGC
>HW521259.1 JP 2014057597-A/255: Targeted Whole Genome Amplification Method for Identification of Pathogens
AGATAAACG
>HW521255.1 JP 2014057597-A/251: Targeted Whole Genome Amplification Method for Identification of Pathogens
ACGRTAAAA
>HW521254.1 JP 2014057597-A/250: Targeted Whole Genome Amplification Method for Identification of Pathogens
ACGGTTTTA
>HW521253.1 JP 2014057597-A/249: Targeted Whole Genome Amplification Method for Identification of Pathogens
ACGGTTATC
>HW521252.1 JP 2014057597-A/248: Targeted Whole Genome Amplification Method for Identification of Pathogens
ACGATGTTG
>HW521251.1 JP 2014057597-A/247: Targeted Whole Genome Amplification Method for Identification of Pathogens
ACGAATGAT
>HW521250.1 JP 2014057597-A/246: Targeted Whole Genome Amplification Method for Identification of Pathogens
ACCGCATCA
>HW521249.1 JP 2014057597-A/245: Targeted Whole Genome Amplification Method for Identification of Pathogens
ACCGATAAT
>HW521244.1 JP 2014057597-A/240: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATCGTTGC
>HW521243.1 JP 2014057597-A/239: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATCGTTAA
>HW521242.1 JP 2014057597-A/238: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATCGTATC
>HW521241.1 JP 2014057597-A/237: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATCGCCCA
>HW521240.1 JP 2014057597-A/236: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATCCAGCG
>HW521237.1 JP 2014057597-A/233: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATAACGCA
>HW521236.1 JP 2014057597-A/232: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAGTAACGA
>HW521235.1 JP 2014057597-A/231: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAGCGGTTC
>HW521234.1 JP 2014057597-A/230: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAGCGATCA
>HW521229.1 JP 2014057597-A/225: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAGAAACGC
>HW521227.1 JP 2014057597-A/223: Targeted Whole Genome Amplification Method for Identification of Pathogens
AACGTGAAC
>HW521226.1 JP 2014057597-A/222: Targeted Whole Genome Amplification Method for Identification of Pathogens
AACGCTTCW
>HW521225.1 JP 2014057597-A/221: Targeted Whole Genome Amplification Method for Identification of Pathogens
AACGATATT
>HW521223.1 JP 2014057597-A/219: Targeted Whole Genome Amplification Method for Identification of Pathogens
AACCGCCTT
>HW521222.1 JP 2014057597-A/218: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAATTAGCG
>HW521220.1 JP 2014057597-A/216: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAATACGCT
>HW521216.1 JP 2014057597-A/212: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAGCCGAT
>HW521212.1 JP 2014057597-A/208: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAACCGTTA
>HW521211.1 JP 2014057597-A/207: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAACCGTAT
>HW521210.1 JP 2014057597-A/206: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAACCGCCA
>HW521209.1 JP 2014057597-A/205: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAGGCGG
>HW521187.1 JP 2014057597-A/183: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTTTTTTT
>HW521186.1 JP 2014057597-A/182: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATTTTTTT
>HW521185.1 JP 2014057597-A/181: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAATTTTTT
>HW521184.1 JP 2014057597-A/180: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAATTTTT
>HW521183.1 JP 2014057597-A/179: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAATTTT
>HW521182.1 JP 2014057597-A/178: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAATTT
>HW521181.1 JP 2014057597-A/177: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAAATT
>HW521180.1 JP 2014057597-A/176: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAAAAT
>HW521107.1 JP 2014057597-A/103: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTTTT
>HW521106.1 JP 2014057597-A/102: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTTTC
>HW521105.1 JP 2014057597-A/101: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTTCC
>HW521104.1 JP 2014057597-A/100: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTCCC
>HW521103.1 JP 2014057597-A/99: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTCCCC
>HW521102.1 JP 2014057597-A/98: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTCCCCC
>HW521101.1 JP 2014057597-A/97: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTCCCCCC
>HW521100.1 JP 2014057597-A/96: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTCCCCCCC
>HW521099.1 JP 2014057597-A/95: Targeted Whole Genome Amplification Method for Identification of Pathogens
TCCCCCCCC
>HW521098.1 JP 2014057597-A/94: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGGGGGGGG
>HW521097.1 JP 2014057597-A/93: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCGGGGGGG
>HW521096.1 JP 2014057597-A/92: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCGGGGGG
>HW521095.1 JP 2014057597-A/91: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCGGGGG
>HW521094.1 JP 2014057597-A/90: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCGGGG
>HW521093.1 JP 2014057597-A/89: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCGGG
>HW521092.1 JP 2014057597-A/88: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCCGG
>HW521091.1 JP 2014057597-A/87: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCCCG
>HW521090.1 JP 2014057597-A/86: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAAAAA
>HW521024.1 JP 2014057597-A/20: Targeted Whole Genome Amplification Method for Identification of Pathogens
GGGGGGGGG
>HW521023.1 JP 2014057597-A/19: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCCCC
>HW527655.1 JP 2014506888-A/2: Method for treating breast cancer by decreasing the expression of adenine nucleotide translocator 2 mRNA
TTCAAGAGA
>DI344803.1 KR 1020130008017-A/79: METHODS OF TREATING AUTOIMMUNE DISEASES WITH DLL4 ANTAGONISTS
GGTACATCC
>DI344796.1 KR 1020130008017-A/63: METHODS OF TREATING AUTOIMMUNE DISEASES WITH DLL4 ANTAGONISTS
GGTGCGTCC
>DI344782.1 KR 1020130008017-A/31: METHODS OF TREATING AUTOIMMUNE DISEASES WITH DLL4 ANTAGONISTS
GATGCATCC
>DI344774.1 KR 1020130008017-A/15: METHODS OF TREATING AUTOIMMUNE DISEASES WITH DLL4 ANTAGONISTS
TTGGTTTCT
>DI338792.1 KR 1020130090492-A/10: Novel Brassica juncea Czern ''MISO'' useful hybridizing rape
ACCTCAGCT
>DI347871.1 KR 1020130012132-A/75: Humanized anti-CXCR4 antibodies for the treatment of cancer
TGGGCATCC
>DI347857.1 KR 1020130012132-A/61: Humanized anti-CXCR4 antibodies for the treatment of cancer
TGGGCCTCT
>DI347832.1 KR 1020130012132-A/36: Humanized anti-CXCR4 antibodies for the treatment of cancer
TGGGCCAGC
>DI339822.1 KR 1020130105006-A/19: Method for analyzing regulatory sequence of gene expression in microgravity
TCCATGCAT
>DI339814.1 KR 1020130105006-A/11: Method for analyzing regulatory sequence of gene expression in microgravity
TCTCTCTCT
>DI351083.1 KR 1020130014620-A/94: CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity
TGNCGTTTT
>DI351038.1 KR 1020130109981-A/371: ANTIBODIES TO HUMAN GDF8
ACTACATCC
>DI351027.1 KR 1020130109981-A/325: ANTIBODIES TO HUMAN GDF8
AAGATTTCT
>DI343867.1 KR 1020120133376-A/61: STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIES
GTTGCATCC
>DI343859.1 KR 1020120133376-A/45: STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIES
GCTGCATCC
>DI350982.1 KR 1020130109981-A/189: ANTIBODIES TO HUMAN GDF8
GCTACATCC
>DI350962.1 KR 1020130109981-A/141: ANTIBODIES TO HUMAN GDF8
GTTGCATCC
>DI350955.1 KR 1020130109981-A/125: ANTIBODIES TO HUMAN GDF8
CGGATGTCC
>DI350918.1 KR 1020130109981-A/13: ANTIBODIES TO HUMAN GDF8
GGTGTATCC
>DI351169.1 KR 1020130118227-A/53: OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
CAGGCAGGC
>DI351163.1 KR 1020130118227-A/47: OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
GCAGCAGCA
>DI351159.1 KR 1020130118227-A/43: OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
AGCAGCAGC
>DI351155.1 KR 1020130118227-A/39: OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
CAGCAGCAG
>DI357927.1 KR 1020130079486-A/15: STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES
GCTGCATTC
>DI351476.1 KR 1020130118229-A/4: METHOD OF DNA SEQUENCING BY HYBRIDISATION
ACAGCCAGC
>DI356683.1 KR 1020130100963-A/36: Novel antibody for the diagnosis and/or prognosis of cancer
GTTGCATCT
>DI356675.1 KR 1020130100963-A/28: Novel antibody for the diagnosis and/or prognosis of cancer
CAGATGTCC
>DI354390.1 KR 1020130043155-A/176: METHODS OF TREATMENT USING TLR7 AND/OR TLR9 INHIBITORS
TCTNNCNTT
>DI363349.1 KR 1020130048800-A/45: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
GATGTACCC
>DI363347.1 KR 1020130048800-A/43: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
ACAATGAGT
>DI363342.1 KR 1020130048800-A/38: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
AGAACTGGG
>DI363341.1 KR 1020130048800-A/37: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
CAAACCAGA
>DI363340.1 KR 1020130048800-A/36: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
CCGTTGGTC
>DI363339.1 KR 1020130048800-A/35: MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
GAGAGTTGG
>DI362167.1 KR 1020130093624-A/9: Composition for inducing pluripotent stem cell, and use thereof
TAAGAAAAA
>DI365483.1 KR 1020130072273-A/59: STRAIN INDEPENDENT AMPLIFICATION OF PATHOGENS AND VACCINES THERETO
CCACCATGG
>DI364410.1 KR 1020130103562-A/48: COMPOSITIONS OF A PEPTIDE TARGETING SYSTEM FOR TREATING CANCER
AAAGCGGCG
>DI364401.1 KR 1020130103562-A/36: COMPOSITIONS OF A PEPTIDE TARGETING SYSTEM FOR TREATING CANCER
CGTGGTGAC
>DI365969.1 KR 1020130094342-A/118: METHODS AND COMPOSITIONS FOR DETECTING MUTATION IN THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR GENE
GGCAGATGC
>DI365741.1 KR 1020130072273-A/374: STRAIN INDEPENDENT AMPLIFICATION OF PATHOGENS AND VACCINES THERETO
AGAGTGACG
>DI365614.1 KR 1020130072273-A/214: STRAIN INDEPENDENT AMPLIFICATION OF PATHOGENS AND VACCINES THERETO
GAGTGAGGG
>DI365613.1 KR 1020130072273-A/213: STRAIN INDEPENDENT AMPLIFICATION OF PATHOGENS AND VACCINES THERETO
GAGTGAAGG
>DI365612.1 KR 1020130072273-A/212: STRAIN INDEPENDENT AMPLIFICATION OF PATHOGENS AND VACCINES THERETO
GAGTGATGG
>DI350247.1 KR 1020130086533-A/16: Novel anti-cMet antibody
AGGGCTTCT
>DI249534.1 KR 1020130016736-A/66: Kit and method for detecting amino acid variation of Hepatatis B virus
CACGCGAGA
>DI249532.1 KR 1020130016736-A/64: Kit and method for detecting amino acid variation of Hepatatis B virus
ATATATACA
>DI248217.1 KR 1020120134547-A/13: A marker comprising anti-ATIC autoantibodies and a composition comprising antigen thereof for diagnosing liver cancer
GGGACTTAT
>GN041933.1 Sequence 9 from Patent WO2009014445
CCTGTTAAG
>HW501682.1 JP 2014039550-A/888: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGGTGCTC
>HW501681.1 JP 2014039550-A/887: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCACCTCTT
>HW501680.1 JP 2014039550-A/886: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGAAGGTC
>HW501679.1 JP 2014039550-A/885: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTTCACTT
>HW501678.1 JP 2014039550-A/884: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCTATGTC
>HW501677.1 JP 2014039550-A/883: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CATAGGCTT
>HW501676.1 JP 2014039550-A/882: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGATCTGTC
>HW501675.1 JP 2014039550-A/881: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGATCGTT
>HW501674.1 JP 2014039550-A/880: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGCCTTTTC
>HW501673.1 JP 2014039550-A/879: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AAAGGCGTT
>HW501672.1 JP 2014039550-A/878: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGGTGCTC
>HW501671.1 JP 2014039550-A/877: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCACCTGTT
>HW501670.1 JP 2014039550-A/876: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGAAGGTC
>HW501669.1 JP 2014039550-A/875: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTTCAGTT
>HW501668.1 JP 2014039550-A/874: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGTCTCTC
>HW501667.1 JP 2014039550-A/873: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGACCATT
>HW501666.1 JP 2014039550-A/872: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGAGACCTC
>HW501665.1 JP 2014039550-A/871: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCTCATT
>HW501664.1 JP 2014039550-A/870: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCTGGCTC
>HW501663.1 JP 2014039550-A/869: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCAGACTT
>HW501662.1 JP 2014039550-A/868: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGAGACCTC
>HW501661.1 JP 2014039550-A/867: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCTCCTT
>HW501660.1 JP 2014039550-A/866: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACTTGCTC
>HW501659.1 JP 2014039550-A/865: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAAGTGTT
>HW501658.1 JP 2014039550-A/864: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TAGCTCGTC
>HW501657.1 JP 2014039550-A/863: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAGCTATT
>HW501656.1 JP 2014039550-A/862: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGTCTCTC
>HW501655.1 JP 2014039550-A/861: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGACCGTT
>HW501654.1 JP 2014039550-A/860: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCTGGCTC
>HW501653.1 JP 2014039550-A/859: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCAGAGTT
>HW501652.1 JP 2014039550-A/858: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAGACCTC
>HW501651.1 JP 2014039550-A/857: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCTCGTT
>HW501650.1 JP 2014039550-A/856: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACGGATGTC
>HW501649.1 JP 2014039550-A/855: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CATCCGTTT
>HW501648.1 JP 2014039550-A/854: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGCTCTATC
>HW501647.1 JP 2014039550-A/853: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TAGAGCCTT
>HW501646.1 JP 2014039550-A/852: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGCTCGTC
>HW501645.1 JP 2014039550-A/851: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAGCTGTT
>HW501644.1 JP 2014039550-A/850: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCGCGTCTC
>HW501643.1 JP 2014039550-A/849: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GACGCGATT
>HW501642.1 JP 2014039550-A/848: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACAAGCCTC
>HW501641.1 JP 2014039550-A/847: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGCTTGTTT
>HW501640.1 JP 2014039550-A/846: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AAGGTGCTC
>HW501639.1 JP 2014039550-A/845: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCACCTTTT
>HW501638.1 JP 2014039550-A/844: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGCTCTATC
>HW501637.1 JP 2014039550-A/843: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TAGAGCGTT
>HW501636.1 JP 2014039550-A/842: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAAGAGGTC
>HW501635.1 JP 2014039550-A/841: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTCTTCTT
>HW501634.1 JP 2014039550-A/840: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGTGTGTC
>HW501633.1 JP 2014039550-A/839: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACACAGTT
>HW501632.1 JP 2014039550-A/838: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGTCTCTC
>HW501631.1 JP 2014039550-A/837: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGACCTTT
>HW501630.1 JP 2014039550-A/836: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATCTGGCTC
>HW501629.1 JP 2014039550-A/835: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCAGATTT
>HW501628.1 JP 2014039550-A/834: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGAGACCTC
>HW501627.1 JP 2014039550-A/833: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCTCTTT
>HW501626.1 JP 2014039550-A/832: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAAGAGGTC
>HW501625.1 JP 2014039550-A/831: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTCTTGTT
>HW501624.1 JP 2014039550-A/830: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGCTAATC
>HW501623.1 JP 2014039550-A/829: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTAGCGGTT
>HW501622.1 JP 2014039550-A/828: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AAGCTCGTC
>HW501621.1 JP 2014039550-A/827: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAGCTTTT
>HW501620.1 JP 2014039550-A/826: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCTGTTC
>HW501619.1 JP 2014039550-A/825: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACAGACCTT
>HW501618.1 JP 2014039550-A/824: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGCACTCTC
>HW501617.1 JP 2014039550-A/823: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGTGCCTT
>HW501616.1 JP 2014039550-A/822: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTCTGTTC
>HW501615.1 JP 2014039550-A/821: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACAGACGTT
>HW501614.1 JP 2014039550-A/820: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCAGCCTTC
>HW501613.1 JP 2014039550-A/819: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGCTGATT
>HW501612.1 JP 2014039550-A/818: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GACTAGCTC
>HW501611.1 JP 2014039550-A/817: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTAGTCTT
>HW501610.1 JP 2014039550-A/816: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGATGGTC
>HW501609.1 JP 2014039550-A/815: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCATCCATT
>HW501608.1 JP 2014039550-A/814: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGCACTCTC
>HW501607.1 JP 2014039550-A/813: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGTGCGTT
>HW501606.1 JP 2014039550-A/812: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGCCTTC
>HW501605.1 JP 2014039550-A/811: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGCTGCTT
>HW501604.1 JP 2014039550-A/810: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCTCTCCTC
>HW501603.1 JP 2014039550-A/809: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGAGAGATT
>HW501602.1 JP 2014039550-A/808: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTCTCCTC
>HW501601.1 JP 2014039550-A/807: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGAGAGCTT
>HW501600.1 JP 2014039550-A/806: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACTAGCTC
>HW501599.1 JP 2014039550-A/805: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTAGTGTT
>HW501598.1 JP 2014039550-A/804: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAGCCTTC
>HW501597.1 JP 2014039550-A/803: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGCTGGTT
>HW501596.1 JP 2014039550-A/802: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGGATTTC
>HW501595.1 JP 2014039550-A/801: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AATCCGCTT
>HW501594.1 JP 2014039550-A/800: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGCACGTC
>HW501593.1 JP 2014039550-A/799: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTGCTCTT
>HW501592.1 JP 2014039550-A/798: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCAGTGTC
>HW501591.1 JP 2014039550-A/797: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACTGACTT
>HW501590.1 JP 2014039550-A/796: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTCTCCTC
>HW501589.1 JP 2014039550-A/795: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGAGAGGTT
>HW501588.1 JP 2014039550-A/794: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAACGGCTC
>HW501587.1 JP 2014039550-A/793: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCGTTCTT
>HW501586.1 JP 2014039550-A/792: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCGAACTC
>HW501585.1 JP 2014039550-A/791: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTCGGCTT
>HW501584.1 JP 2014039550-A/790: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTACCATC
>HW501583.1 JP 2014039550-A/789: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGTAGGTT
>HW501582.1 JP 2014039550-A/788: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGCAAATC
>HW501581.1 JP 2014039550-A/787: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTTGCGGTT
>HW501580.1 JP 2014039550-A/786: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCAGTTC
>HW501579.1 JP 2014039550-A/785: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTGACCTT
>HW501578.1 JP 2014039550-A/784: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCCGTTC
>HW501577.1 JP 2014039550-A/783: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACGGCACTT
>HW501576.1 JP 2014039550-A/782: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTCAGTTC
>HW501575.1 JP 2014039550-A/781: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTGACGTT
>HW501574.1 JP 2014039550-A/780: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGCCGTTC
>HW501573.1 JP 2014039550-A/779: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACGGCAGTT
>HW501572.1 JP 2014039550-A/778: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGCGTATC
>HW501571.1 JP 2014039550-A/777: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TACGCTCTT
>HW501570.1 JP 2014039550-A/776: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGAAGGTC
>HW501569.1 JP 2014039550-A/775: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTTCCGTT
>HW501568.1 JP 2014039550-A/774: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTCACCTC
>HW501567.1 JP 2014039550-A/773: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTGAGGTT
>HW501566.1 JP 2014039550-A/772: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATGCCGTTC
>HW501565.1 JP 2014039550-A/771: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACGGCATTT
>HW501564.1 JP 2014039550-A/770: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGCCAGTC
>HW501563.1 JP 2014039550-A/769: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGGCTCTT
>HW501562.1 JP 2014039550-A/768: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGGAACTC
>HW501561.1 JP 2014039550-A/767: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTCCTCTT
>HW501560.1 JP 2014039550-A/766: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGAGTGTTC
>HW501559.1 JP 2014039550-A/765: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACACTCCTT
>HW501558.1 JP 2014039550-A/764: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGGAACTC
>HW501557.1 JP 2014039550-A/763: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTCCTGTT
>HW501556.1 JP 2014039550-A/762: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTGGATTC
>HW501555.1 JP 2014039550-A/761: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATCCAGGTT
>HW501554.1 JP 2014039550-A/760: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAGTGTTC
>HW501553.1 JP 2014039550-A/759: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACACTCGTT
>HW501552.1 JP 2014039550-A/758: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGATAGTC
>HW501551.1 JP 2014039550-A/757: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTATCCGTT
>HW501550.1 JP 2014039550-A/756: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GATGCTGTC
>HW501549.1 JP 2014039550-A/755: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGCATCTT
>HW501548.1 JP 2014039550-A/754: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAACGACTC
>HW501547.1 JP 2014039550-A/753: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCGTTCTT
>HW501546.1 JP 2014039550-A/752: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAGTCCTC
>HW501545.1 JP 2014039550-A/751: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGACTGGTT
>HW501544.1 JP 2014039550-A/750: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGACTTTC
>HW501543.1 JP 2014039550-A/749: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AAGTCCGTT
>HW501542.1 JP 2014039550-A/748: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAAGGTTC
>HW501541.1 JP 2014039550-A/747: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACCTTGCTT
>HW501540.1 JP 2014039550-A/746: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGCTCTTC
>HW501539.1 JP 2014039550-A/745: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGAGCCGTT
>HW501538.1 JP 2014039550-A/744: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAAGGTTC
>HW501537.1 JP 2014039550-A/743: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACCTTGGTT
>HW501536.1 JP 2014039550-A/742: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGAGAGTTC
>HW501535.1 JP 2014039550-A/741: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTCTCCTT
>HW501534.1 JP 2014039550-A/740: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCTGCTC
>HW501533.1 JP 2014039550-A/739: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGCACTT
>HW501532.1 JP 2014039550-A/738: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAGAGTTC
>HW501531.1 JP 2014039550-A/737: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTCTCGTT
>HW501530.1 JP 2014039550-A/736: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGTCCGTC
>HW501529.1 JP 2014039550-A/735: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGACACTT
>HW501528.1 JP 2014039550-A/734: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCATCTGTC
>HW501527.1 JP 2014039550-A/733: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGATGGTT
>HW501526.1 JP 2014039550-A/732: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGAAAGTC
>HW501525.1 JP 2014039550-A/731: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTTTCCGTT
>HW501524.1 JP 2014039550-A/730: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGTCTCTC
>HW501523.1 JP 2014039550-A/729: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGACGGTT
>HW501522.1 JP 2014039550-A/728: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAGACCTC
>HW501521.1 JP 2014039550-A/727: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCTGGTT
>HW501520.1 JP 2014039550-A/726: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATGTCCGTC
>HW501519.1 JP 2014039550-A/725: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGACATTT
>HW501518.1 JP 2014039550-A/724: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGCACTTC
>HW501517.1 JP 2014039550-A/723: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGTGCCGTT
>HW501516.1 JP 2014039550-A/722: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTCTGTTC
>HW501515.1 JP 2014039550-A/721: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACAGAGGTT
>HW501514.1 JP 2014039550-A/720: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCAGCTC
>HW501513.1 JP 2014039550-A/719: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTGCACTT
>HW501512.1 JP 2014039550-A/718: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGATGGTC
>HW501511.1 JP 2014039550-A/717: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCATCGGTT
>HW501510.1 JP 2014039550-A/716: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCGATGTC
>HW501509.1 JP 2014039550-A/715: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CATCGACTT
>HW501508.1 JP 2014039550-A/714: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAGCACTC
>HW501507.1 JP 2014039550-A/713: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCTGGTT
>HW501506.1 JP 2014039550-A/712: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTCAGTTC
>HW501505.1 JP 2014039550-A/711: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTGAGGTT
>HW501504.1 JP 2014039550-A/710: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGCGTTGTC
>HW501503.1 JP 2014039550-A/709: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAACGCCTT
>HW501502.1 JP 2014039550-A/708: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGTGTGTC
>HW501501.1 JP 2014039550-A/707: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACACGGTT
>HW501500.1 JP 2014039550-A/706: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TAGTGGCTC
>HW501499.1 JP 2014039550-A/705: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCACTATT
>HW501498.1 JP 2014039550-A/704: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGCGATGTC
>HW501497.1 JP 2014039550-A/703: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CATCGCCTT
>HW501496.1 JP 2014039550-A/702: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGAGTTC
>HW501495.1 JP 2014039550-A/701: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTCTGCTT
>HW501494.1 JP 2014039550-A/700: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAGGAGTC
>HW501493.1 JP 2014039550-A/699: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCCTGGTT
>HW501492.1 JP 2014039550-A/698: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GACAGGCTC
>HW501491.1 JP 2014039550-A/697: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCTGTCTT
>HW501490.1 JP 2014039550-A/696: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TAGCACGAC
>HW501489.1 JP 2014039550-A/695: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTGCTAGA
>HW501488.1 JP 2014039550-A/694: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACGAGAAC
>HW501487.1 JP 2014039550-A/693: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCTCGTGGA
>HW501486.1 JP 2014039550-A/692: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TAACGGCAC
>HW501485.1 JP 2014039550-A/691: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCGTTAGA
>HW501484.1 JP 2014039550-A/690: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCTCCGCAC
>HW501483.1 JP 2014039550-A/689: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGGAGAGA
>HW501482.1 JP 2014039550-A/688: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTTCGGAC
>HW501481.1 JP 2014039550-A/687: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGAAACGA
>HW501480.1 JP 2014039550-A/686: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGCACGAC
>HW501479.1 JP 2014039550-A/685: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTGCTGGA
>HW501478.1 JP 2014039550-A/684: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCAGTGAC
>HW501477.1 JP 2014039550-A/683: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACTGAGGA
>HW501476.1 JP 2014039550-A/682: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTTTCGGAC
>HW501475.1 JP 2014039550-A/681: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGAAAGGA
>HW501474.1 JP 2014039550-A/680: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AAGGAGCAC
>HW501473.1 JP 2014039550-A/679: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTCCTTGA
>HW501472.1 JP 2014039550-A/678: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCACTCAC
>HW501471.1 JP 2014039550-A/677: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGTGCTGA
>HW501470.1 JP 2014039550-A/676: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAACGGCAC
>HW501469.1 JP 2014039550-A/675: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCGTTGGA
>HW501468.1 JP 2014039550-A/674: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGAGCACAC
>HW501467.1 JP 2014039550-A/673: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCTCAGA
>HW501466.1 JP 2014039550-A/672: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGAGCACAC
>HW501465.1 JP 2014039550-A/671: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCTCCGA
>HW501464.1 JP 2014039550-A/670: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTACCAAC
>HW501463.1 JP 2014039550-A/669: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGTAGCGA
>HW501462.1 JP 2014039550-A/668: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCCGAACAC
>HW501461.1 JP 2014039550-A/667: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTCGGAGA
>HW501460.1 JP 2014039550-A/666: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGATGGAC
>HW501459.1 JP 2014039550-A/665: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCATCCTGA
>HW501458.1 JP 2014039550-A/664: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCTCTAC
>HW501457.1 JP 2014039550-A/663: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGAGCACGA
>HW501456.1 JP 2014039550-A/662: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACAGCCTAC
>HW501455.1 JP 2014039550-A/661: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGCTGTGA
>HW501454.1 JP 2014039550-A/660: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTCTCCAC
>HW501453.1 JP 2014039550-A/659: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGAGAGTGA
>HW501452.1 JP 2014039550-A/658: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGTCGAGAC
>HW501451.1 JP 2014039550-A/657: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCGACAGA
>HW501450.1 JP 2014039550-A/656: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAGCACAC
>HW501449.1 JP 2014039550-A/655: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCTCGGA
>HW501448.1 JP 2014039550-A/654: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGCTCTAC
>HW501447.1 JP 2014039550-A/653: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGAGCAGGA
>HW501446.1 JP 2014039550-A/652: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCGAGAC
>HW501445.1 JP 2014039550-A/651: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCGACCGA
>HW501444.1 JP 2014039550-A/650: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AAGCACGAC
>HW501443.1 JP 2014039550-A/649: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTGCTTGA
>HW501442.1 JP 2014039550-A/648: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTCCGCAC
>HW501441.1 JP 2014039550-A/647: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGGAGTGA
>HW501440.1 JP 2014039550-A/646: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AAACGGCAC
>HW501439.1 JP 2014039550-A/645: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCGTTTGA
>HW501438.1 JP 2014039550-A/644: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTCGAGAC
>HW501437.1 JP 2014039550-A/643: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCGACGGA
>HW501436.1 JP 2014039550-A/642: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTAGGAGAC
>HW501435.1 JP 2014039550-A/641: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCCTACGA
>HW501434.1 JP 2014039550-A/640: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGAAGGAC
>HW501433.1 JP 2014039550-A/639: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTTCCAGA
>HW501432.1 JP 2014039550-A/638: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCTCACCAC
>HW501431.1 JP 2014039550-A/637: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTGAGAGA
>HW501430.1 JP 2014039550-A/636: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTCACCAC
>HW501429.1 JP 2014039550-A/635: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTGAGCGA
>HW501428.1 JP 2014039550-A/634: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGAGCACAC
>HW501427.1 JP 2014039550-A/633: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCTCTGA
>HW501426.1 JP 2014039550-A/632: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TACGGTCAC
>HW501425.1 JP 2014039550-A/631: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GACCGTAGA
>HW501424.1 JP 2014039550-A/630: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCTGGCAC
>HW501423.1 JP 2014039550-A/629: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCAGCAGA
>HW501422.1 JP 2014039550-A/628: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACCGAACAC
>HW501421.1 JP 2014039550-A/627: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTCGGTGA
>HW501420.1 JP 2014039550-A/626: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGCGTAAC
>HW501419.1 JP 2014039550-A/625: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TACGCTGGA
>HW501418.1 JP 2014039550-A/624: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGTCGAGAC
>HW501417.1 JP 2014039550-A/623: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCGACTGA
>HW501416.1 JP 2014039550-A/622: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TACGCCTAC
>HW501415.1 JP 2014039550-A/621: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGCGTAGA
>HW501414.1 JP 2014039550-A/620: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCGGAAAC
>HW501413.1 JP 2014039550-A/619: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTCCGACGA
>HW501412.1 JP 2014039550-A/618: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCTGACAC
>HW501411.1 JP 2014039550-A/617: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCAGAGGA
>HW501410.1 JP 2014039550-A/616: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TACCGCTAC
>HW501409.1 JP 2014039550-A/615: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCGGTAGA
>HW501408.1 JP 2014039550-A/614: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGTGTGAC
>HW501407.1 JP 2014039550-A/613: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACACCAGA
>HW501406.1 JP 2014039550-A/612: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TAGCCAGAC
>HW501405.1 JP 2014039550-A/611: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGGCTAGA
>HW501404.1 JP 2014039550-A/610: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGAAGGAC
>HW501403.1 JP 2014039550-A/609: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTTCCTGA
>HW501402.1 JP 2014039550-A/608: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTCACCAC
>HW501401.1 JP 2014039550-A/607: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTGAGTGA
>HW501400.1 JP 2014039550-A/606: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AACGGTCAC
>HW501399.1 JP 2014039550-A/605: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GACCGTTGA
>HW501398.1 JP 2014039550-A/604: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGCACTAC
>HW501397.1 JP 2014039550-A/603: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGTGCAGGA
>HW501396.1 JP 2014039550-A/602: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGTGTGAC
>HW501395.1 JP 2014039550-A/601: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACACCGGA
>HW501394.1 JP 2014039550-A/600: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGCCAGAC
>HW501393.1 JP 2014039550-A/599: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGGCTGGA
>HW501392.1 JP 2014039550-A/598: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTCGCAAC
>HW501391.1 JP 2014039550-A/597: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCGAACGA
>HW501390.1 JP 2014039550-A/596: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTTCGCAAC
>HW501389.1 JP 2014039550-A/595: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCGAAGGA
>HW501388.1 JP 2014039550-A/594: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTGGATAC
>HW501387.1 JP 2014039550-A/593: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATCCAGCGA
>HW501386.1 JP 2014039550-A/592: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCGTTAC
>HW501385.1 JP 2014039550-A/591: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AACGACCGA
>HW501384.1 JP 2014039550-A/590: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGTGTGAC
>HW501383.1 JP 2014039550-A/589: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACACCTGA
>HW501382.1 JP 2014039550-A/588: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AAGCCAGAC
>HW501381.1 JP 2014039550-A/587: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGGCTTGA
>HW501380.1 JP 2014039550-A/586: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTTTCGAC
>HW501379.1 JP 2014039550-A/585: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAAACCGA
>HW501378.1 JP 2014039550-A/584: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGTTCGGAC
>HW501377.1 JP 2014039550-A/583: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGAACAGA
>HW501376.1 JP 2014039550-A/582: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCAGTCCAC
>HW501375.1 JP 2014039550-A/581: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGACTGAGA
>HW501374.1 JP 2014039550-A/580: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTTTCGAC
>HW501373.1 JP 2014039550-A/579: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAAACGGA
>HW501372.1 JP 2014039550-A/578: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGCAGTGAC
>HW501371.1 JP 2014039550-A/577: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACTGCCGA
>HW501370.1 JP 2014039550-A/576: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTTCGGAC
>HW501369.1 JP 2014039550-A/575: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGAACCGA
>HW501368.1 JP 2014039550-A/574: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGTCCAC
>HW501367.1 JP 2014039550-A/573: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGACTGCGA
>HW501366.1 JP 2014039550-A/572: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCTCCACAC
>HW501365.1 JP 2014039550-A/571: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGGAGAGA
>HW501364.1 JP 2014039550-A/570: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTCCACAC
>HW501363.1 JP 2014039550-A/569: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGGAGCGA
>HW501362.1 JP 2014039550-A/568: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGCAGTGAC
>HW501361.1 JP 2014039550-A/567: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACTGCGGA
>HW501360.1 JP 2014039550-A/566: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTTCGGAC
>HW501359.1 JP 2014039550-A/565: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGAACGGA
>HW501358.1 JP 2014039550-A/564: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAACGACAC
>HW501357.1 JP 2014039550-A/563: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCGTTGGA
>HW501356.1 JP 2014039550-A/562: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGCTCTAC
>HW501355.1 JP 2014039550-A/561: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGAGCCAGA
>HW501354.1 JP 2014039550-A/560: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCCTGCTAC
>HW501353.1 JP 2014039550-A/559: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCAGGAGA
>HW501352.1 JP 2014039550-A/558: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCTGCTAC
>HW501351.1 JP 2014039550-A/557: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCAGGCGA
>HW501350.1 JP 2014039550-A/556: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCAGTGAC
>HW501349.1 JP 2014039550-A/555: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACTGCTGA
>HW501348.1 JP 2014039550-A/554: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGAGGAGAC
>HW501347.1 JP 2014039550-A/553: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCCTCAGA
>HW501346.1 JP 2014039550-A/552: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGTTCGGAC
>HW501345.1 JP 2014039550-A/551: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGAACTGA
>HW501344.1 JP 2014039550-A/550: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACAGTCCAC
>HW501343.1 JP 2014039550-A/549: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGACTGTGA
>HW501342.1 JP 2014039550-A/548: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCCATAC
>HW501341.1 JP 2014039550-A/547: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATGGCACGA
>HW501340.1 JP 2014039550-A/546: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTACTGGAC
>HW501339.1 JP 2014039550-A/545: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAGTAGGA
>HW501338.1 JP 2014039550-A/544: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTCCACAC
>HW501337.1 JP 2014039550-A/543: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGGAGTGA
>HW501336.1 JP 2014039550-A/542: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTGCTGCAC
>HW501335.1 JP 2014039550-A/541: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGCAAGA
>HW501334.1 JP 2014039550-A/540: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCATCTGAC
>HW501333.1 JP 2014039550-A/539: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGATGCGA
>HW501332.1 JP 2014039550-A/538: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAGGAGAC
>HW501331.1 JP 2014039550-A/537: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCCTCGGA
>HW501330.1 JP 2014039550-A/536: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGCCTTTAC
>HW501329.1 JP 2014039550-A/535: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AAAGGCGGA
>HW501328.1 JP 2014039550-A/534: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCCTGAAC
>HW501327.1 JP 2014039550-A/533: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCAGGACGA
>HW501326.1 JP 2014039550-A/532: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGAGGAGAC
>HW501325.1 JP 2014039550-A/531: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCCTCTGA
>HW501324.1 JP 2014039550-A/530: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCGTTGAC
>HW501323.1 JP 2014039550-A/529: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAACGACGA
>HW501322.1 JP 2014039550-A/528: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCACCGAC
>HW501321.1 JP 2014039550-A/527: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGTGACGA
>HW501320.1 JP 2014039550-A/526: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTATGCCAC
>HW501319.1 JP 2014039550-A/525: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGCATACGA
>HW501318.1 JP 2014039550-A/524: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTAGGCAAC
>HW501317.1 JP 2014039550-A/523: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCCTACGA
>HW501316.1 JP 2014039550-A/522: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCCAGAAC
>HW501315.1 JP 2014039550-A/521: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCTGGACGA
>HW501314.1 JP 2014039550-A/520: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTTCAGAC
>HW501313.1 JP 2014039550-A/519: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGAACCGA
>HW501312.1 JP 2014039550-A/518: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTTCAGAC
>HW501311.1 JP 2014039550-A/517: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGAACGGA
>HW501310.1 JP 2014039550-A/516: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGCTGCAC
>HW501309.1 JP 2014039550-A/515: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGCCTGA
>HW501308.1 JP 2014039550-A/514: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGTGTGAC
>HW501307.1 JP 2014039550-A/513: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACACGCGA
>HW501306.1 JP 2014039550-A/512: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTCCTGAC
>HW501305.1 JP 2014039550-A/511: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGGAACGA
>HW501304.1 JP 2014039550-A/510: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGCAGCAC
>HW501303.1 JP 2014039550-A/509: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTGCCTGA
>HW501302.1 JP 2014039550-A/508: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGGAGAC
>HW501301.1 JP 2014039550-A/507: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCCTGCGA
>HW501300.1 JP 2014039550-A/506: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTAGCTGAC
>HW501299.1 JP 2014039550-A/505: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGCTACGA
>HW501298.1 JP 2014039550-A/504: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGCCATCT
>HW501297.1 JP 2014039550-A/503: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATGGCAGGT
>HW501296.1 JP 2014039550-A/502: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACGCCAACT
>HW501295.1 JP 2014039550-A/501: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTGGCGTGT
>HW501294.1 JP 2014039550-A/500: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTTACGCT
>HW501293.1 JP 2014039550-A/499: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTAACCGT
>HW501292.1 JP 2014039550-A/498: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCGTCTCCT
>HW501291.1 JP 2014039550-A/497: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGACGAGT
>HW501290.1 JP 2014039550-A/496: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGCTAACT
>HW501289.1 JP 2014039550-A/495: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTAGCCGGT
>HW501288.1 JP 2014039550-A/494: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGTCCGCT
>HW501287.1 JP 2014039550-A/493: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGACAGGT
>HW501286.1 JP 2014039550-A/492: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCAGACCCT
>HW501285.1 JP 2014039550-A/491: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCTGAGT
>HW501284.1 JP 2014039550-A/490: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCTGACCT
>HW501283.1 JP 2014039550-A/489: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCAGCAGT
>HW501282.1 JP 2014039550-A/488: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCGGCTACT
>HW501281.1 JP 2014039550-A/487: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TAGCCGAGT
>HW501280.1 JP 2014039550-A/486: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGACCCT
>HW501279.1 JP 2014039550-A/485: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCTGCGT
>HW501278.1 JP 2014039550-A/484: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGCTGACCT
>HW501277.1 JP 2014039550-A/483: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCAGCCGT
>HW501276.1 JP 2014039550-A/482: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCGGAACT
>HW501275.1 JP 2014039550-A/481: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTCCGCAGT
>HW501274.1 JP 2014039550-A/480: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACCTGCTCT
>HW501273.1 JP 2014039550-A/479: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCAGGTGT
>HW501272.1 JP 2014039550-A/478: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCCTGACT
>HW501271.1 JP 2014039550-A/477: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCAGGAGGT
>HW501270.1 JP 2014039550-A/476: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGCTGACCT
>HW501269.1 JP 2014039550-A/475: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCAGCGGT
>HW501268.1 JP 2014039550-A/474: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCTCTACT
>HW501267.1 JP 2014039550-A/473: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TAGAGGCGT
>HW501266.1 JP 2014039550-A/472: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGCACTCT
>HW501265.1 JP 2014039550-A/471: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGTGCCAGT
>HW501264.1 JP 2014039550-A/470: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGACGACT
>HW501263.1 JP 2014039550-A/469: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCGTCAGGT
>HW501262.1 JP 2014039550-A/468: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATGCTGCCT
>HW501261.1 JP 2014039550-A/467: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGCATGT
>HW501260.1 JP 2014039550-A/466: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCGTTGCT
>HW501259.1 JP 2014039550-A/465: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAACGAGGT
>HW501258.1 JP 2014039550-A/464: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTCACCGCT
>HW501257.1 JP 2014039550-A/463: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGTGAAGT
>HW501256.1 JP 2014039550-A/462: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACAGACCCT
>HW501255.1 JP 2014039550-A/461: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCTGTGT
>HW501254.1 JP 2014039550-A/460: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGTCGCACT
>HW501253.1 JP 2014039550-A/459: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCGACAGT
>HW501252.1 JP 2014039550-A/458: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACGGCTACT
>HW501251.1 JP 2014039550-A/457: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TAGCCGTGT
>HW501250.1 JP 2014039550-A/456: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTACAGGCT
>HW501249.1 JP 2014039550-A/455: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTGTAGGT
>HW501248.1 JP 2014039550-A/454: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCGCACT
>HW501247.1 JP 2014039550-A/453: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCGACCGT
>HW501246.1 JP 2014039550-A/452: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTCTGTCT
>HW501245.1 JP 2014039550-A/451: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACAGAGCGT
>HW501244.1 JP 2014039550-A/450: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCCACTCCT
>HW501243.1 JP 2014039550-A/449: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGTGGAGT
>HW501242.1 JP 2014039550-A/448: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCGGAACT
>HW501241.1 JP 2014039550-A/447: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTCCGCTGT
>HW501240.1 JP 2014039550-A/446: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTGCAGCCT
>HW501239.1 JP 2014039550-A/445: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTGCAAGT
>HW501238.1 JP 2014039550-A/444: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCACCGCT
>HW501237.1 JP 2014039550-A/443: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGTGAGGT
>HW501236.1 JP 2014039550-A/442: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCACTCCT
>HW501235.1 JP 2014039550-A/441: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGTGGCGT
>HW501234.1 JP 2014039550-A/440: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTCGCACT
>HW501233.1 JP 2014039550-A/439: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCGACGGT
>HW501232.1 JP 2014039550-A/438: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAATCGCCT
>HW501231.1 JP 2014039550-A/437: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGATTCGT
>HW501230.1 JP 2014039550-A/436: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTATGCCCT
>HW501229.1 JP 2014039550-A/435: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGCATAGGT
>HW501228.1 JP 2014039550-A/434: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGCACTCT
>HW501227.1 JP 2014039550-A/433: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGTGCCTGT
>HW501226.1 JP 2014039550-A/432: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAAGCGACT
>HW501225.1 JP 2014039550-A/431: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCGCTTCGT
>HW501224.1 JP 2014039550-A/430: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGATGGCT
>HW501223.1 JP 2014039550-A/429: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCATCGCGT
>HW501222.1 JP 2014039550-A/428: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAATCGCCT
>HW501221.1 JP 2014039550-A/427: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGATTGGT
>HW501220.1 JP 2014039550-A/426: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGTGCTCT
>HW501219.1 JP 2014039550-A/425: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCACTCGT
>HW501218.1 JP 2014039550-A/424: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAAGCGACT
>HW501217.1 JP 2014039550-A/423: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCGCTTGGT
>HW501216.1 JP 2014039550-A/422: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGTGCTCT
>HW501215.1 JP 2014039550-A/421: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCACTGGT
>HW501214.1 JP 2014039550-A/420: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCCAGACT
>HW501213.1 JP 2014039550-A/419: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCTGGAGGT
>HW501212.1 JP 2014039550-A/418: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGTCGCACT
>HW501211.1 JP 2014039550-A/417: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCGACTGT
>HW501210.1 JP 2014039550-A/416: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATCACCGCT
>HW501209.1 JP 2014039550-A/415: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGTGATGT
>HW501208.1 JP 2014039550-A/414: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTAGTCCT
>HW501207.1 JP 2014039550-A/413: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GACTACCGT
>HW501206.1 JP 2014039550-A/412: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACCACTCCT
>HW501205.1 JP 2014039550-A/411: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGTGGTGT
>HW501204.1 JP 2014039550-A/410: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATGCAGCCT
>HW501203.1 JP 2014039550-A/409: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTGCATGT
>HW501202.1 JP 2014039550-A/408: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCAGCACCT
>HW501201.1 JP 2014039550-A/407: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCTGAGT
>HW501200.1 JP 2014039550-A/406: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTAGTCCT
>HW501199.1 JP 2014039550-A/405: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GACTACGGT
>HW501198.1 JP 2014039550-A/404: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGCACCT
>HW501197.1 JP 2014039550-A/403: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCTGCGT
>HW501196.1 JP 2014039550-A/402: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACGATGGCT
>HW501195.1 JP 2014039550-A/401: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCATCGTGT
>HW501194.1 JP 2014039550-A/400: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCGATGCT
>HW501193.1 JP 2014039550-A/399: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CATCGAGGT
>HW501192.1 JP 2014039550-A/398: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGACTGGCT
>HW501191.1 JP 2014039550-A/397: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAGTCAGT
>HW501190.1 JP 2014039550-A/396: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGACTGGCT
>HW501189.1 JP 2014039550-A/395: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAGTCCGT
>HW501188.1 JP 2014039550-A/394: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTCAGTCT
>HW501187.1 JP 2014039550-A/393: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTGAGCGT
>HW501186.1 JP 2014039550-A/392: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGACTGGCT
>HW501185.1 JP 2014039550-A/391: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAGTCGGT
>HW501184.1 JP 2014039550-A/390: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGCTGCCT
>HW501183.1 JP 2014039550-A/389: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGCCAGT
>HW501182.1 JP 2014039550-A/388: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGAAGGCT
>HW501181.1 JP 2014039550-A/387: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTTCGCGT
>HW501180.1 JP 2014039550-A/386: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGTCCGCT
>HW501179.1 JP 2014039550-A/385: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGACCAGT
>HW501178.1 JP 2014039550-A/384: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCCTGGCCT
>HW501177.1 JP 2014039550-A/383: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCAGGAGT
>HW501176.1 JP 2014039550-A/382: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGACTGGCT
>HW501175.1 JP 2014039550-A/381: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAGTCTGT
>HW501174.1 JP 2014039550-A/380: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGCCATCT
>HW501173.1 JP 2014039550-A/379: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATGGCCTGT
>HW501172.1 JP 2014039550-A/378: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCGTGTGCT
>HW501171.1 JP 2014039550-A/377: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACACGAGT
>HW501170.1 JP 2014039550-A/376: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCGTTGCT
>HW501169.1 JP 2014039550-A/375: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAACGCAGT
>HW501168.1 JP 2014039550-A/374: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGTCCGCT
>HW501167.1 JP 2014039550-A/373: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGACCTGT
>HW501166.1 JP 2014039550-A/372: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACCTGGCCT
>HW501165.1 JP 2014039550-A/371: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCAGGTGT
>HW501164.1 JP 2014039550-A/370: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCCTGACT
>HW501163.1 JP 2014039550-A/369: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCAGGCTGT
>HW501162.1 JP 2014039550-A/368: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGCAGCCT
>HW501161.1 JP 2014039550-A/367: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTGCCAGT
>HW501160.1 JP 2014039550-A/366: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGACGACT
>HW501159.1 JP 2014039550-A/365: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCGTCCTGT
>HW501158.1 JP 2014039550-A/364: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGTGTCT
>HW501157.1 JP 2014039550-A/363: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACACTGCGT
>HW501156.1 JP 2014039550-A/362: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAGGCACT
>HW501155.1 JP 2014039550-A/361: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCCTCGGT
>HW501154.1 JP 2014039550-A/360: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCGTTGCT
>HW501153.1 JP 2014039550-A/359: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAACGCTGT
>HW501152.1 JP 2014039550-A/358: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGACAGGCT
>HW501151.1 JP 2014039550-A/357: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTGTCTGT
>HW501150.1 JP 2014039550-A/356: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGGAGACT
>HW501149.1 JP 2014039550-A/355: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCTCCTCGT
>HW501148.1 JP 2014039550-A/354: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCAGTGCT
>HW501147.1 JP 2014039550-A/353: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACTGGCGT
>HW501146.1 JP 2014039550-A/352: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCACCGCT
>HW501145.1 JP 2014039550-A/351: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGTGCTGT
>HW501144.1 JP 2014039550-A/350: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGATGCCCT
>HW501143.1 JP 2014039550-A/349: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGCATCTGT
>HW501142.1 JP 2014039550-A/348: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTTCCTGCT
>HW501141.1 JP 2014039550-A/347: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGGAAGGT
>HW501140.1 JP 2014039550-A/346: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCGATGCT
>HW501139.1 JP 2014039550-A/345: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CATCGCAGT
>HW501138.1 JP 2014039550-A/344: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGAGGCACT
>HW501137.1 JP 2014039550-A/343: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCCTCTGT
>HW501136.1 JP 2014039550-A/342: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGTGGCCT
>HW501135.1 JP 2014039550-A/341: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCACTCGT
>HW501134.1 JP 2014039550-A/340: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCCAGACT
>HW501133.1 JP 2014039550-A/339: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCTGGCTGT
>HW501132.1 JP 2014039550-A/338: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGTGGCCT
>HW501131.1 JP 2014039550-A/337: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCACTGGT
>HW501130.1 JP 2014039550-A/336: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACCAGTGCT
>HW501129.1 JP 2014039550-A/335: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACTGGTGT
>HW501128.1 JP 2014039550-A/334: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCGATGCT
>HW501127.1 JP 2014039550-A/333: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CATCGCTGT
>HW501126.1 JP 2014039550-A/332: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AAGTGGCCT
>HW501125.1 JP 2014039550-A/331: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCACTTGT
>HW501124.1 JP 2014039550-A/330: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGCTACCT
>HW501123.1 JP 2014039550-A/329: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTAGCCTGT
>HW501122.1 JP 2014039550-A/328: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGAGTGCT
>HW501121.1 JP 2014039550-A/327: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACTCTCGT
>HW501120.1 JP 2014039550-A/326: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCCGTCCT
>HW501119.1 JP 2014039550-A/325: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GACGGCTGT
>HW501118.1 JP 2014039550-A/324: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGAGTGCT
>HW501117.1 JP 2014039550-A/323: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACTCTGGT
>HW501116.1 JP 2014039550-A/322: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGTCCTGCT
>HW501115.1 JP 2014039550-A/321: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGGACAGT
>HW501114.1 JP 2014039550-A/320: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCCTGCT
>HW501113.1 JP 2014039550-A/319: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGGACCGT
>HW501112.1 JP 2014039550-A/318: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CACGTCTCT
>HW501111.1 JP 2014039550-A/317: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGACGTGGT
>HW501110.1 JP 2014039550-A/316: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTCCTGCT
>HW501109.1 JP 2014039550-A/315: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGGACGGT
>HW501108.1 JP 2014039550-A/314: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGGCAACCT
>HW501107.1 JP 2014039550-A/313: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTGCCTGT
>HW500914.1 JP 2014039550-A/120: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTACGAGAA
>HW500913.1 JP 2014039550-A/119: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCGTAGCC
>HW500912.1 JP 2014039550-A/118: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGAGAGGAA
>HW500911.1 JP 2014039550-A/117: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTCTCTCC
>HW500910.1 JP 2014039550-A/116: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCTGTGGAA
>HW500909.1 JP 2014039550-A/115: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCACAGACC
>HW500908.1 JP 2014039550-A/114: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGTAGCGAA
>HW500907.1 JP 2014039550-A/113: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGCTACTCC
>HW500906.1 JP 2014039550-A/112: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCTGTCGAA
>HW500905.1 JP 2014039550-A/111: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGACAGACC
>HW500904.1 JP 2014039550-A/110: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCAGACAA
>HW500903.1 JP 2014039550-A/109: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCTGCTCC
>HW500902.1 JP 2014039550-A/108: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACATGGCAA
>HW500901.1 JP 2014039550-A/107: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCATGTCC
>HW500900.1 JP 2014039550-A/106: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTTCTGCAA
>HW500899.1 JP 2014039550-A/105: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGAAGCC
>HW500898.1 JP 2014039550-A/104: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCCATCCAA
>HW500897.1 JP 2014039550-A/103: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGATGGACC
>HW500896.1 JP 2014039550-A/102: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGTCGTCAA
>HW500895.1 JP 2014039550-A/101: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GACGACACC
>HW500894.1 JP 2014039550-A/100: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCGGATAA
>HW500893.1 JP 2014039550-A/99: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATCCGCACC
>HW500892.1 JP 2014039550-A/98: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCTGGTAA
>HW500891.1 JP 2014039550-A/97: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACCAGAGCC
>HW500890.1 JP 2014039550-A/96: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGTGGAGTC
>HW500889.1 JP 2014039550-A/95: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCCACTTT
>HW500888.1 JP 2014039550-A/94: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCGTCAGTC
>HW500887.1 JP 2014039550-A/93: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGACGATT
>HW500886.1 JP 2014039550-A/92: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTTCAGGTC
>HW500885.1 JP 2014039550-A/91: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTGAAGTT
>HW500884.1 JP 2014039550-A/90: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTGTGGTC
>HW500883.1 JP 2014039550-A/89: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCACAGTTT
>HW500882.1 JP 2014039550-A/88: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAAAGCGTC
>HW500881.1 JP 2014039550-A/87: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGCTTTGTT
>HW500880.1 JP 2014039550-A/86: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGATCGTC
>HW500879.1 JP 2014039550-A/85: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGATCTGTT
>HW500878.1 JP 2014039550-A/84: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGTATGTC
>HW500877.1 JP 2014039550-A/83: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CATACGCTT
>HW500876.1 JP 2014039550-A/82: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AACGCTGTC
>HW500875.1 JP 2014039550-A/81: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGCGTTTT
>HW500874.1 JP 2014039550-A/80: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGAAACTC
>HW500873.1 JP 2014039550-A/79: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTTCGGTT
>HW500872.1 JP 2014039550-A/78: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTTCGACTC
>HW500871.1 JP 2014039550-A/77: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCGAAGTT
>HW500870.1 JP 2014039550-A/76: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCACTACTC
>HW500869.1 JP 2014039550-A/75: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTAGTGCTT
>HW500868.1 JP 2014039550-A/74: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTTAGGCTC
>HW500867.1 JP 2014039550-A/73: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCTAAGTT
>HW500866.1 JP 2014039550-A/72: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AAGCGACAC
>HW500865.1 JP 2014039550-A/71: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCGCTTGA
>HW500864.1 JP 2014039550-A/70: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGCTACAC
>HW500863.1 JP 2014039550-A/69: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTAGCCAGA
>HW500862.1 JP 2014039550-A/68: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTCAGGCAC
>HW500861.1 JP 2014039550-A/67: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCCTGAAGA
>HW500860.1 JP 2014039550-A/66: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAACTGCAC
>HW500859.1 JP 2014039550-A/65: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAGTTGGA
>HW500858.1 JP 2014039550-A/64: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAGCAAAC
>HW500857.1 JP 2014039550-A/63: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TTGCTCGGA
>HW500856.1 JP 2014039550-A/62: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTCTGAAC
>HW500855.1 JP 2014039550-A/61: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCAGAGCGA
>HW500854.1 JP 2014039550-A/60: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGACCAAC
>HW500853.1 JP 2014039550-A/59: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGGTCACGA
>HW500852.1 JP 2014039550-A/58: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGTAAGAC
>HW500851.1 JP 2014039550-A/57: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTTACGCGA
>HW500850.1 JP 2014039550-A/56: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TACGCAGAC
>HW500849.1 JP 2014039550-A/55: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGCGTAGA
>HW500848.1 JP 2014039550-A/54: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTACAGGAC
>HW500847.1 JP 2014039550-A/53: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTGTAGGA
>HW500846.1 JP 2014039550-A/52: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCCAACAC
>HW500845.1 JP 2014039550-A/51: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTGGCAGA
>HW500844.1 JP 2014039550-A/50: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AACGCACAC
>HW500843.1 JP 2014039550-A/49: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCGTTGA
>HW500842.1 JP 2014039550-A/48: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTTAGACT
>HW500841.1 JP 2014039550-A/47: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGCTACGGT
>HW500840.1 JP 2014039550-A/46: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGACTCACT
>HW500839.1 JP 2014039550-A/45: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGAGTCCGT
>HW500838.1 JP 2014039550-A/44: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GAGAAGGCT
>HW500837.1 JP 2014039550-A/43: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTTCTCGT
>HW500836.1 JP 2014039550-A/42: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGATCGGCT
>HW500835.1 JP 2014039550-A/41: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCGATCTGT
>HW500834.1 JP 2014039550-A/40: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AGCAACGCT
>HW500833.1 JP 2014039550-A/39: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTTGCTGT
>HW500832.1 JP 2014039550-A/38: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AACACCGCT
>HW500831.1 JP 2014039550-A/37: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGGTGTTGT
>HW500830.1 JP 2014039550-A/36: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCCTTCGCT
>HW500829.1 JP 2014039550-A/35: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAAGGAGT
>HW500828.1 JP 2014039550-A/34: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGAACTGCT
>HW500827.1 JP 2014039550-A/33: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAGTTCGGT
>HW500826.1 JP 2014039550-A/32: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTCTTGCT
>HW500825.1 JP 2014039550-A/31: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CAAGAGCGT
>HW500824.1 JP 2014039550-A/30: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTTGACCT
>HW500823.1 JP 2014039550-A/29: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTCAAGCGT
>HW500822.1 JP 2014039550-A/28: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCCAAGCCT
>HW500821.1 JP 2014039550-A/27: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTTGGAGT
>HW500820.1 JP 2014039550-A/26: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
AACACGCCT
>HW500819.1 JP 2014039550-A/25: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGTGTTGT
>HW500818.1 JP 2014039550-A/24: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGACCTACA
>HW500817.1 JP 2014039550-A/23: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TAGGTCCAG
>HW500816.1 JP 2014039550-A/22: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACTGGAGCA
>HW500815.1 JP 2014039550-A/21: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTCCAGTAG
>HW500814.1 JP 2014039550-A/20: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACGACTTGC
>HW500813.1 JP 2014039550-A/19: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGAACGAG
>HW500812.1 JP 2014039550-A/18: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CTGTAGGCA
>HW500811.1 JP 2014039550-A/17: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCTACAGAG
>HW500810.1 JP 2014039550-A/16: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATGCTGGCA
>HW500809.1 JP 2014039550-A/15: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CCAGCATAG
>HW500808.1 JP 2014039550-A/14: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GACTACGCA
>HW500807.1 JP 2014039550-A/13: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGTAGTCAG
>HW500806.1 JP 2014039550-A/12: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACGCTGAAC
>HW500805.1 JP 2014039550-A/11: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
CGACTTGAC
>HW500804.1 JP 2014039550-A/10: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GGTCAACCA
>HW500803.1 JP 2014039550-A/9: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTTGACCAG
>HW500802.1 JP 2014039550-A/8: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ATGGCACCA
>HW500801.1 JP 2014039550-A/7: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GTGCCATAG
>HW500800.1 JP 2014039550-A/6: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
ACAGAGCCA
>HW500799.1 JP 2014039550-A/5: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCTCTGTAG
>HW500798.1 JP 2014039550-A/4: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TGTACGCCA
>HW500797.1 JP 2014039550-A/3: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCGTACAAG
>HW500796.1 JP 2014039550-A/2: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
TCGTTGCCA
>HW500795.1 JP 2014039550-A/1: METHODS FOR SYNTHESIS OF ENCODED LIBRARIES
GCAACGAAG
>HW504598.1 JP 2014504150-A/21: Compositions of a peptide targeting system for treating cancer
AAAGCGGCG
>HW504586.1 JP 2014504150-A/9: Compositions of a peptide targeting system for treating cancer
CGTGGTGAC
>HW504510.1 JP 2014504147-A/2: ANTIBODIES FOR THE TREATMENT OF HIV
TGGGCATCC
>HW472351.1 JP 2013013414-A/58: A Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby
CACCACGTC
>HW465094.1 JP 2014036652-A/94: CpG Oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity
TGNCGTTTT
>HW468719.1 JP 2014500014-A/115: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
TCTACATCC
>HW468709.1 JP 2014500014-A/105: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
AAGGCGTCT
>HW468699.1 JP 2014500014-A/95: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
GCTGCATCC
>HW468689.1 JP 2014500014-A/85: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
GCTGCATCC
>HW468679.1 JP 2014500014-A/75: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
TTGGGCTCT
>HW468669.1 JP 2014500014-A/65: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
GCTGCATCC
>HW468659.1 JP 2014500014-A/55: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
CTGGGTTCT
>HW468651.1 JP 2014500014-A/47: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
TGGGCATCT
>HW468643.1 JP 2014500014-A/39: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
GGTGCATCC
>HW468635.1 JP 2014500014-A/31: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
AAGATTTCT
>HW468627.1 JP 2014500014-A/23: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
GGTGCATCC
>HW468619.1 JP 2014500014-A/15: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
GCGGCGTCT
>HW468611.1 JP 2014500014-A/7: Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
TGGGCATCT
>HW464958.1 JP 2014031373-A/85: STABILIZED IMMUNE MODULATORY RNA (SIMRA) COMPOUNDS FOR TLR7 AND TLR8
CCCNNNCCC
>HW468215.1 JP 2014501493-A/63: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
ATATACCTG
>HW468214.1 JP 2014501493-A/62: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
ACACACCTG
>HW468213.1 JP 2014501493-A/61: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
ACATACTTG
>HW468212.1 JP 2014501493-A/60: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
ACTTACTCC
>HW468209.1 JP 2014501493-A/57: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
TATGACCTG
>HW468161.1 JP 2014501493-A/9: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
ACTTTCATA
>HW468160.1 JP 2014501493-A/8: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
GCAGACTTA
>HW468159.1 JP 2014501493-A/7: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
TTTCTTTAA
>HW468158.1 JP 2014501493-A/6: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
TAAAAAATC
>HW468157.1 JP 2014501493-A/5: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
AAAATCTTA
>HW468156.1 JP 2014501493-A/4: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
ATCTTATTC
>HW468155.1 JP 2014501493-A/3: A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
TCTTATTCA
>HW430572.1 JP 2014027930-A/87: A Virus causing respiratory tract illness in susceptible mammals
TAGTTAATT
>HW430571.1 JP 2014027930-A/86: A Virus causing respiratory tract illness in susceptible mammals
GGGACCAGT
>HW430570.1 JP 2014027930-A/85: A Virus causing respiratory tract illness in susceptible mammals
AGGACCAAT
>HW430569.1 JP 2014027930-A/84: A Virus causing respiratory tract illness in susceptible mammals
GAGACAAAT
>HW430568.1 JP 2014027930-A/83: A Virus causing respiratory tract illness in susceptible mammals
GGGATAAAT
>HW430567.1 JP 2014027930-A/82: A Virus causing respiratory tract illness in susceptible mammals
GGGACAAGT
>HW470225.1 JP 2014500028-A/117: METHODS AND COMPOSITIONS FOR DETECTING MUTATION IN THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR GENE
GGCAGATGC
>HW424334.1 JP 2013544511-A/36: COMPOSITIONS AND METHODS FOR ACTIVATING EXPRESSION BY A SPECIFIC ENDOGENOUS miRNA
TTTTTTATT
>HW424328.1 JP 2013544511-A/30: COMPOSITIONS AND METHODS FOR ACTIVATING EXPRESSION BY A SPECIFIC ENDOGENOUS miRNA
TTATTTANN
>HW418418.1 JP 2013543117-A/2: Means and Methods for diagnosing cancer using an antibody which specifically binds to BRAF V600E
ACAGAGAAA
>HW418417.1 JP 2013543117-A/1: Means and Methods for diagnosing cancer using an antibody which specifically binds to BRAF V600E
ACAGTGAAA
>HW418379.1 JP 2013542194-A/188: Anti-CD48 Antibodies and Uses Thereof
GGTGCATCC
>HW418373.1 JP 2013542194-A/182: Anti-CD48 Antibodies and Uses Thereof
GGTGCATCC
>HW418363.1 JP 2013542194-A/172: Anti-CD48 Antibodies and Uses Thereof
GCTGCTTCC
>HW418353.1 JP 2013542194-A/162: Anti-CD48 Antibodies and Uses Thereof
GCTGCATCC
>HW418343.1 JP 2013542194-A/152: Anti-CD48 Antibodies and Uses Thereof
GCTGCATCC
>HW418333.1 JP 2013542194-A/142: Anti-CD48 Antibodies and Uses Thereof
GCTGCATCC
>HW418323.1 JP 2013542194-A/132: Anti-CD48 Antibodies and Uses Thereof
GCTGCATCC
>HW418313.1 JP 2013542194-A/122: Anti-CD48 Antibodies and Uses Thereof
TTGGTTTCT
>HW418303.1 JP 2013542194-A/112: Anti-CD48 Antibodies and Uses Thereof
AAGATTTCT
>HW418293.1 JP 2013542194-A/102: Anti-CD48 Antibodies and Uses Thereof
GCTGCATCC
>HW418284.1 JP 2013542194-A/93: Anti-CD48 Antibodies and Uses Thereof
GGTGCATCC
>HW418278.1 JP 2013542194-A/87: Anti-CD48 Antibodies and Uses Thereof
GCGGCATCC
>HW418270.1 JP 2013542194-A/79: Anti-CD48 Antibodies and Uses Thereof
GGTTCATCC
>HW418266.1 JP 2013542194-A/75: Anti-CD48 Antibodies and Uses Thereof
GATGCATCC
>HW418262.1 JP 2013542194-A/71: Anti-CD48 Antibodies and Uses Thereof
GCTGCATCC
>HW418254.1 JP 2013542194-A/63: Anti-CD48 Antibodies and Uses Thereof
GATGCATCC
>HW418246.1 JP 2013542194-A/55: Anti-CD48 Antibodies and Uses Thereof
GCTGCATCC
>HW418238.1 JP 2013542194-A/47: Anti-CD48 Antibodies and Uses Thereof
GATGCATCC
>HW418230.1 JP 2013542194-A/39: Anti-CD48 Antibodies and Uses Thereof
GCTGCATCC
>HW418222.1 JP 2013542194-A/31: Anti-CD48 Antibodies and Uses Thereof
GATGCATCC
>HW418214.1 JP 2013542194-A/23: Anti-CD48 Antibodies and Uses Thereof
GATGCATCC
>HW418206.1 JP 2013542194-A/15: Anti-CD48 Antibodies and Uses Thereof
GGTGCATCC
>HW418198.1 JP 2013542194-A/7: Anti-CD48 Antibodies and Uses Thereof
GATGCATCC
>HW424222.1 JP 2013544510-A/36: COMPOSITIONS AND METHODS FOR SPECIFIC CLEAVAGE OF EXOGENOUS RNA IN A CELL
TTTTTTATT
>HW424216.1 JP 2013544510-A/30: COMPOSITIONS AND METHODS FOR SPECIFIC CLEAVAGE OF EXOGENOUS RNA IN A CELL
TTATTTANN
>HW413324.1 JP 2014012014-A/7: RECOMBINANT EXPRESSION VECTOR ELEMENTS (REVES) FOR ENHANCING EXPRESSION OF RECOMBINANT PROTEINS IN HOST CELLS
AATATATTT
>HW413320.1 JP 2014012014-A/3: RECOMBINANT EXPRESSION VECTOR ELEMENTS (REVES) FOR ENHANCING EXPRESSION OF RECOMBINANT PROTEINS IN HOST CELLS
AATAAAYAA
>HW413253.1 JP 2014012013-A/7: VECTORS WITH MODIFIED INITIATION CODON FOR THE TRANSLATION OF AAV-REP78 USEFUL FOR PRODUCTION OF AAV IN INSECT CELLS
CCTGTTAAG
>HW416158.1 JP 2013540420-A/5: RECOMBINANT ANTIBODY STRUCTURES BINDING TO AND BLOCKING THE ACTIVITY OF VASCULAR ENDOTHELIAL GROWTH FACTOR 2 (VEGFR-2/KDR)
GACACATCC
>HW392127.1 JP 2013253084-A/17: Use of an anti-CD151 antibody in the treatment of cancer
TATGCATCC
>HW392119.1 JP 2013253084-A/9: Use of an anti-CD151 antibody in the treatment of cancer
TCTGCATCC
>HW409035.1 JP 2013230158-A/21: BIOLOGICAL PRODUCTS
GCCGCCACC
>XM_007152073.1 Phaseolus vulgaris hypothetical protein (PHAVU_004G1052000g) mRNA, partial cds
ATGGTGAAG
>HW382530.1 JP 2013226143-A/111: High Affinity Antibodies to Human IL-6 Receptor
GCTGCATCC
>HW382522.1 JP 2013226143-A/103: High Affinity Antibodies to Human IL-6 Receptor
GATGCATCC
>HW382514.1 JP 2013226143-A/95: High Affinity Antibodies to Human IL-6 Receptor
GTTGCATCC
>HW382506.1 JP 2013226143-A/87: High Affinity Antibodies to Human IL-6 Receptor
GCTGCATCC
>HW382498.1 JP 2013226143-A/79: High Affinity Antibodies to Human IL-6 Receptor
GCTGCATCC
>HW382490.1 JP 2013226143-A/71: High Affinity Antibodies to Human IL-6 Receptor
GATGCATCC
>HW382482.1 JP 2013226143-A/63: High Affinity Antibodies to Human IL-6 Receptor
GTTGCATCC
>HW382474.1 JP 2013226143-A/55: High Affinity Antibodies to Human IL-6 Receptor
GATGCATCC
>HW382466.1 JP 2013226143-A/47: High Affinity Antibodies to Human IL-6 Receptor
GATGCATCC
>HW382458.1 JP 2013226143-A/39: High Affinity Antibodies to Human IL-6 Receptor
GATGCATCC
>HW382450.1 JP 2013226143-A/31: High Affinity Antibodies to Human IL-6 Receptor
GATGCATCC
>HW382442.1 JP 2013226143-A/23: High Affinity Antibodies to Human IL-6 Receptor
GATGCATCC
>HW382434.1 JP 2013226143-A/15: High Affinity Antibodies to Human IL-6 Receptor
GGTGCATCC
>HW382426.1 JP 2013226143-A/7: High Affinity Antibodies to Human IL-6 Receptor
GGTGCATCC
>HW389448.1 JP 2013539355-A/10: Novel antibody for the diagnosis and/or prognosis of cancer
GTTGCATCT
>HW389440.1 JP 2013539355-A/2: Novel antibody for the diagnosis and/or prognosis of cancer
CAGATGTCC
>HW389124.1 JP 2013538796-A/2: Safe and Functional Humanized Antibodies
GGTGACTAC
>HW367205.1 JP 2012193192-A/16: Method for modulating responsiveness to steroids
AGTTCGTCC
>FW348783.1 JP 2010053132-A/13: Compositions and methods for generating chimeric heteromultimers
TTAACTTTA
>HW364874.1 JP 2012196214-A/15: RATIONALLY-DESIGNED MEGANULEASES WITH ALTERED SEQUENCE SPECIFICITY AND AND-BINDING AFFINITY
CTCCGGGTC
>HW364791.1 JP 2012175982-A/1: NUCLEIC ACID BINDING POLYPEPTIDE LIBRARY
GNNNCGGCG
>HW364875.1 JP 2012196214-A/16: RATIONALLY-DESIGNED MEGANULEASES WITH ALTERED SEQUENCE SPECIFICITY AND AND-BINDING AFFINITY
TGCGGTGTC
>HW364871.1 JP 2012196214-A/12: RATIONALLY-DESIGNED MEGANULEASES WITH ALTERED SEQUENCE SPECIFICITY AND AND-BINDING AFFINITY
GAAGAGCTC
>HW364792.1 JP 2012175982-A/2: NUCLEIC ACID BINDING POLYPEPTIDE LIBRARY
GNNNCGGCG
>HW364876.1 JP 2012196214-A/17: RATIONALLY-DESIGNED MEGANULEASES WITH ALTERED SEQUENCE SPECIFICITY AND AND-BINDING AFFINITY
CAGGCTGTC
>HW364872.1 JP 2012196214-A/13: RATIONALLY-DESIGNED MEGANULEASES WITH ALTERED SEQUENCE SPECIFICITY AND AND-BINDING AFFINITY
TGACTGTTC
>HW364793.1 JP 2012175982-A/3: NUCLEIC ACID BINDING POLYPEPTIDE LIBRARY
GCNNCGGCG
>HW364873.1 JP 2012196214-A/14: RATIONALLY-DESIGNED MEGANULEASES WITH ALTERED SEQUENCE SPECIFICITY AND AND-BINDING AFFINITY
AACCCTCTC
>HW364794.1 JP 2012175982-A/4: NUCLEIC ACID BINDING POLYPEPTIDE LIBRARY
GCGGNNNNN
>JC468226.1 Sequence 14 from Patent EP2598882
GGTGACTAC
>JC439205.1 Sequence 39 from Patent EP2311982
ACGTTCAGT
>JC450260.1 Sequence 795 from Patent EP2489275
GAAGAAATA
>JC450257.1 Sequence 792 from Patent EP2489275
GTAGAATAC
>JC372187.1 Sequence 5757 from Patent EP2470660
AATAAAAAA
>JC371897.1 Sequence 5467 from Patent EP2470660
TAGAGAAGA
>JC371754.1 Sequence 5324 from Patent EP2470660
GATATCACC
>JC371705.1 Sequence 5275 from Patent EP2470660
GGAATATCT
>JC371665.1 Sequence 5235 from Patent EP2470660
GGCAAATGT
>JC371502.1 Sequence 5072 from Patent EP2470660
AATCCAAAT
>JC371441.1 Sequence 5011 from Patent EP2470660
TCTAGCAAT
>JC370988.1 Sequence 4558 from Patent EP2470660
GTGCTAGAT
>JC365767.1 Sequence 19 from Patent EP2468770
GGTGACTAC
>JC280433.1 Sequence 733 from Patent WO2012101252
TTGGGTTTT
>JC280409.1 Sequence 709 from Patent WO2012101252
GGTGCATCC
>JC280385.1 Sequence 685 from Patent WO2012101252
AAGGTTTCT
>JC280361.1 Sequence 661 from Patent WO2012101252
AAGGTTTCT
>JC287164.1 Sequence 188 from Patent WO2012071372
TTGGGTTCT
>JC287144.1 Sequence 168 from Patent WO2012071372
TGGGCATCT
>JC287117.1 Sequence 141 from Patent WO2012071372
ACTGCATTC
>JC287097.1 Sequence 121 from Patent WO2012071372
GCTGCATCC
>JC287077.1 Sequence 101 from Patent WO2012071372
GCTACATCC
>JC287057.1 Sequence 81 from Patent WO2012071372
GCTGCATCC
>JC287037.1 Sequence 61 from Patent WO2012071372
ACTGCATCC
>JC287021.1 Sequence 45 from Patent WO2012071372
TTGGGTTCT
>JC287005.1 Sequence 29 from Patent WO2012071372
TTGGGTTCT
>JC286989.1 Sequence 13 from Patent WO2012071372
TTGGGTTCT
>JC258380.1 Sequence 78 from Patent EP2361979
CCGCGTGGC
>JC258376.1 Sequence 74 from Patent EP2361979
CCGACTGGC
>JC258372.1 Sequence 70 from Patent EP2361979
CCGCATGGC
>JC258368.1 Sequence 66 from Patent EP2361979
CCGAGTGGC
>JC258385.1 Sequence 83 from Patent EP2361979
CCGGTTGGC
>JC258382.1 Sequence 80 from Patent EP2361979
CCGCATGGC
>JC258378.1 Sequence 76 from Patent EP2361979
CCGACTGGC
>JC258374.1 Sequence 72 from Patent EP2361979
CCGGTTGGC
>JC258370.1 Sequence 68 from Patent EP2361979
CCGCGTGGC
>JC275674.1 Sequence 16 from Patent WO2011151412
AGGGCTTCT
>JC280313.1 Sequence 613 from Patent WO2012101252
GGTGCATCC
>JC280289.1 Sequence 589 from Patent WO2012101252
GATGCATCC
>JC280265.1 Sequence 565 from Patent WO2012101252
GGTGCATCC
>JC280241.1 Sequence 541 from Patent WO2012101252
GGTGCATCC
>JC280217.1 Sequence 517 from Patent WO2012101252
TTGGGTTTT
>JC280193.1 Sequence 493 from Patent WO2012101252
GGTGCATCC
>JC280169.1 Sequence 469 from Patent WO2012101252
AAGGCGTCT
>JC280145.1 Sequence 445 from Patent WO2012101252
AAGGCGTCT
>JC280121.1 Sequence 421 from Patent WO2012101252
AAGGCGTCT
>JC280097.1 Sequence 397 from Patent WO2012101252
AAGGCGTCT
>JC280073.1 Sequence 373 from Patent WO2012101252
GGTGCATCC
>JC280049.1 Sequence 349 from Patent WO2012101252
AAGGCGTCT
>JC280025.1 Sequence 325 from Patent WO2012101252
AAGGTTTCT
>JC280001.1 Sequence 301 from Patent WO2012101252
TTGGGTTCT
>JC279977.1 Sequence 277 from Patent WO2012101252
TTGGGTTTT
>JC279953.1 Sequence 253 from Patent WO2012101252
TTGGGTTTT
>JC279929.1 Sequence 229 from Patent WO2012101252
TTGGGTTCT
>JC279905.1 Sequence 205 from Patent WO2012101252
TTGGGTTCT
>JC279881.1 Sequence 181 from Patent WO2012101252
TTGGGTTCT
>JC279857.1 Sequence 157 from Patent WO2012101252
AAGGTTTCT
>JC279833.1 Sequence 133 from Patent WO2012101252
GCTGCATCC
>JC279809.1 Sequence 109 from Patent WO2012101252
GCTGCATCC
>JC279785.1 Sequence 85 from Patent WO2012101252
TGGGCATCT
>JC279761.1 Sequence 61 from Patent WO2012101252
TGGGCCTCT
>JC279737.1 Sequence 37 from Patent WO2012101252
AAGGCGTCT
>JC279713.1 Sequence 13 from Patent WO2012101252
GGTGCATCC
>JC280337.1 Sequence 637 from Patent WO2012101252
AAGGTTTCT
>JC325707.1 Sequence 733 from Patent WO2012101253
TTGGGTTTT
>JC325683.1 Sequence 709 from Patent WO2012101253
GGTGCATCC
>JC325659.1 Sequence 685 from Patent WO2012101253
AAGGTTTCT
>JC325635.1 Sequence 661 from Patent WO2012101253
AAGGTTTCT
>JC325611.1 Sequence 637 from Patent WO2012101253
AAGGTTTCT
>JC325587.1 Sequence 613 from Patent WO2012101253
GGTGCATCC
>JC325563.1 Sequence 589 from Patent WO2012101253
GATGCATCC
>JC325539.1 Sequence 565 from Patent WO2012101253
GGTGCATCC
>JC325515.1 Sequence 541 from Patent WO2012101253
GGTGCATCC
>JC325491.1 Sequence 517 from Patent WO2012101253
TTGGGTTTT
>JC325467.1 Sequence 493 from Patent WO2012101253
GGTGCATCC
>JC325443.1 Sequence 469 from Patent WO2012101253
AAGGCGTCT
>JC325419.1 Sequence 445 from Patent WO2012101253
AAGGCGTCT
>JC325395.1 Sequence 421 from Patent WO2012101253
AAGGCGTCT
>JC325371.1 Sequence 397 from Patent WO2012101253
AAGGCGTCT
>JC325347.1 Sequence 373 from Patent WO2012101253
GGTGCATCC
>JC325323.1 Sequence 349 from Patent WO2012101253
AAGGCGTCT
>JC325299.1 Sequence 325 from Patent WO2012101253
AAGGTTTCT
>JC325275.1 Sequence 301 from Patent WO2012101253
TTGGGTTCT
>JC325251.1 Sequence 277 from Patent WO2012101253
TTGGGTTTT
>JC325227.1 Sequence 253 from Patent WO2012101253
TTGGGTTTT
>JC325203.1 Sequence 229 from Patent WO2012101253
TTGGGTTCT
>JC325179.1 Sequence 205 from Patent WO2012101253
TTGGGTTCT
>JC362389.1 Sequence 36 from Patent EP2402370
GTTGCATCT
>JC362381.1 Sequence 28 from Patent EP2402370
CAGATGTCC
>JC325155.1 Sequence 181 from Patent WO2012101253
TTGGGTTCT
>JC325131.1 Sequence 157 from Patent WO2012101253
AAGGTTTCT
>JC325107.1 Sequence 133 from Patent WO2012101253
GCTGCATCC
>JC325083.1 Sequence 109 from Patent WO2012101253
GCTGCATCC
>JC325059.1 Sequence 85 from Patent WO2012101253
TGGGCATCT
>JC325035.1 Sequence 61 from Patent WO2012101253
TGGGCCTCT
>JC325011.1 Sequence 37 from Patent WO2012101253
AAGGCGTCT
>JC324987.1 Sequence 13 from Patent WO2012101253
GGTGCATCC
>JC296422.1 Sequence 493 from Patent WO2013112438
GCTGCAACC
>JC296398.1 Sequence 469 from Patent WO2013112438
GCTACATCC
>JC370396.1 Sequence 3966 from Patent EP2470660
TGTGAGATA
>JC370289.1 Sequence 3859 from Patent EP2470660
ATATATTGT
>JC370242.1 Sequence 3812 from Patent EP2470660
GGTGATAAT
>JC370197.1 Sequence 3767 from Patent EP2470660
GGCTCTAAT
>JC369975.1 Sequence 3545 from Patent EP2470660
CTAAAATTA
>JC369918.1 Sequence 3488 from Patent EP2470660
CCGTGAGAG
>JC369894.1 Sequence 3464 from Patent EP2470660
GTGTTGGAT
>JC369869.1 Sequence 3439 from Patent EP2470660
TTTAAAGAA
>JC369829.1 Sequence 3399 from Patent EP2470660
TTTTTTTAA
>JC369819.1 Sequence 3389 from Patent EP2470660
AAAAAGTTT
>JC369643.1 Sequence 3213 from Patent EP2470660
AGCAGGAAA
>JC296374.1 Sequence 445 from Patent WO2013112438
TCTGCATCC
>JC296350.1 Sequence 421 from Patent WO2013112438
GCTGCATCC
>JC296326.1 Sequence 397 from Patent WO2013112438
TTGGGTTCT
>JC296302.1 Sequence 373 from Patent WO2013112438
AAGGCGTCT
>JC296278.1 Sequence 349 from Patent WO2013112438
TTGGGTTCT
>JC296254.1 Sequence 325 from Patent WO2013112438
GGTGCGTCC
>JC296230.1 Sequence 301 from Patent WO2013112438
AAGGCGTCT
>JC296206.1 Sequence 277 from Patent WO2013112438
GCTGCATCC
>JC296182.1 Sequence 253 from Patent WO2013112438
GCTGCATCC
>JC296158.1 Sequence 229 from Patent WO2013112438
GGTGCATCC
>JC296134.1 Sequence 205 from Patent WO2013112438
GCTGCATCC
>JC296110.1 Sequence 181 from Patent WO2013112438
GCTACATCC
>JC296086.1 Sequence 157 from Patent WO2013112438
GCTGCATCC
>JC296062.1 Sequence 133 from Patent WO2013112438
GGTGCATCC
>JC296038.1 Sequence 109 from Patent WO2013112438
AAGGCGTCT
>JC296014.1 Sequence 85 from Patent WO2013112438
GCTGCATCC
>JC295990.1 Sequence 61 from Patent WO2013112438
AGTGCATCC
>JC269262.1 Sequence 68 from Patent EP2415784
ACCACATCC
>JC269233.1 Sequence 39 from Patent EP2415784
GCTGCAACA
>JC269228.1 Sequence 34 from Patent EP2415784
CGTGCATCC
>JC324389.1 Sequence 191 from Patent WO2012174178
AAGGCGTCT
>JC324355.1 Sequence 157 from Patent WO2012174178
GTTGCAGCC
>JC324339.1 Sequence 141 from Patent WO2012174178
AAGGTTTCT
>JC324323.1 Sequence 125 from Patent WO2012174178
ACTGCATCC
>JC324307.1 Sequence 109 from Patent WO2012174178
CCTGCATCC
>JC324291.1 Sequence 93 from Patent WO2012174178
ACTACTTCC
>JC324275.1 Sequence 77 from Patent WO2012174178
AAGGCGTCT
>JC324259.1 Sequence 61 from Patent WO2012174178
AAGGCGTCT
>JC324243.1 Sequence 45 from Patent WO2012174178
GCTGCATCC
>JC324227.1 Sequence 29 from Patent WO2012174178
AAGGCGTCT
>JC324211.1 Sequence 13 from Patent WO2012174178
GCTGCATCC
>JC277435.1 Sequence 76 from Patent WO2011088076
CYCRCCGYY
>JC295966.1 Sequence 37 from Patent WO2013112438
GATGCATCT
>JC295942.1 Sequence 13 from Patent WO2013112438
GGTGCATCC
>JC264108.1 Sequence 58 from Patent WO2012175576
TGGGCCTCT
>JC264083.1 Sequence 33 from Patent WO2012175576
TGGGCATCC
>JC272064.1 Sequence 13 from Patent WO2011157294
AGCAGCATT
>JC353944.1 Sequence 24 from Patent EP2500036
GCTGCATCC
>JC353937.1 Sequence 17 from Patent EP2500036
GCAAGTAGG
>JC339441.1 Sequence 12 from Patent EP2367935
TTTCCGAAA
>JC339440.1 Sequence 11 from Patent EP2367935
GAAACTTTC
>JC245726.1 Sequence 87 from Patent EP2325209
MAGGTRAGT
>JC225706.1 Sequence 234 from Patent EP2479277
GCCGCCACC
>JC225373.1 Sequence 43 from Patent WO2013015821
TGGGCATCC
>JC225357.1 Sequence 27 from Patent WO2013015821
TGGGCATCC
>JC225341.1 Sequence 11 from Patent WO2013015821
CGGGCATCC
>JC222747.1 Sequence 13 from Patent WO2012004631
GACACATCC
>JC221188.1 Sequence 68 from Patent EP2415785
ACCACATCC
>JC221159.1 Sequence 39 from Patent EP2415785
GCTGCAACA
>JC221154.1 Sequence 34 from Patent EP2415785
CGTGCATCC
>JC218430.1 Sequence 109 from Patent WO2013026835
TTTGACTAC
>JC217196.1 Sequence 68 from Patent EP2535357
ACCACATCC
>JC217167.1 Sequence 39 from Patent EP2535357
GCTGCAACA
>JC217162.1 Sequence 34 from Patent EP2535357
CGTGCATCC
>JC216408.1 Sequence 36 from Patent WO2012007280
GTTGCATCT
>JC216400.1 Sequence 28 from Patent WO2012007280
CAGATGTCC
>JC234599.1 Sequence 109 from Patent WO2013026839
TTTGACTAC
>JC208665.1 Sequence 16 from Patent WO2012007919
GGCCGACGT
>JC208664.1 Sequence 15 from Patent WO2012007919
GGCCGACAT
>JC208657.1 Sequence 8 from Patent WO2012007919
TGCCACCGG
>JC208654.1 Sequence 5 from Patent WO2012007919
TACCGACAT
>JC193510.1 Sequence 3 from Patent WO2012131004
TTTGATTAC
>JC190526.1 Sequence 643 from Patent EP2521776
GCTTCTGGA
>JC190523.1 Sequence 640 from Patent EP2521776
GCTTCTGGA
>JC210352.1 Sequence 75 from Patent WO2011121040
TGGGCATCC
>JC210338.1 Sequence 61 from Patent WO2011121040
TGGGCCTCT
>JC210313.1 Sequence 36 from Patent WO2011121040
TGGGCCAGC
>JC188739.1 Sequence 13 from Patent WO2013017562
TGGGCATCC
>JC182692.1 Sequence 2 from Patent WO2012164083
TAATCCATG
>JC108372.1 Sequence 8 from Patent EP2666857
TGACATTGC
>JC108373.1 Sequence 9 from Patent EP2666857
TGACAAAGC
>JC106271.1 Sequence 27 from Patent WO2013177191
ATCGACCTT
>JC102565.1 Sequence 154 from Patent WO2013148250
AATATAAAT
>JC102557.1 Sequence 146 from Patent WO2013148250
TATGTCTCA
>JC102549.1 Sequence 138 from Patent WO2013148250
TATGTCTCA
>JC102541.1 Sequence 130 from Patent WO2013148250
CGGATGTCC
>JC102533.1 Sequence 122 from Patent WO2013148250
TGGGCATCC
>JC102525.1 Sequence 114 from Patent WO2013148250
CGGATGTCC
>JC102517.1 Sequence 106 from Patent WO2013148250
TGGGCATCC
>JC102509.1 Sequence 98 from Patent WO2013148250
GATGCCTCA
>JC102501.1 Sequence 90 from Patent WO2013148250
ACGGCATCC
>JC102493.1 Sequence 82 from Patent WO2013148250
TTGGTATCC
>JC101447.1 Sequence 42 from Patent WO2013181615
TTVYCCWAG
>JC101407.1 Sequence 2 from Patent WO2013181615
TTACCCAAG
>JC171224.1 Sequence 381 from Patent WO2013152001
AAGGCGTCT
>JC171208.1 Sequence 365 from Patent WO2013152001
AAGGCGTCT
>JC171192.1 Sequence 349 from Patent WO2013152001
TGGGCATCT
>JC171176.1 Sequence 333 from Patent WO2013152001
TGGGCATCT
>JC171160.1 Sequence 317 from Patent WO2013152001
TGGGCATCT
>JC171144.1 Sequence 301 from Patent WO2013152001
GGTACATCC
>JC171128.1 Sequence 285 from Patent WO2013152001
TGGGCATCT
>JC171112.1 Sequence 269 from Patent WO2013152001
GATGCATCC
>JC171096.1 Sequence 253 from Patent WO2013152001
TGGGCATCT
>JC171080.1 Sequence 237 from Patent WO2013152001
GGTGCATCC
>JC171064.1 Sequence 221 from Patent WO2013152001
GCTGCATCC
>JC171048.1 Sequence 205 from Patent WO2013152001
GCTGCATCC
>JC171032.1 Sequence 189 from Patent WO2013152001
GGTGCATCC
>JC171016.1 Sequence 173 from Patent WO2013152001
GCTGCATCC
>JC171000.1 Sequence 157 from Patent WO2013152001
GATGCATCC
>JC170984.1 Sequence 141 from Patent WO2013152001
GCTGCATCC
>JC170968.1 Sequence 125 from Patent WO2013152001
TGGGCATCT
>JC170952.1 Sequence 109 from Patent WO2013152001
GCTGCATCC
>JC170936.1 Sequence 93 from Patent WO2013152001
GCTGCATCC
>JC170920.1 Sequence 77 from Patent WO2013152001
GCTGCATCC
>JC170904.1 Sequence 61 from Patent WO2013152001
GCTGCATCC
>JC170888.1 Sequence 45 from Patent WO2013152001
GCTGCATCC
>JC170872.1 Sequence 29 from Patent WO2013152001
GCTGCATCC
>JC170856.1 Sequence 13 from Patent WO2013152001
GCTGCATCC
>JC110503.1 Sequence 1 from Patent WO2013173693
TTCAGAAGG
>HW341440.1 JP 2013223495-A/127: High Affinity Human Antibodies to Human IL-4R Receptor
GATGCATCC
>HW341428.1 JP 2013223495-A/115: High Affinity Human Antibodies to Human IL-4R Receptor
GATGCATCC
>HW341416.1 JP 2013223495-A/103: High Affinity Human Antibodies to Human IL-4R Receptor
GTTGCATCC
>HW341404.1 JP 2013223495-A/91: High Affinity Human Antibodies to Human IL-4R Receptor
GCTGCATCC
>HW341392.1 JP 2013223495-A/79: High Affinity Human Antibodies to Human IL-4R Receptor
TTGGGTTCT
>HW341380.1 JP 2013223495-A/67: High Affinity Human Antibodies to Human IL-4R Receptor
AGTGCCTCC
>HW341368.1 JP 2013223495-A/55: High Affinity Human Antibodies to Human IL-4R Receptor
GCTGCATCC
>HW341356.1 JP 2013223495-A/43: High Affinity Human Antibodies to Human IL-4R Receptor
TTGGGTTCT
>HW341344.1 JP 2013223495-A/31: High Affinity Human Antibodies to Human IL-4R Receptor
GCTGTATCC
>HW341332.1 JP 2013223495-A/19: High Affinity Human Antibodies to Human IL-4R Receptor
GCTGCATCC
>HW341320.1 JP 2013223495-A/7: High Affinity Human Antibodies to Human IL-4R Receptor
GCTGCATCC
>HW341224.1 JP 2013220103-A/256: SOMATIC HYPERMUTATION SYSTEMS
AGTAGGTTG
>HW341223.1 JP 2013220103-A/255: SOMATIC HYPERMUTATION SYSTEMS
AGCAGGTTG
>HW341222.1 JP 2013220103-A/254: SOMATIC HYPERMUTATION SYSTEMS
AGCAGGCTA
>HW341221.1 JP 2013220103-A/253: SOMATIC HYPERMUTATION SYSTEMS
AGCAGGTTA
>HW341220.1 JP 2013220103-A/252: SOMATIC HYPERMUTATION SYSTEMS
AGCAGGCTG
>HW341219.1 JP 2013220103-A/251: SOMATIC HYPERMUTATION SYSTEMS
AGCAGGCTT
>HW341218.1 JP 2013220103-A/250: SOMATIC HYPERMUTATION SYSTEMS
AGTAGGCTA
>HW341217.1 JP 2013220103-A/249: SOMATIC HYPERMUTATION SYSTEMS
AGTAGGTTA
>HW341216.1 JP 2013220103-A/248: SOMATIC HYPERMUTATION SYSTEMS
AGTAGGCTG
>HW341215.1 JP 2013220103-A/247: SOMATIC HYPERMUTATION SYSTEMS
AGTAGGCTT
>HW341214.1 JP 2013220103-A/246: SOMATIC HYPERMUTATION SYSTEMS
TCTCGCTTG
>HW341213.1 JP 2013220103-A/245: SOMATIC HYPERMUTATION SYSTEMS
TCTCGCCTC
>HW341212.1 JP 2013220103-A/244: SOMATIC HYPERMUTATION SYSTEMS
TCTCGCCTA
>HW341211.1 JP 2013220103-A/243: SOMATIC HYPERMUTATION SYSTEMS
TCTCGCTTA
>HW341210.1 JP 2013220103-A/242: SOMATIC HYPERMUTATION SYSTEMS
TCTCGCCTG
>HW341209.1 JP 2013220103-A/241: SOMATIC HYPERMUTATION SYSTEMS
TCTCGCCTT
>HW341208.1 JP 2013220103-A/240: SOMATIC HYPERMUTATION SYSTEMS
TCTCGGTTG
>HW341207.1 JP 2013220103-A/239: SOMATIC HYPERMUTATION SYSTEMS
TCTCGGCTC
>HW341206.1 JP 2013220103-A/238: SOMATIC HYPERMUTATION SYSTEMS
TCTCGGCTA
>HW341205.1 JP 2013220103-A/237: SOMATIC HYPERMUTATION SYSTEMS
TCTCGGTTA
>HW341204.1 JP 2013220103-A/236: SOMATIC HYPERMUTATION SYSTEMS
TCTCGGCTG
>HW341203.1 JP 2013220103-A/235: SOMATIC HYPERMUTATION SYSTEMS
TCTCGGCTT
>HW341202.1 JP 2013220103-A/234: SOMATIC HYPERMUTATION SYSTEMS
TCTAGATTG
>HW341201.1 JP 2013220103-A/233: SOMATIC HYPERMUTATION SYSTEMS
TCTAGACTC
>HW341200.1 JP 2013220103-A/232: SOMATIC HYPERMUTATION SYSTEMS
TCTAGACTA
>HW341199.1 JP 2013220103-A/231: SOMATIC HYPERMUTATION SYSTEMS
TCTAGATTA
>HW341198.1 JP 2013220103-A/230: SOMATIC HYPERMUTATION SYSTEMS
TCTAGACTG
>HW341197.1 JP 2013220103-A/229: SOMATIC HYPERMUTATION SYSTEMS
TCTAGACTT
>HW341196.1 JP 2013220103-A/228: SOMATIC HYPERMUTATION SYSTEMS
TCTCGTTTG
>HW341195.1 JP 2013220103-A/227: SOMATIC HYPERMUTATION SYSTEMS
TCTCGTCTC
>HW341194.1 JP 2013220103-A/226: SOMATIC HYPERMUTATION SYSTEMS
TCTCGTCTA
>HW341193.1 JP 2013220103-A/225: SOMATIC HYPERMUTATION SYSTEMS
TCTCGTTTA
>HW341192.1 JP 2013220103-A/224: SOMATIC HYPERMUTATION SYSTEMS
TCTCGTCTG
>HW341191.1 JP 2013220103-A/223: SOMATIC HYPERMUTATION SYSTEMS
TCTCGTCTT
>HW341190.1 JP 2013220103-A/222: SOMATIC HYPERMUTATION SYSTEMS
TCTAGGTTG
>HW341189.1 JP 2013220103-A/221: SOMATIC HYPERMUTATION SYSTEMS
TCTAGGCTC
>HW341188.1 JP 2013220103-A/220: SOMATIC HYPERMUTATION SYSTEMS
TCTAGGCTA
>HW341187.1 JP 2013220103-A/219: SOMATIC HYPERMUTATION SYSTEMS
TCTAGGTTA
>HW341186.1 JP 2013220103-A/218: SOMATIC HYPERMUTATION SYSTEMS
TCTAGGCTG
>HW341185.1 JP 2013220103-A/217: SOMATIC HYPERMUTATION SYSTEMS
TCTAGGCTT
>HW341184.1 JP 2013220103-A/216: SOMATIC HYPERMUTATION SYSTEMS
TCTCGATTG
>HW341183.1 JP 2013220103-A/215: SOMATIC HYPERMUTATION SYSTEMS
TCTCGACTC
>HW341182.1 JP 2013220103-A/214: SOMATIC HYPERMUTATION SYSTEMS
TCTCGACTA
>HW341181.1 JP 2013220103-A/213: SOMATIC HYPERMUTATION SYSTEMS
TCTCGATTA
>HW341180.1 JP 2013220103-A/212: SOMATIC HYPERMUTATION SYSTEMS
TCTCGACTG
>HW341179.1 JP 2013220103-A/211: SOMATIC HYPERMUTATION SYSTEMS
TCTCGACTT
>HW341178.1 JP 2013220103-A/210: SOMATIC HYPERMUTATION SYSTEMS
TCCCGCTTG
>HW341177.1 JP 2013220103-A/209: SOMATIC HYPERMUTATION SYSTEMS
TCCCGCCTC
>HW341176.1 JP 2013220103-A/208: SOMATIC HYPERMUTATION SYSTEMS
TCCCGCCTA
>HW341175.1 JP 2013220103-A/207: SOMATIC HYPERMUTATION SYSTEMS
TCCCGCTTA
>HW341174.1 JP 2013220103-A/206: SOMATIC HYPERMUTATION SYSTEMS
TCCCGCCTG
>HW341173.1 JP 2013220103-A/205: SOMATIC HYPERMUTATION SYSTEMS
TCCCGCCTT
>HW341172.1 JP 2013220103-A/204: SOMATIC HYPERMUTATION SYSTEMS
TCCCGGTTG
>HW341171.1 JP 2013220103-A/203: SOMATIC HYPERMUTATION SYSTEMS
TCCCGGCTC
>HW341170.1 JP 2013220103-A/202: SOMATIC HYPERMUTATION SYSTEMS
TCCCGGCTA
>HW341169.1 JP 2013220103-A/201: SOMATIC HYPERMUTATION SYSTEMS
TCCCGGTTA
>HW341168.1 JP 2013220103-A/200: SOMATIC HYPERMUTATION SYSTEMS
TCCCGGCTG
>HW341167.1 JP 2013220103-A/199: SOMATIC HYPERMUTATION SYSTEMS
TCCCGGCTT
>HW341166.1 JP 2013220103-A/198: SOMATIC HYPERMUTATION SYSTEMS
TCCAGATTG
>HW341165.1 JP 2013220103-A/197: SOMATIC HYPERMUTATION SYSTEMS
TCCAGACTC
>HW341164.1 JP 2013220103-A/196: SOMATIC HYPERMUTATION SYSTEMS
TCCAGACTA
>HW341163.1 JP 2013220103-A/195: SOMATIC HYPERMUTATION SYSTEMS
TCCAGATTA
>HW341162.1 JP 2013220103-A/194: SOMATIC HYPERMUTATION SYSTEMS
TCCAGACTG
>HW341161.1 JP 2013220103-A/193: SOMATIC HYPERMUTATION SYSTEMS
TCCAGACTT
>HW341160.1 JP 2013220103-A/192: SOMATIC HYPERMUTATION SYSTEMS
TCCCGTTTG
>HW341159.1 JP 2013220103-A/191: SOMATIC HYPERMUTATION SYSTEMS
TCCCGTCTC
>HW341158.1 JP 2013220103-A/190: SOMATIC HYPERMUTATION SYSTEMS
TCCCGTCTA
>HW341157.1 JP 2013220103-A/189: SOMATIC HYPERMUTATION SYSTEMS
TCCCGTTTA
>HW341156.1 JP 2013220103-A/188: SOMATIC HYPERMUTATION SYSTEMS
TCCCGTCTG
>HW341155.1 JP 2013220103-A/187: SOMATIC HYPERMUTATION SYSTEMS
TCCCGTCTT
>HW341154.1 JP 2013220103-A/186: SOMATIC HYPERMUTATION SYSTEMS
TCCAGGTTG
>HW341153.1 JP 2013220103-A/185: SOMATIC HYPERMUTATION SYSTEMS
TCCAGGCTC
>HW341152.1 JP 2013220103-A/184: SOMATIC HYPERMUTATION SYSTEMS
TCCAGGCTA
>HW341151.1 JP 2013220103-A/183: SOMATIC HYPERMUTATION SYSTEMS
TCCAGGTTA
>HW341150.1 JP 2013220103-A/182: SOMATIC HYPERMUTATION SYSTEMS
TCCAGGCTG
>HW341149.1 JP 2013220103-A/181: SOMATIC HYPERMUTATION SYSTEMS
TCCAGGCTT
>HW341148.1 JP 2013220103-A/180: SOMATIC HYPERMUTATION SYSTEMS
TCCCGATTG
>HW341147.1 JP 2013220103-A/179: SOMATIC HYPERMUTATION SYSTEMS
TCCCGACTC
>HW341146.1 JP 2013220103-A/178: SOMATIC HYPERMUTATION SYSTEMS
TCCCGACTA
>HW341145.1 JP 2013220103-A/177: SOMATIC HYPERMUTATION SYSTEMS
TCCCGATTA
>HW341144.1 JP 2013220103-A/176: SOMATIC HYPERMUTATION SYSTEMS
TCCCGACTG
>HW341143.1 JP 2013220103-A/175: SOMATIC HYPERMUTATION SYSTEMS
TCCCGACTT
>HW341142.1 JP 2013220103-A/174: SOMATIC HYPERMUTATION SYSTEMS
TCGCGCTTG
>HW341141.1 JP 2013220103-A/173: SOMATIC HYPERMUTATION SYSTEMS
TCGCGCCTC
>HW341140.1 JP 2013220103-A/172: SOMATIC HYPERMUTATION SYSTEMS
TCGCGCCTA
>HW341139.1 JP 2013220103-A/171: SOMATIC HYPERMUTATION SYSTEMS
TCGCGCTTA
>HW341138.1 JP 2013220103-A/170: SOMATIC HYPERMUTATION SYSTEMS
TCGCGCCTG
>HW341137.1 JP 2013220103-A/169: SOMATIC HYPERMUTATION SYSTEMS
TCGCGCCTT
>HW341136.1 JP 2013220103-A/168: SOMATIC HYPERMUTATION SYSTEMS
TCGCGGTTG
>HW341135.1 JP 2013220103-A/167: SOMATIC HYPERMUTATION SYSTEMS
TCGCGGCTC
>HW341134.1 JP 2013220103-A/166: SOMATIC HYPERMUTATION SYSTEMS
TCGCGGCTA
>HW341133.1 JP 2013220103-A/165: SOMATIC HYPERMUTATION SYSTEMS
TCGCGGTTA
>HW341132.1 JP 2013220103-A/164: SOMATIC HYPERMUTATION SYSTEMS
TCGCGGCTG
>HW341131.1 JP 2013220103-A/163: SOMATIC HYPERMUTATION SYSTEMS
TCGCGGCTT
>HW341130.1 JP 2013220103-A/162: SOMATIC HYPERMUTATION SYSTEMS
TCGAGATTG
>HW341129.1 JP 2013220103-A/161: SOMATIC HYPERMUTATION SYSTEMS
TCGAGACTC
>HW341128.1 JP 2013220103-A/160: SOMATIC HYPERMUTATION SYSTEMS
TCGAGACTA
>HW341127.1 JP 2013220103-A/159: SOMATIC HYPERMUTATION SYSTEMS
TCGAGATTA
>HW341126.1 JP 2013220103-A/158: SOMATIC HYPERMUTATION SYSTEMS
TCGAGACTG
>HW341125.1 JP 2013220103-A/157: SOMATIC HYPERMUTATION SYSTEMS
TCGAGACTT
>HW341124.1 JP 2013220103-A/156: SOMATIC HYPERMUTATION SYSTEMS
TCGCGTTTG
>HW341123.1 JP 2013220103-A/155: SOMATIC HYPERMUTATION SYSTEMS
TCGCGTCTC
>HW341122.1 JP 2013220103-A/154: SOMATIC HYPERMUTATION SYSTEMS
TCGCGTCTA
>HW341121.1 JP 2013220103-A/153: SOMATIC HYPERMUTATION SYSTEMS
TCGCGTTTA
>HW341120.1 JP 2013220103-A/152: SOMATIC HYPERMUTATION SYSTEMS
TCGCGTCTG
>HW341119.1 JP 2013220103-A/151: SOMATIC HYPERMUTATION SYSTEMS
TCGCGTCTT
>HW341118.1 JP 2013220103-A/150: SOMATIC HYPERMUTATION SYSTEMS
TCGAGGTTG
>HW341117.1 JP 2013220103-A/149: SOMATIC HYPERMUTATION SYSTEMS
TCGAGGCTC
>HW341116.1 JP 2013220103-A/148: SOMATIC HYPERMUTATION SYSTEMS
TCGAGGCTA
>HW341115.1 JP 2013220103-A/147: SOMATIC HYPERMUTATION SYSTEMS
TCGAGGTTA
>HW341114.1 JP 2013220103-A/146: SOMATIC HYPERMUTATION SYSTEMS
TCGAGGCTG
>HW341113.1 JP 2013220103-A/145: SOMATIC HYPERMUTATION SYSTEMS
TCGAGGCTT
>HW341112.1 JP 2013220103-A/144: SOMATIC HYPERMUTATION SYSTEMS
TCGCGATTG
>HW341111.1 JP 2013220103-A/143: SOMATIC HYPERMUTATION SYSTEMS
TCGCGACTC
>HW341110.1 JP 2013220103-A/142: SOMATIC HYPERMUTATION SYSTEMS
TCGCGACTA
>HW341109.1 JP 2013220103-A/141: SOMATIC HYPERMUTATION SYSTEMS
TCGCGATTA
>HW341108.1 JP 2013220103-A/140: SOMATIC HYPERMUTATION SYSTEMS
TCGCGACTG
>HW341107.1 JP 2013220103-A/139: SOMATIC HYPERMUTATION SYSTEMS
TCGCGACTT
>HW341106.1 JP 2013220103-A/138: SOMATIC HYPERMUTATION SYSTEMS
AGCCGCTTG
>HW341105.1 JP 2013220103-A/137: SOMATIC HYPERMUTATION SYSTEMS
AGCCGCCTC
>HW341104.1 JP 2013220103-A/136: SOMATIC HYPERMUTATION SYSTEMS
AGCCGCCTA
>HW341103.1 JP 2013220103-A/135: SOMATIC HYPERMUTATION SYSTEMS
AGCCGCTTA
>HW341102.1 JP 2013220103-A/134: SOMATIC HYPERMUTATION SYSTEMS
AGCCGCCTG
>HW341101.1 JP 2013220103-A/133: SOMATIC HYPERMUTATION SYSTEMS
AGCCGCCTT
>HW341100.1 JP 2013220103-A/132: SOMATIC HYPERMUTATION SYSTEMS
AGCCGGTTG
>HW341099.1 JP 2013220103-A/131: SOMATIC HYPERMUTATION SYSTEMS
AGCCGGCTC
>HW341098.1 JP 2013220103-A/130: SOMATIC HYPERMUTATION SYSTEMS
AGCCGGCTA
>HW341097.1 JP 2013220103-A/129: SOMATIC HYPERMUTATION SYSTEMS
AGCCGGTTA
>HW341096.1 JP 2013220103-A/128: SOMATIC HYPERMUTATION SYSTEMS
AGCCGGCTG
>HW341095.1 JP 2013220103-A/127: SOMATIC HYPERMUTATION SYSTEMS
AGCCGGCTT
>HW341094.1 JP 2013220103-A/126: SOMATIC HYPERMUTATION SYSTEMS
AGCAGATTG
>HW341093.1 JP 2013220103-A/125: SOMATIC HYPERMUTATION SYSTEMS
AGCAGACTC
>HW341092.1 JP 2013220103-A/124: SOMATIC HYPERMUTATION SYSTEMS
AGCAGACTA
>HW341091.1 JP 2013220103-A/123: SOMATIC HYPERMUTATION SYSTEMS
AGCAGATTA
>HW341090.1 JP 2013220103-A/122: SOMATIC HYPERMUTATION SYSTEMS
AGCAGACTG
>HW341089.1 JP 2013220103-A/121: SOMATIC HYPERMUTATION SYSTEMS
AGCAGACTT
>HW341088.1 JP 2013220103-A/120: SOMATIC HYPERMUTATION SYSTEMS
AGCCGTTTG
>HW341087.1 JP 2013220103-A/119: SOMATIC HYPERMUTATION SYSTEMS
AGCCGTCTC
>HW341086.1 JP 2013220103-A/118: SOMATIC HYPERMUTATION SYSTEMS
AGCCGTCTA
>HW341085.1 JP 2013220103-A/117: SOMATIC HYPERMUTATION SYSTEMS
AGCCGTTTA
>HW341084.1 JP 2013220103-A/116: SOMATIC HYPERMUTATION SYSTEMS
AGCCGTCTG
>HW341083.1 JP 2013220103-A/115: SOMATIC HYPERMUTATION SYSTEMS
AGCCGTCTT
>HW341082.1 JP 2013220103-A/114: SOMATIC HYPERMUTATION SYSTEMS
AGCAGGTTG
>HW341081.1 JP 2013220103-A/113: SOMATIC HYPERMUTATION SYSTEMS
AGCAGGCTC
>HW341080.1 JP 2013220103-A/112: SOMATIC HYPERMUTATION SYSTEMS
AGCAGGCTA
>HW341079.1 JP 2013220103-A/111: SOMATIC HYPERMUTATION SYSTEMS
AGCAGGTTA
>HW341078.1 JP 2013220103-A/110: SOMATIC HYPERMUTATION SYSTEMS
AGCAGGCTG
>HW341077.1 JP 2013220103-A/109: SOMATIC HYPERMUTATION SYSTEMS
AGCAGGCTT
>HW341076.1 JP 2013220103-A/108: SOMATIC HYPERMUTATION SYSTEMS
AGCCGATTG
>HW341075.1 JP 2013220103-A/107: SOMATIC HYPERMUTATION SYSTEMS
AGCCGACTC
>HW341074.1 JP 2013220103-A/106: SOMATIC HYPERMUTATION SYSTEMS
AGCCGACTA
>HW341073.1 JP 2013220103-A/105: SOMATIC HYPERMUTATION SYSTEMS
AGCCGATTA
>HW341072.1 JP 2013220103-A/104: SOMATIC HYPERMUTATION SYSTEMS
AGCCGACTG
>HW341071.1 JP 2013220103-A/103: SOMATIC HYPERMUTATION SYSTEMS
AGCCGACTT
>HW341070.1 JP 2013220103-A/102: SOMATIC HYPERMUTATION SYSTEMS
TCACGCTTG
>HW341069.1 JP 2013220103-A/101: SOMATIC HYPERMUTATION SYSTEMS
TCACGCCTC
>HW341068.1 JP 2013220103-A/100: SOMATIC HYPERMUTATION SYSTEMS
TCACGCCTA
>HW341067.1 JP 2013220103-A/99: SOMATIC HYPERMUTATION SYSTEMS
TCACGCTTA
>HW341066.1 JP 2013220103-A/98: SOMATIC HYPERMUTATION SYSTEMS
TCACGCCTG
>HW341065.1 JP 2013220103-A/97: SOMATIC HYPERMUTATION SYSTEMS
TCACGCCTT
>HW341064.1 JP 2013220103-A/96: SOMATIC HYPERMUTATION SYSTEMS
TCACGGTTG
>HW341063.1 JP 2013220103-A/95: SOMATIC HYPERMUTATION SYSTEMS
TCACGGCTC
>HW341062.1 JP 2013220103-A/94: SOMATIC HYPERMUTATION SYSTEMS
TCACGGCTA
>HW341061.1 JP 2013220103-A/93: SOMATIC HYPERMUTATION SYSTEMS
TCACGGTTA
>HW341060.1 JP 2013220103-A/92: SOMATIC HYPERMUTATION SYSTEMS
TCACGGCTG
>HW341059.1 JP 2013220103-A/91: SOMATIC HYPERMUTATION SYSTEMS
TCACGGCTT
>HW341058.1 JP 2013220103-A/90: SOMATIC HYPERMUTATION SYSTEMS
TCAAGATTG
>HW341057.1 JP 2013220103-A/89: SOMATIC HYPERMUTATION SYSTEMS
TCAAGACTC
>HW341056.1 JP 2013220103-A/88: SOMATIC HYPERMUTATION SYSTEMS
TCAAGACTA
>HW341055.1 JP 2013220103-A/87: SOMATIC HYPERMUTATION SYSTEMS
TCAAGATTA
>HW341054.1 JP 2013220103-A/86: SOMATIC HYPERMUTATION SYSTEMS
TCAAGACTG
>HW341053.1 JP 2013220103-A/85: SOMATIC HYPERMUTATION SYSTEMS
TCAAGACTT
>HW341052.1 JP 2013220103-A/84: SOMATIC HYPERMUTATION SYSTEMS
TCACGTTTG
>HW341051.1 JP 2013220103-A/83: SOMATIC HYPERMUTATION SYSTEMS
TCACGTCTC
>HW341050.1 JP 2013220103-A/82: SOMATIC HYPERMUTATION SYSTEMS
TCACGTCTA
>HW341049.1 JP 2013220103-A/81: SOMATIC HYPERMUTATION SYSTEMS
TCACGTTTA
>HW341048.1 JP 2013220103-A/80: SOMATIC HYPERMUTATION SYSTEMS
TCACGTCTG
>HW341047.1 JP 2013220103-A/79: SOMATIC HYPERMUTATION SYSTEMS
TCACGTCTT
>HW341046.1 JP 2013220103-A/78: SOMATIC HYPERMUTATION SYSTEMS
TCAAGGTTG
>HW341045.1 JP 2013220103-A/77: SOMATIC HYPERMUTATION SYSTEMS
TCAAGGCTC
>HW341044.1 JP 2013220103-A/76: SOMATIC HYPERMUTATION SYSTEMS
TCAAGGCTA
>HW341043.1 JP 2013220103-A/75: SOMATIC HYPERMUTATION SYSTEMS
TCAAGGTTA
>HW341042.1 JP 2013220103-A/74: SOMATIC HYPERMUTATION SYSTEMS
TCAAGGCTG
>HW341041.1 JP 2013220103-A/73: SOMATIC HYPERMUTATION SYSTEMS
TCAAGGCTT
>HW341040.1 JP 2013220103-A/72: SOMATIC HYPERMUTATION SYSTEMS
TCACGATTG
>HW341039.1 JP 2013220103-A/71: SOMATIC HYPERMUTATION SYSTEMS
TCACGACTC
>HW341038.1 JP 2013220103-A/70: SOMATIC HYPERMUTATION SYSTEMS
TCACGACTA
>HW341037.1 JP 2013220103-A/69: SOMATIC HYPERMUTATION SYSTEMS
TCACGATTA
>HW341036.1 JP 2013220103-A/68: SOMATIC HYPERMUTATION SYSTEMS
TCACGACTG
>HW341035.1 JP 2013220103-A/67: SOMATIC HYPERMUTATION SYSTEMS
TCACGACTT
>HW341034.1 JP 2013220103-A/66: SOMATIC HYPERMUTATION SYSTEMS
AGTCGCTTG
>HW341033.1 JP 2013220103-A/65: SOMATIC HYPERMUTATION SYSTEMS
AGTCGCCTC
>HW341032.1 JP 2013220103-A/64: SOMATIC HYPERMUTATION SYSTEMS
AGTCGCCTA
>HW341031.1 JP 2013220103-A/63: SOMATIC HYPERMUTATION SYSTEMS
AGTCGCTTA
>HW341030.1 JP 2013220103-A/62: SOMATIC HYPERMUTATION SYSTEMS
AGTCGCCTG
>HW341029.1 JP 2013220103-A/61: SOMATIC HYPERMUTATION SYSTEMS
AGTCGCCTT
>HW341028.1 JP 2013220103-A/60: SOMATIC HYPERMUTATION SYSTEMS
AGTCGGTTG
>HW341027.1 JP 2013220103-A/59: SOMATIC HYPERMUTATION SYSTEMS
AGTCGGCTC
>HW341026.1 JP 2013220103-A/58: SOMATIC HYPERMUTATION SYSTEMS
AGTCGGCTA
>HW341025.1 JP 2013220103-A/57: SOMATIC HYPERMUTATION SYSTEMS
AGTCGGTTA
>HW341024.1 JP 2013220103-A/56: SOMATIC HYPERMUTATION SYSTEMS
AGTCGGCTG
>HW341023.1 JP 2013220103-A/55: SOMATIC HYPERMUTATION SYSTEMS
AGTCGGCTT
>HW341022.1 JP 2013220103-A/54: SOMATIC HYPERMUTATION SYSTEMS
AGTAGATTG
>HW341021.1 JP 2013220103-A/53: SOMATIC HYPERMUTATION SYSTEMS
AGTAGACTC
>HW341020.1 JP 2013220103-A/52: SOMATIC HYPERMUTATION SYSTEMS
AGTAGACTA
>HW341019.1 JP 2013220103-A/51: SOMATIC HYPERMUTATION SYSTEMS
AGTAGATTA
>HW341018.1 JP 2013220103-A/50: SOMATIC HYPERMUTATION SYSTEMS
AGTAGACTG
>HW341017.1 JP 2013220103-A/49: SOMATIC HYPERMUTATION SYSTEMS
AGTAGACTT
>HW341016.1 JP 2013220103-A/48: SOMATIC HYPERMUTATION SYSTEMS
AGTCGTTTG
>HW341015.1 JP 2013220103-A/47: SOMATIC HYPERMUTATION SYSTEMS
AGTCGTCTC
>HW341014.1 JP 2013220103-A/46: SOMATIC HYPERMUTATION SYSTEMS
AGTCGTCTA
>HW341013.1 JP 2013220103-A/45: SOMATIC HYPERMUTATION SYSTEMS
AGTCGTTTA
>HW341012.1 JP 2013220103-A/44: SOMATIC HYPERMUTATION SYSTEMS
AGTCGTCTG
>HW341011.1 JP 2013220103-A/43: SOMATIC HYPERMUTATION SYSTEMS
AGTCGTCTT
>HW341010.1 JP 2013220103-A/42: SOMATIC HYPERMUTATION SYSTEMS
AGTAGGTTG
>HW341009.1 JP 2013220103-A/41: SOMATIC HYPERMUTATION SYSTEMS
AGTAGGCTC
>HW341008.1 JP 2013220103-A/40: SOMATIC HYPERMUTATION SYSTEMS
AGTAGGCTA
>HW341007.1 JP 2013220103-A/39: SOMATIC HYPERMUTATION SYSTEMS
AGTAGGTTA
>HW341006.1 JP 2013220103-A/38: SOMATIC HYPERMUTATION SYSTEMS
AGTAGGCTG
>HW341005.1 JP 2013220103-A/37: SOMATIC HYPERMUTATION SYSTEMS
AGTAGGCTT
>HW341004.1 JP 2013220103-A/36: SOMATIC HYPERMUTATION SYSTEMS
AGTCGATTG
>HW341003.1 JP 2013220103-A/35: SOMATIC HYPERMUTATION SYSTEMS
AGTCGACTC
>HW341002.1 JP 2013220103-A/34: SOMATIC HYPERMUTATION SYSTEMS
AGTCGACTA
>HW341001.1 JP 2013220103-A/33: SOMATIC HYPERMUTATION SYSTEMS
AGTCGATTA
>HW341000.1 JP 2013220103-A/32: SOMATIC HYPERMUTATION SYSTEMS
AGTCGACTG
>HW340999.1 JP 2013220103-A/31: SOMATIC HYPERMUTATION SYSTEMS
AGTCGACTT
>HW340998.1 JP 2013220103-A/30: SOMATIC HYPERMUTATION SYSTEMS
TACAGCTAT
>HW340951.1 JP 2013198487-A/367: High Affinity Human Antibodies to PCSK9
TTGGGTTTT
>HW340939.1 JP 2013198487-A/355: High Affinity Human Antibodies to PCSK9
GGTGCATCC
>HW340927.1 JP 2013198487-A/343: High Affinity Human Antibodies to PCSK9
AAGGTTTCT
>HW340915.1 JP 2013198487-A/331: High Affinity Human Antibodies to PCSK9
AAGGTTTCT
>HW340903.1 JP 2013198487-A/319: High Affinity Human Antibodies to PCSK9
AAGGTTTCT
>HW340891.1 JP 2013198487-A/307: High Affinity Human Antibodies to PCSK9
GGTGCATCC
>HW340879.1 JP 2013198487-A/295: High Affinity Human Antibodies to PCSK9
GATGCATCC
>HW340867.1 JP 2013198487-A/283: High Affinity Human Antibodies to PCSK9
GGTGCATCC
>HW340855.1 JP 2013198487-A/271: High Affinity Human Antibodies to PCSK9
GGTGCATCC
>HW340843.1 JP 2013198487-A/259: High Affinity Human Antibodies to PCSK9
TTGGGTTTT
>HW340831.1 JP 2013198487-A/247: High Affinity Human Antibodies to PCSK9
GGTGCATCC
>HW340819.1 JP 2013198487-A/235: High Affinity Human Antibodies to PCSK9
AAGGCGTCT
>HW340807.1 JP 2013198487-A/223: High Affinity Human Antibodies to PCSK9
AAGGCGTCT
>HW340795.1 JP 2013198487-A/211: High Affinity Human Antibodies to PCSK9
AAGGCGTCT
>HW340783.1 JP 2013198487-A/199: High Affinity Human Antibodies to PCSK9
AAGGCGTCT
>HW340771.1 JP 2013198487-A/187: High Affinity Human Antibodies to PCSK9
GGTGCATCC
>HW340759.1 JP 2013198487-A/175: High Affinity Human Antibodies to PCSK9
AAGGCGTCT
>HW340747.1 JP 2013198487-A/163: High Affinity Human Antibodies to PCSK9
AAGGTTTCT
>HW340735.1 JP 2013198487-A/151: High Affinity Human Antibodies to PCSK9
TTGGGTTCT
>HW340723.1 JP 2013198487-A/139: High Affinity Human Antibodies to PCSK9
TTGGGTTTT
>HW340711.1 JP 2013198487-A/127: High Affinity Human Antibodies to PCSK9
TTGGGTTTT
>HW340699.1 JP 2013198487-A/115: High Affinity Human Antibodies to PCSK9
TTGGGTTCT
>HW340687.1 JP 2013198487-A/103: High Affinity Human Antibodies to PCSK9
TTGGGTTCT
>HW340675.1 JP 2013198487-A/91: High Affinity Human Antibodies to PCSK9
TTGGGTTCT
>HW340663.1 JP 2013198487-A/79: High Affinity Human Antibodies to PCSK9
AAGGTTTCT
>HW340651.1 JP 2013198487-A/67: High Affinity Human Antibodies to PCSK9
GCTGCATCC
>HW340639.1 JP 2013198487-A/55: High Affinity Human Antibodies to PCSK9
GCTGCATCC
>HW340627.1 JP 2013198487-A/43: High Affinity Human Antibodies to PCSK9
TGGGCATCT
>HW340615.1 JP 2013198487-A/31: High Affinity Human Antibodies to PCSK9
TGGGCCTCT
>HW340603.1 JP 2013198487-A/19: High Affinity Human Antibodies to PCSK9
AAGGCGTCT
>HW340591.1 JP 2013198487-A/7: High Affinity Human Antibodies to PCSK9
GGTGCATCC
>HW340422.1 JP 2013198488-A/163: METHODS FOR SELECTING MEDICATIONS
CCGAGTGCG
>HW340408.1 JP 2013198488-A/149: METHODS FOR SELECTING MEDICATIONS
GTTGCCGCT
>HW340407.1 JP 2013198488-A/148: METHODS FOR SELECTING MEDICATIONS
GTTGCCGCC
>HW340393.1 JP 2013198488-A/134: METHODS FOR SELECTING MEDICATIONS
GCGCAGCTA
>HW340392.1 JP 2013198488-A/133: METHODS FOR SELECTING MEDICATIONS
GCGCAGCTC
>HW340373.1 JP 2013198488-A/114: METHODS FOR SELECTING MEDICATIONS
TGGCTGCGG
>HW340358.1 JP 2013198488-A/99: METHODS FOR SELECTING MEDICATIONS
CGACAGGGG
>HW340332.1 JP 2013198488-A/73: METHODS FOR SELECTING MEDICATIONS
GTGGGACGG
>HW340323.1 JP 2013198488-A/64: METHODS FOR SELECTING MEDICATIONS
GGTCCGGGC
>HW340322.1 JP 2013198488-A/63: METHODS FOR SELECTING MEDICATIONS
GGTCCGGGT
>HW340312.1 JP 2013198488-A/53: METHODS FOR SELECTING MEDICATIONS
CCAGGAGCG
>JC087932.1 Sequence 9 from Patent EP2663323
TTCACTGTG
>JC087908.1 Sequence 93 from Patent WO2013156443
AAGAAAAAG
>JC087907.1 Sequence 92 from Patent WO2013156443
AAGAAGAAA
>JC087897.1 Sequence 82 from Patent WO2013156443
GAGGAAGAG
>JC087896.1 Sequence 81 from Patent WO2013156443
GAGGAGGAA
>JC087868.1 Sequence 53 from Patent WO2013156443
TACTATTAC
>JC087867.1 Sequence 52 from Patent WO2013156443
TACTACTAT
>JC087845.1 Sequence 30 from Patent WO2013156443
ATCATTATC
>JC087844.1 Sequence 29 from Patent WO2013156443
ATCATCATT
>JC087843.1 Sequence 28 from Patent WO2013156443
CACCATCAC
>JC087842.1 Sequence 27 from Patent WO2013156443
CACCACCAT
>JC087822.1 Sequence 7 from Patent WO2013156443
CGTCGCCGT
>JC087821.1 Sequence 6 from Patent WO2013156443
CGTCGTCGC
>JC061439.1 Sequence 21 from Patent EP2650366
CAGGCTGTC
>JC061438.1 Sequence 20 from Patent EP2650366
TGCGGTGTC
>JC061437.1 Sequence 19 from Patent EP2650366
CTCCGGGTC
>JC061436.1 Sequence 18 from Patent EP2650366
AACCCTCTC
>JC061435.1 Sequence 17 from Patent EP2650366
TGACTGTTC
>JC061434.1 Sequence 16 from Patent EP2650366
GAAGAGCTC
>JC061402.1 Sequence 21 from Patent EP2650365
CAGGCTGTC
>JC061401.1 Sequence 20 from Patent EP2650365
TGCGGTGTC
>JC061400.1 Sequence 19 from Patent EP2650365
CTCCGGGTC
>JC061399.1 Sequence 18 from Patent EP2650365
AACCCTCTC
>JC061398.1 Sequence 17 from Patent EP2650365
TGACTGTTC
>JC061397.1 Sequence 16 from Patent EP2650365
GAAGAGCTC
>JC060391.1 Sequence 67 from Patent EP2650368
GGGTTTGGG
>JC060380.1 Sequence 56 from Patent EP2650368
GGTTTTTGG
>JC057240.1 Sequence 19 from Patent EP2650308
GGTGACTAC
>JC048581.1 Sequence 6 from Patent EP2659904
CCCGTGCAT
>JC048580.1 Sequence 5 from Patent EP2659904
ATGCACGGG
>JC047970.1 Sequence 43 from Patent EP2660317
GACAGCCTG
>JC047969.1 Sequence 42 from Patent EP2660317
CAGGCTGTC
>JC047966.1 Sequence 39 from Patent EP2660317
GACACCGCA
>JC047965.1 Sequence 38 from Patent EP2660317
TGCGGTGTC
>JC047957.1 Sequence 30 from Patent EP2660317
CCTCCTCAG
>JC047956.1 Sequence 29 from Patent EP2660317
CTGAGGAGG
>JC047949.1 Sequence 22 from Patent EP2660317
GTCCCATTA
>JC047948.1 Sequence 21 from Patent EP2660317
TAATGGGAC
>JC047941.1 Sequence 14 from Patent EP2660317
GACAGTTCC
>JC047940.1 Sequence 13 from Patent EP2660317
GGAACTGTC
>JC047939.1 Sequence 12 from Patent EP2660317
GACGTTCTG
>JC047938.1 Sequence 11 from Patent EP2660317
CAGAACGTC
>JC046265.1 Sequence 11 from Patent WO2013167265
CAGGTACGG
>JB973470.1 Sequence 6 from Patent EP2683411
ATTACTTGA
>JB973267.1 Sequence 121 from Patent EP2683387
TTCCTTGGT
>JB973194.1 Sequence 48 from Patent EP2683387
TCCGTTTGC
>JB973184.1 Sequence 38 from Patent EP2683387
CGTTATGGC
>JB973182.1 Sequence 36 from Patent EP2683387
TTATGACCT
>JB973179.1 Sequence 33 from Patent EP2683387
GCGCGCCGG
>JB973170.1 Sequence 24 from Patent EP2683387
CGTTRTGGC
>JB973158.1 Sequence 12 from Patent EP2683387
TGTAAATGA
>JB973157.1 Sequence 11 from Patent EP2683387
AATGYCTTG
>JB973156.1 Sequence 10 from Patent EP2683387
GGGGRCATA
>JB988262.1 Sequence 45 from Patent WO2013025936
TTCAAGAGA
>JB980054.1 Sequence 45 from Patent WO2014004427
TTGGTTTCT
>JB980038.1 Sequence 29 from Patent WO2014004427
TTGGTTTCT
>JB980022.1 Sequence 13 from Patent WO2014004427
TTGGTTTCT
>JB971797.1 Sequence 461 from Patent EP2679234
TGCGACGGC
>JC047945.1 Sequence 18 from Patent EP2660317
GGTAGCGAA
>JC047944.1 Sequence 17 from Patent EP2660317
TTCGCTACC
>JC047943.1 Sequence 16 from Patent EP2660317
GACCGTTAT
>JC047942.1 Sequence 15 from Patent EP2660317
ATAACGGTC
>JC047937.1 Sequence 10 from Patent EP2660317
GACGTTTTG
>JC047936.1 Sequence 9 from Patent EP2660317
CAAAACGTC
>JC047935.1 Sequence 8 from Patent EP2660317
GACAGTTTC
>JC047934.1 Sequence 7 from Patent EP2660317
GAAACTGTC
>JB973049.1 Sequence 152 from Patent EP2683729
GGCNNNACG
>JB971333.1 Sequence 15 from Patent EP2680010
TGACNNNGC
>JB971320.1 Sequence 2 from Patent EP2680010
TGABNNNGC
>JB971319.1 Sequence 1 from Patent EP2680010
TGABNNNGC
>JB971315.1 Sequence 15 from Patent EP2680009
TGACNNNGC
>JB971302.1 Sequence 2 from Patent EP2680009
TGABNNNGC
>JB971301.1 Sequence 1 from Patent EP2680009
TGABNNNGC
>JB971297.1 Sequence 15 from Patent EP2680008
TGACNNNGC
>JB971284.1 Sequence 2 from Patent EP2680008
TGABNNNGC
>JB971283.1 Sequence 1 from Patent EP2680008
TGABNNNGC
>JB971279.1 Sequence 15 from Patent EP2680007
TGACNNNGC
>JB971266.1 Sequence 2 from Patent EP2680007
TGABNNNGC
>JB971265.1 Sequence 1 from Patent EP2680007
TGABNNNGC
>JB985926.1 Sequence 7 from Patent WO2014011050
TCCCTCCAG
>JB980390.1 Sequence 381 from Patent WO2014004427
GCTGCATCC
>JB980374.1 Sequence 365 from Patent WO2014004427
TTTGCTTCC
>JB980358.1 Sequence 349 from Patent WO2014004427
GCGGCATCC
>JB980342.1 Sequence 333 from Patent WO2014004427
GCTGCATCC
>JB980326.1 Sequence 317 from Patent WO2014004427
TTTGCTTCC
>JB980310.1 Sequence 301 from Patent WO2014004427
GCTGCTTCC
>JB980294.1 Sequence 285 from Patent WO2014004427
GCTGCATCC
>JB980278.1 Sequence 269 from Patent WO2014004427
GCTGCATCC
>JB980262.1 Sequence 253 from Patent WO2014004427
GCTGCATCC
>JB980246.1 Sequence 237 from Patent WO2014004427
GATGCGTCT
>JB980230.1 Sequence 221 from Patent WO2014004427
GATGCATCC
>JB980214.1 Sequence 205 from Patent WO2014004427
AAGGCGTCT
>JB980198.1 Sequence 189 from Patent WO2014004427
GATGCATCC
>JB980182.1 Sequence 173 from Patent WO2014004427
GATGCATCC
>JB980166.1 Sequence 157 from Patent WO2014004427
GATGCATCC
>JB980150.1 Sequence 141 from Patent WO2014004427
GATGCATCC
>JB980134.1 Sequence 125 from Patent WO2014004427
AAGGCGTCT
>JB980118.1 Sequence 109 from Patent WO2014004427
AAGGCGTCT
>JB980102.1 Sequence 93 from Patent WO2014004427
GATGCATCT
>JB980086.1 Sequence 77 from Patent WO2014004427
TTGGTCTCT
>JB980070.1 Sequence 61 from Patent WO2014004427
GATGCATCC
>JB974629.1 Sequence 18 from Patent EP2684954
TCTCAGGCG
>JB974578.1 Sequence 41 from Patent EP2678433
GCCGCCATG
>HW320689.1 WO 2013140890-A/2: Method for detecting target nucleic acid molecule
ACTACCTCA
>HW329050.1 JP 2013530685-A/202: REAGENTS AND METHODS FOR TREATING CANCER
GAAGATGAG
>HW320026.1 JP 2013172740-A/13: METHODS FOR BINDING AN EXOGENOUS MOLECULE TO CELLULAR CHROMATIN
CTCCTCCCC
>HW320025.1 JP 2013172740-A/12: METHODS FOR BINDING AN EXOGENOUS MOLECULE TO CELLULAR CHROMATIN
GGGGAGGAG
>HW335617.1 JP 2013531989-A/177: METHODS OF TREATMENT USING TLR7 AND/OR TLR9 INHIBITORS
NNNCNTTCT
>HW335616.1 JP 2013531989-A/176: METHODS OF TREATMENT USING TLR7 AND/OR TLR9 INHIBITORS
NNNCNTTCT
>HW335615.1 JP 2013531989-A/175: METHODS OF TREATMENT USING TLR7 AND/OR TLR9 INHIBITORS
TCTNNCNTT
>HW312047.1 JP 2013527749-A/13: Human monoclonal antibody generated from human B-cells able to neutralize influenza A viruses
GGCGCATCC
>HW312036.1 JP 2013527749-A/2: Human monoclonal antibody generated from human B-cells able to neutralize influenza A viruses
GGTGCATCC
>HW064959.1 JP 2012527899-A/43: MONOCLONAL ANTIBODIES AGAINST INFLUENZA VIRUS GENERATED BY CYCLICAL ADMINISTRATION AND USES THEREOF
CTGGCGAGC
>HW064952.1 JP 2012527899-A/36: MONOCLONAL ANTIBODIES AGAINST INFLUENZA VIRUS GENERATED BY CYCLICAL ADMINISTRATION AND USES THEREOF
CGTGCATCC
>HW064936.1 JP 2012527899-A/20: MONOCLONAL ANTIBODIES AGAINST INFLUENZA VIRUS GENERATED BY CYCLICAL ADMINISTRATION AND USES THEREOF
AAAGTTTCC
>HW055350.1 JP 2012524526-A/18: Universal Tags, Probes and Detection Methods for Multiple Targets Detection of Biomolecules
AGTGTCGTA
>HW055343.1 JP 2012524526-A/11: Universal Tags, Probes and Detection Methods for Multiple Targets Detection of Biomolecules
CAGGTCGCA
>HW055338.1 JP 2012524526-A/6: Universal Tags, Probes and Detection Methods for Multiple Targets Detection of Biomolecules
AGTGTCGTA
>HV959683.1 JP 2012196206-A/16: MET inhibitors for enhancing radiotherapy efficacy
GCTGCATCC
>HV959680.1 JP 2012196206-A/13: MET inhibitors for enhancing radiotherapy efficacy
GCAAGTAGG
>HV780021.1 JP 2012514475-A/203: Recurrent Gene Fusions in Cancer
TGCTTCTCC
>HV779974.1 JP 2012514475-A/156: Recurrent Gene Fusions in Cancer
ACTCATCAC
>HV779927.1 JP 2012514475-A/109: Recurrent Gene Fusions in Cancer
AGAAAGTTT
>HV779909.1 JP 2012514475-A/91: Recurrent Gene Fusions in Cancer
AAGCCCTTC
>HV757327.1 JP 2012508271-A/1: Diagnostic and/or therapeutic agent, method for the manufacture thereof and use thereof
CAGCCACAT
>HV743741.1 JP 2012504955-A/89: Dengue Virus Neutralizing Antibodies and Uses Thereof
GATGATAGC
>HV743733.1 JP 2012504955-A/81: Dengue Virus Neutralizing Antibodies and Uses Thereof
GAAGTTTCC
>HV743716.1 JP 2012504955-A/64: Dengue Virus Neutralizing Antibodies and Uses Thereof
GGTAATAGC
>HV743709.1 JP 2012504955-A/57: Dengue Virus Neutralizing Antibodies and Uses Thereof
CAAGATACC
>HV743698.1 JP 2012504955-A/46: Dengue Virus Neutralizing Antibodies and Uses Thereof
ACTACATCC
>HV743690.1 JP 2012504955-A/38: Dengue Virus Neutralizing Antibodies and Uses Thereof
GGTAACAAC
>HV743681.1 JP 2012504955-A/29: Dengue Virus Neutralizing Antibodies and Uses Thereof
GCTGCATCC
>HV743673.1 JP 2012504955-A/21: Dengue Virus Neutralizing Antibodies and Uses Thereof
TATGATAGC
>HV743665.1 JP 2012504955-A/13: Dengue Virus Neutralizing Antibodies and Uses Thereof
GGTGCATCC
>HV743657.1 JP 2012504955-A/5: Dengue Virus Neutralizing Antibodies and Uses Thereof
AGGGATACC
>HW307545.1 JP 2013526870-A/4: METHOD OF DNA SEQUENCING BY HYBRIDISATION
ACAGCCAGC
>HW298860.1 JP 2013523106-A/44: NOVEL HUMANIZED ANTI CXCR4 ANTIBODIES FOR THE TREATMENT OF CANCER
TGGGCATCC
>HW298846.1 JP 2013523106-A/30: NOVEL HUMANIZED ANTI CXCR4 ANTIBODIES FOR THE TREATMENT OF CANCER
TGGGCCTCT
>HW298821.1 JP 2013523106-A/5: NOVEL HUMANIZED ANTI CXCR4 ANTIBODIES FOR THE TREATMENT OF CANCER
TGGGCCAGC
>DI246720.1 KR 1020120127513-A/50: ANTIBODIES SPECIFIC FOR HUMAN CD22 AND THEIR THERAPEUTIC AND DIAGNOSTIC USES
GCCGCCACC
>DI246056.1 KR 1020120107521-A/117: IDENTIFICATION OF CLONAL CELLS BY REPEATS IN (EG.) T-CELL RECEPTOR V/D/J GENES
GTAGAGATG
>DI246052.1 KR 1020120107521-A/113: IDENTIFICATION OF CLONAL CELLS BY REPEATS IN (EG.) T-CELL RECEPTOR V/D/J GENES
GTGGATACA
>DI246023.1 KR 1020120107521-A/84: IDENTIFICATION OF CLONAL CELLS BY REPEATS IN (EG.) T-CELL RECEPTOR V/D/J GENES
GGTATAACC
>DI246019.1 KR 1020120107521-A/80: IDENTIFICATION OF CLONAL CELLS BY REPEATS IN (EG.) T-CELL RECEPTOR V/D/J GENES
GGTACAACT
>DI232477.1 KR 1020110111474-A/203: RECURRENT GENE FUSIONS IN CANCER
TGCTTCTCC
>DI232430.1 KR 1020110111474-A/156: RECURRENT GENE FUSIONS IN CANCER
ACTCATCAC
>DI232383.1 KR 1020110111474-A/109: RECURRENT GENE FUSIONS IN CANCER
AGAAAGTTT
>DI232365.1 KR 1020110111474-A/91: RECURRENT GENE FUSIONS IN CANCER
AAGCCCTTC
>DI207871.1 KR 1020100021650-A/19: HUMANIZED ANTIBODIES TO AMYLOID BETA
GGTGACTAC
>DI231330.1 KR 1020110102397-A/10: METHODS FOR SELECTING PROTEASE RESISTANT POLYPEPTIDES
CCAAGCTCG
>DI206162.1 KR 1020110053911-A/35: Genotyping Method
AGCTGGTGC
>DI206161.1 KR 1020110053911-A/34: Genotyping Method
GAGCTGGTT
>DI206160.1 KR 1020110053911-A/33: Genotyping Method
TGGAGCTGT
>DI230402.1 KR 1020110097839-A/16: ANTI-cMET ANTIBODY
AGGGCTTCT
>DI228211.1 KR 1020110050753-A/50: Calicheamicin derivative-carrier conjugates
GCCGCCACC
>DI227705.1 KR 1020110084504-A/190: MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS
GCTGGTAAA
>DI195966.1 KR 1020100019429-A/78: NUCLEIC ACID ENZYMES AND COMPLEXES AND METHODS FOR THEIR USE
ACGGCGGAG
>DI195991.1 KR 1020100019429-A/104: NUCLEIC ACID ENZYMES AND COMPLEXES AND METHODS FOR THEIR USE
ACGTGGAGG
>DI194865.1 KR 1020100014724-A/7: Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
AATATATTT
>DI194861.1 KR 1020100014724-A/3: Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
AATAAAYAA
>DI193669.1 KR 1020090127256-A/25: HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF
GACAATGAT
>DI193683.1 KR 1020090127256-A/47: HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF
TGGGCATCT
>DI193675.1 KR 1020090127256-A/31: HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF
CAGGATTCC
>DI241821.1 KR 1020120094474-A/29: Chimeric antibodies specific for CD151 and use thereof in the treatment of cancer
GGGGCATCC
>DI241812.1 KR 1020120094474-A/11: Chimeric antibodies specific for CD151 and use thereof in the treatment of cancer
GAAGCATCC
>DI192405.1 KR 1020090106481-A/4: SHRNA-MEDIATED INHIBITION OF EXPRESSION OF ALPHA-1,6-FUCOSYLTRANSFERASE
TTCAAGAGA
>DI192138.1 KR 1020090067219-A/36: USE OF AN ANTI-CD151 ANTIBODY IN THE TREATMENT OF CANCER
TATGCATCC
>DI192130.1 KR 1020090067219-A/28: USE OF AN ANTI-CD151 ANTIBODY IN THE TREATMENT OF CANCER
TCTGCATCC
>DI223823.1 KR 1020110049802-A/119: NEUTRALIZING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USES THEREOF
GAGGTCACT
>DI223815.1 KR 1020110049802-A/103: NEUTRALIZING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USES THEREOF
ACTAATAAT
>DI223807.1 KR 1020110049802-A/87: NEUTRALIZING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USES THEREOF
GACGCATCC
>DI223799.1 KR 1020110049802-A/72: NEUTRALIZING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USES THEREOF
GAAGTTTCC
>DI223792.1 KR 1020110049802-A/58: NEUTRALIZING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USES THEREOF
GGTGCATCA
>DI223784.1 KR 1020110049802-A/43: NEUTRALIZING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USES THEREOF
GAAGTTTTC
>DI223776.1 KR 1020110049802-A/27: NEUTRALIZING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USES THEREOF
GATGCATCC
>DI223768.1 KR 1020110049802-A/11: NEUTRALIZING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USES THEREOF
GGTGCATCC
>DI240738.1 KR 1020120100890-A/37: AN ASSAY FOR DETERMINING A MOLECULAR RISK ASSESSMENT OF A COMPLEX POLYMICROBIAL SAMPLE SUSPECTED TO CONTAIN AN EHEC
GCGAAAATT
>DI240728.1 KR 1020120100890-A/9: AN ASSAY FOR DETERMINING A MOLECULAR RISK ASSESSMENT OF A COMPLEX POLYMICROBIAL SAMPLE SUSPECTED TO CONTAIN AN EHEC
CACCAATAC
>DI240727.1 KR 1020120100890-A/4: AN ASSAY FOR DETERMINING A MOLECULAR RISK ASSESSMENT OF A COMPLEX POLYMICROBIAL SAMPLE SUSPECTED TO CONTAIN AN EHEC
AGCYTTACG
>DI222735.1 KR 1020110052585-A/365: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GGCAACAAC
>DI222722.1 KR 1020110052585-A/346: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GATGCATCC
>DI222712.1 KR 1020110052585-A/326: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
AAGAATAAT
>DI222693.1 KR 1020110052585-A/288: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GGTAACAAC
>DI222685.1 KR 1020110052585-A/272: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
ACTACATCC
>DI222677.1 KR 1020110052585-A/256: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GACGTCACT
>DI222662.1 KR 1020110052585-A/226: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GCTGCATCC
>DI222648.1 KR 1020110052585-A/198: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
CAAGATACG
>DI222626.1 KR 1020110052585-A/155: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GGTGCATCC
>DI222618.1 KR 1020110052585-A/139: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GATGTCGAT
>DI222610.1 KR 1020110052585-A/123: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
CAAGATTCC
>DI222602.1 KR 1020110052585-A/107: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GAGGTTTCT
>DI222594.1 KR 1020110052585-A/91: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GATGGCAGT
>DI222586.1 KR 1020110052585-A/75: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GATGTCAGT
>DI222578.1 KR 1020110052585-A/59: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GACAATGAT
>DI222570.1 KR 1020110052585-A/43: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
AAAGACACT
>DI222562.1 KR 1020110052585-A/27: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
GATGATAGC
>DI222554.1 KR 1020110052585-A/11: HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
AAGGCGTCT
>DI240654.1 KR 1020120051734-A/46: Anti-cMET antibody and its use for the detection and the diagnosis of cancer
GACACATCC
>DI240640.1 KR 1020120051734-A/19: Anti-cMET antibody and its use for the detection and the diagnosis of cancer
TATGCTTCC
>DI222058.1 KR 1020110055517-A/15: HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF
AAGGTTTCT
>DI186956.1 KR 1020110044374-A/33: Pharmaceutical composition for inhibiting growth and/or metastasis of cancer cells
CTTGAAGAC
>DI186955.1 KR 1020110044374-A/32: Pharmaceutical composition for inhibiting growth and/or metastasis of cancer cells
CTGGAGGAT
>DI186954.1 KR 1020110044374-A/31: Pharmaceutical composition for inhibiting growth and/or metastasis of cancer cells
TTGGCAGAT
>DI186953.1 KR 1020110044374-A/30: Pharmaceutical composition for inhibiting growth and/or metastasis of cancer cells
TTGGCTGAT
>DI186952.1 KR 1020110044374-A/29: Pharmaceutical composition for inhibiting growth and/or metastasis of cancer cells
TTAGGAGAT
>DI186951.1 KR 1020110044374-A/28: Pharmaceutical composition for inhibiting growth and/or metastasis of cancer cells
TTATCCGAT
>DI182278.1 KR 1020100097488-A/33: Polypeptides or fusion proteins thereof having inhibitory activity against transendothelial migration of leucocytes
CTTGAAGAC
>DI182277.1 KR 1020100097488-A/32: Polypeptides or fusion proteins thereof having inhibitory activity against transendothelial migration of leucocytes
CTGGAGGAT
>DI182276.1 KR 1020100097488-A/31: Polypeptides or fusion proteins thereof having inhibitory activity against transendothelial migration of leucocytes
TTGGCAGAT
>DI182275.1 KR 1020100097488-A/30: Polypeptides or fusion proteins thereof having inhibitory activity against transendothelial migration of leucocytes
TTGGCTGAT
>DI182274.1 KR 1020100097488-A/29: Polypeptides or fusion proteins thereof having inhibitory activity against transendothelial migration of leucocytes
TTAGGAGAT
>DI182273.1 KR 1020100097488-A/28: Polypeptides or fusion proteins thereof having inhibitory activity against transendothelial migration of leucocytes
TTATCCGAT
>DI182226.1 KR 1020090092245-A/72: METHOD OF REGULATING A PHOSPHORYLATED PROTEIN-MEDIATED INTRACELLULAR SIGNAL TRANSDUCTION USING AN ANTIBODY SPECIFICALLY BINDING TO THE PHOSPHORYLATED PROTEIN
GGTAGCGCG
>DI180942.1 KR 1020090027693-A/9: Therapeutic agent for Alzheimer's disease
TAAGAAAAA
>DI210474.1 KR 1020100092041-A/78: Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
CCGACGTCA
>DI210473.1 KR 1020100092041-A/77: Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
CCAACATCA
>DI217314.1 KR 1020110102198-A/29: Human monoclonal antibody generated from human B-cells able to neutralize influenza A viruses
GGCGCATCC
>DI217303.1 KR 1020110102198-A/18: Human monoclonal antibody generated from human B-cells able to neutralize influenza A viruses
GGTGCATCC
>DI174263.1 KR 1020090116475-A/10: Method of analyzing the accuracy of probe nucleic acids immobilized on a microarray substrate
GCCCTGGAA
>DI173479.1 KR 1020090099719-A/9: A knock-out vector constructed by using CFP reporter knock-in vector and methods for preparing thereof and knocking out gene in animal cell
CCGGGTACC
>DI173239.1 KR 1020090093706-A/12: Gene Delivery Systems Exhibiting Enhanced Tumor-Specific Expression
CCCAGCCCC
>DI171920.1 KR 1020090042364-A/9: A knock-out vector constructed by using RFP reporter knock-in vector and methods for preparing thereof and knocking out gene in animal cell
CCGAAGCTT
>DI171902.1 KR 1020090042363-A/9: A knock-out vector constructed by using GFP reporter knock-in vector and methods for preparing thereof and knocking out gene in animal cell
CCGAAGCTT
>DI215676.1 KR 1020110043548-A/59: WDRPUH EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME
ACCACATCC
>DI215664.1 KR 1020110043548-A/39: WDRPUH EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME
GCTGCAACA
>DI215659.1 KR 1020110043548-A/34: WDRPUH EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME
CGTGCATCC
>DI236063.1 KR 1020120010275-A/20: COMPOSITIONS AND METHODS FOR PRODUCING A COMPOSITION
GTACTCAGG
>DI169661.1 KR 1020060028691-A/78: Improved method for the recovery of non-segmentednegative-stranded RNA viruses from cDNA
CCGACGTCA
>DI169660.1 KR 1020060028691-A/77: Improved method for the recovery of non-segmentednegative-stranded RNA viruses from cDNA
CCAACATCA
>DI213946.1 KR 1020110004463-A/50: ANTIBODIES SPECIFIC FOR HUMAN CD22 AND THEIR THERAPEUTIC AND DIAGNOSTIC USES
GCCGCCACC
>DI212849.1 KR 1020110010708-A/52: Novel antibodies used to treat cancer
GGGGCATCC
>DI212836.1 KR 1020110010708-A/26: Novel antibodies used to treat cancer
TCGGCATCC
>DI212828.1 KR 1020110010708-A/10: Novel antibodies used to treat cancer
GAAGCATCC
>JB837336.1 Sequence 14 from Patent WO2013106639
TACCCCGGG
>JB759873.1 Sequence 81 from Patent WO2013113326
GGGTTTGGG
>JB759862.1 Sequence 70 from Patent WO2013113326
GGTTTTTGG
>JB760986.1 Sequence 381 from Patent WO2013116296
GCTGCATCC
>JB760970.1 Sequence 365 from Patent WO2013116296
GATGCATCC
>JB760954.1 Sequence 349 from Patent WO2013116296
GATGCATCC
>JB760938.1 Sequence 333 from Patent WO2013116296
TGGGCATCT
>JB760922.1 Sequence 317 from Patent WO2013116296
ACTGCATCC
>JB760906.1 Sequence 301 from Patent WO2013116296
GCTGCATCC
>JB760890.1 Sequence 285 from Patent WO2013116296
AAGGCGTCT
>JB760874.1 Sequence 269 from Patent WO2013116296
AAGGCATCT
>JB760858.1 Sequence 253 from Patent WO2013116296
TTGGGTTCT
>JB760842.1 Sequence 237 from Patent WO2013116296
GCTGCATCC
>JB760826.1 Sequence 221 from Patent WO2013116296
GCTGCATCC
>JB760810.1 Sequence 205 from Patent WO2013116296
AAGGCGTCT
>JB760794.1 Sequence 189 from Patent WO2013116296
AAGGCGTCT
>JB760778.1 Sequence 173 from Patent WO2013116296
TTGGGTTCT
>JB759965.1 Sequence 56 from Patent WO2013113325
GGTTTTTGG
>JB761197.1 Sequence 67 from Patent WO2013113502
GGGTTTGGG
>JB761186.1 Sequence 56 from Patent WO2013113502
GGTTTTTGG
>JB761002.1 Sequence 397 from Patent WO2013116296
GCTGCATCC
>JB760762.1 Sequence 157 from Patent WO2013116296
AAGGCGTCT
>JB760746.1 Sequence 141 from Patent WO2013116296
AAGGCGTCT
>JB760730.1 Sequence 125 from Patent WO2013116296
GGTGCATCC
>JB760714.1 Sequence 109 from Patent WO2013116296
AAGGCGTCT
>JB760698.1 Sequence 93 from Patent WO2013116296
AAGGCGTCT
>JB760682.1 Sequence 77 from Patent WO2013116296
GCTGCATCC
>JB760666.1 Sequence 61 from Patent WO2013116296
AAGACGTCT
>JB760650.1 Sequence 45 from Patent WO2013116296
AAGGCGTCT
>JB760634.1 Sequence 29 from Patent WO2013116296
TGGGCATCT
>JB760618.1 Sequence 13 from Patent WO2013116296
TGGGCATCT
>JB760550.1 Sequence 81 from Patent WO2013113501
GGGTTTGGG
>JB760539.1 Sequence 70 from Patent WO2013113501
GGTTTTTGG
>JB760402.1 Sequence 81 from Patent WO2013113736
GGGTTTGGG
>JB760391.1 Sequence 70 from Patent WO2013113736
GGTTTTTGG
>JB759976.1 Sequence 67 from Patent WO2013113325
GGGTTTGGG
>JB758370.1 Sequence 9 from Patent EP2612911
TAAGAAAAA
>JB758369.1 Sequence 8 from Patent EP2612911
TTTTTCTTA
>HW269960.1 JP 2012067142-A/63: IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
GCCGCCACC
>JB746429.1 Sequence 16 from Patent WO2013064684
TCTGGATCC
>JB743741.1 Sequence 16 from Patent WO2013064685
TCTGGATCC
>JB623883.1 Sequence 33 from Patent EP2610341
CCCGGCGGA
>JB623882.1 Sequence 32 from Patent EP2610341
CGGCTGCTA
>JB623881.1 Sequence 31 from Patent EP2610341
CGCGGCTGA
>JB623880.1 Sequence 30 from Patent EP2610341
CCCGGCGGA
>JB623879.1 Sequence 29 from Patent EP2610341
CCCGCTGAA
>JB623878.1 Sequence 28 from Patent EP2610341
CCCGCCGAA
>JB623877.1 Sequence 27 from Patent EP2610341
CCCGCGGAA
>JB623873.1 Sequence 23 from Patent EP2610341
CCGGCTGAA
>JB623872.1 Sequence 22 from Patent EP2610341
GCGGCTGAA
>JB623871.1 Sequence 21 from Patent EP2610341
CGCCGCCGC
>JB623870.1 Sequence 20 from Patent EP2610341
CGCGGCGGA
>JB623869.1 Sequence 19 from Patent EP2610341
GAGAGGAGC
>JB623868.1 Sequence 18 from Patent EP2610341
CGAGAGGCA
>JB623867.1 Sequence 17 from Patent EP2610341
GCCGAGAGA
>JB623866.1 Sequence 16 from Patent EP2610341
AGGAGAGGA
>JB623862.1 Sequence 12 from Patent EP2610341
ACGAGCGGA
>JB623861.1 Sequence 11 from Patent EP2610341
ACGAGAGGA
>JB623860.1 Sequence 10 from Patent EP2610341
CGGAGCGGA
>JB623859.1 Sequence 9 from Patent EP2610341
CGGAGCGAA
>JB623858.1 Sequence 8 from Patent EP2610341
GCGAGCGGA
>JB623857.1 Sequence 7 from Patent EP2610341
GCGAGAGGA
>JB623856.1 Sequence 6 from Patent EP2610341
GGGAGCGAA
>JB623855.1 Sequence 5 from Patent EP2610341
GCGAGAGAA
>JB623848.1 Sequence 33 from Patent EP2610340
CCCGGCGGA
>JB623847.1 Sequence 32 from Patent EP2610340
CGGCTGCTA
>JB623846.1 Sequence 31 from Patent EP2610340
CGCGGCTGA
>JB623845.1 Sequence 30 from Patent EP2610340
CCCGGCGGA
>JB623844.1 Sequence 29 from Patent EP2610340
CCCGCTGAA
>JB623843.1 Sequence 28 from Patent EP2610340
CCCGCCGAA
>JB623842.1 Sequence 27 from Patent EP2610340
CCCGCGGAA
>JB623838.1 Sequence 23 from Patent EP2610340
CCGGCTGAA
>JB623837.1 Sequence 22 from Patent EP2610340
GCGGCTGAA
>JB623836.1 Sequence 21 from Patent EP2610340
CGCCGCCGC
>JB623835.1 Sequence 20 from Patent EP2610340
CGCGGCGGA
>JB623834.1 Sequence 19 from Patent EP2610340
GAGAGGAGC
>JB623833.1 Sequence 18 from Patent EP2610340
CGAGAGGCA
>JB623832.1 Sequence 17 from Patent EP2610340
GCCGAGAGA
>JB623831.1 Sequence 16 from Patent EP2610340
AGGAGAGGA
>JB623827.1 Sequence 12 from Patent EP2610340
ACGAGCGGA
>JB623826.1 Sequence 11 from Patent EP2610340
ACGAGAGGA
>JB623825.1 Sequence 10 from Patent EP2610340
CGGAGCGGA
>JB623824.1 Sequence 9 from Patent EP2610340
CGGAGCGAA
>JB623823.1 Sequence 8 from Patent EP2610340
GCGAGCGGA
>JB623822.1 Sequence 7 from Patent EP2610340
GCGAGAGGA
>JB623821.1 Sequence 6 from Patent EP2610340
GGGAGCGAA
>JB623820.1 Sequence 5 from Patent EP2610340
GCGAGAGAA
>JB614842.1 Sequence 130 from Patent WO2013070662
GGGCACCTT
>JB614840.1 Sequence 128 from Patent WO2013070662
GCGGTCCGT
>JB614831.1 Sequence 119 from Patent WO2013070662
AAGGTGCCC
>JB614829.1 Sequence 117 from Patent WO2013070662
ACGGACCGC
>JB416418.1 Sequence 81 from Patent EP2623121
GGGTTTGGG
>JB416407.1 Sequence 70 from Patent EP2623121
GGTTTTTGG
>JB407975.1 Sequence 35 from Patent WO2012103035
GGGTTAGGG
>JB407974.1 Sequence 34 from Patent WO2012103035
GAGTATGAG
>JB407967.1 Sequence 27 from Patent WO2012103035
TTAGGGTTA
>JB407966.1 Sequence 26 from Patent WO2012103035
GTTAGGGTT
>JB412675.1 Sequence 16 from Patent WO2013026837
TTTGACTAC
>JB406004.1 Sequence 53 from Patent WO2012150960
CAGGCAGGC
>JB405998.1 Sequence 47 from Patent WO2012150960
GCAGCAGCA
>JB405994.1 Sequence 43 from Patent WO2012150960
AGCAGCAGC
>JB405990.1 Sequence 39 from Patent WO2012150960
CAGCAGCAG
>JB399167.1 Sequence 90 from Patent WO2012030856
GCTTAGCAC
>JB397295.1 Sequence 35 from Patent WO2012103038
GGGTTAGGG
>JB397294.1 Sequence 34 from Patent WO2012103038
GAGTATGAG
>JB397287.1 Sequence 27 from Patent WO2012103038
TTAGGGTTA
>JB397286.1 Sequence 26 from Patent WO2012103038
GTTAGGGTT
>JB394570.1 Sequence 238 from Patent WO2013026833
TTCGACTAC
>JB394406.1 Sequence 74 from Patent WO2013026833
TTTGACTAC
>JB383865.1 Sequence 829 from Patent WO2011031695
GGTGCATCC
>JB383841.1 Sequence 805 from Patent WO2011031695
GCTGCATCC
>JB383817.1 Sequence 781 from Patent WO2011031695
AAGATTTCT
>JB383793.1 Sequence 757 from Patent WO2011031695
AAGATTTCT
>JB383769.1 Sequence 733 from Patent WO2011031695
GCTGCATCC
>JB383745.1 Sequence 709 from Patent WO2011031695
AAGATTTCT
>JB383721.1 Sequence 685 from Patent WO2011031695
AAGATTTCT
>JB383697.1 Sequence 661 from Patent WO2011031695
AAGATTTCT
>JB383673.1 Sequence 637 from Patent WO2011031695
GCTGCATCC
>JB383649.1 Sequence 613 from Patent WO2011031695
AAGATTTCT
>JB383625.1 Sequence 589 from Patent WO2011031695
GCTGCATCC
>JB383601.1 Sequence 565 from Patent WO2011031695
GATGCATCC
>JB383577.1 Sequence 541 from Patent WO2011031695
GCTGCATCC
>JB383553.1 Sequence 517 from Patent WO2011031695
AAGATTTCT
>JB383529.1 Sequence 493 from Patent WO2011031695
GCTGCATCC
>JB383505.1 Sequence 469 from Patent WO2011031695
TCGGCGTCT
>JB383481.1 Sequence 445 from Patent WO2011031695
GGTGCATCC
>JB383457.1 Sequence 421 from Patent WO2011031695
GGTGCATCC
>JB383433.1 Sequence 397 from Patent WO2011031695
TGGGCATCT
>JB383409.1 Sequence 373 from Patent WO2011031695
AAGATTTCT
>JB383385.1 Sequence 349 from Patent WO2011031695
GCTACATCC
>JB383361.1 Sequence 325 from Patent WO2011031695
AAGATTTCT
>JB383337.1 Sequence 301 from Patent WO2011031695
GCTGCATCC
>JB383313.1 Sequence 277 from Patent WO2011031695
TTGGGTTCT
>JB383289.1 Sequence 253 from Patent WO2011031695
GGTGCATCC
>JB383265.1 Sequence 229 from Patent WO2011031695
AAGATTTCT
>JB383241.1 Sequence 205 from Patent WO2011031695
AAGATTTCT
>JB383217.1 Sequence 181 from Patent WO2011031695
AAGATTTCT
>JB383193.1 Sequence 157 from Patent WO2011031695
GCTGCATCC
>JB383169.1 Sequence 133 from Patent WO2011031695
GCTGCATCC
>JB383145.1 Sequence 109 from Patent WO2011031695
GCTGCATCC
>JB383121.1 Sequence 85 from Patent WO2011031695
AAGATTTCT
>JB383097.1 Sequence 61 from Patent WO2011031695
AAAATTTCT
>JB383073.1 Sequence 37 from Patent WO2011031695
AAGATTTCT
>JB383049.1 Sequence 13 from Patent WO2011031695
AAGATTTCT
>JB376363.1 Sequence 5 from Patent WO2013014149
ATGCCGTTT
>JB376360.1 Sequence 2 from Patent WO2013014149
CTGTTTACG
>JB372937.1 Sequence 3 from Patent WO2012042009
ACAGAGAAA
>JB372936.1 Sequence 2 from Patent WO2012042009
ACAGTGAAA
>JB368817.1 Sequence 22 from Patent WO2012044847
AATTATAAT
>JB368810.1 Sequence 15 from Patent WO2012044847
GTACAGCAG
>JB368807.1 Sequence 12 from Patent WO2012044847
GTACAGCAG
>JB364436.1 Sequence 18 from Patent EP2547781
CAGGTAAAT
>JB364435.1 Sequence 17 from Patent EP2547781
CTTGTGACA
>JB360357.1 Sequence 29 from Patent EP2545074
GGCGCATCC
>JB360346.1 Sequence 18 from Patent EP2545074
GGTGCATCC
>JB390341.1 Sequence 375 from Patent WO2012047567
GGTGCATCC
>JB390329.1 Sequence 363 from Patent WO2012047567
GGTGCATCC
>JB390309.1 Sequence 343 from Patent WO2012047567
GCTGCTTCC
>JB390289.1 Sequence 323 from Patent WO2012047567
GCTGCATCC
>JB390269.1 Sequence 303 from Patent WO2012047567
GCTGCATCC
>JB390249.1 Sequence 283 from Patent WO2012047567
GCTGCATCC
>JB390229.1 Sequence 263 from Patent WO2012047567
GCTGCATCC
>JB390209.1 Sequence 243 from Patent WO2012047567
TTGGTTTCT
>JB390189.1 Sequence 223 from Patent WO2012047567
AAGATTTCT
>JB390169.1 Sequence 203 from Patent WO2012047567
GCTGCATCC
>JB390151.1 Sequence 185 from Patent WO2012047567
GGTGCATCC
>JB390139.1 Sequence 173 from Patent WO2012047567
GCGGCATCC
>JB390123.1 Sequence 157 from Patent WO2012047567
GGTTCATCC
>JB390115.1 Sequence 149 from Patent WO2012047567
GATGCATCC
>JB390107.1 Sequence 141 from Patent WO2012047567
GCTGCATCC
>JB390091.1 Sequence 125 from Patent WO2012047567
GATGCATCC
>JB390075.1 Sequence 109 from Patent WO2012047567
GCTGCATCC
>JB390059.1 Sequence 93 from Patent WO2012047567
GATGCATCC
>JB390043.1 Sequence 77 from Patent WO2012047567
GCTGCATCC
>JB390027.1 Sequence 61 from Patent WO2012047567
GATGCATCC
>JB390011.1 Sequence 45 from Patent WO2012047567
GATGCATCC
>JB389995.1 Sequence 29 from Patent WO2012047567
GGTGCATCC
>JB389979.1 Sequence 13 from Patent WO2012047567
GATGCATCC
>HW266326.1 JP 2013518123-A/56: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GGTGCATCC
>HW266318.1 JP 2013518123-A/48: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GGTGCATCC
>HW266310.1 JP 2013518123-A/40: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GGTACATCC
>HW266302.1 JP 2013518123-A/32: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GGTGCGTCC
>HW266294.1 JP 2013518123-A/24: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GGTGCATCC
>HW266286.1 JP 2013518123-A/16: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GATGCATCC
>HW266278.1 JP 2013518123-A/8: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
TTGGTTTCT
>HW266267.1 JP 2013518122-A/56: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GGTGCATCC
>HW266259.1 JP 2013518122-A/48: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GGTGCATCC
>HW266251.1 JP 2013518122-A/40: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GGTACATCC
>HW266243.1 JP 2013518122-A/32: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GGTGCGTCC
>HW266235.1 JP 2013518122-A/24: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GGTGCATCC
>HW266227.1 JP 2013518122-A/16: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
GATGCATCC
>HW266219.1 JP 2013518122-A/8: Methods of Treating Autoimmune Diseases with Dll4 Antagonists
TTGGTTTCT
>HW265695.1 JP 2013516978-A/643: METHODS OF PRODUCING ADENOVIRUS VECTORS AND VIRAL PREPARATIONS GENERATED THEREBY
GCTTCTGGA
>HW265692.1 JP 2013516978-A/640: METHODS OF PRODUCING ADENOVIRUS VECTORS AND VIRAL PREPARATIONS GENERATED THEREBY
GCTTCTGGA
>HW264382.1 JP 2013516456-A/643: COMPOSITIONS AND METHODS FOR TREATING GLIOBLASTOMA GBM
GCTTCTGGA
>HW264379.1 JP 2013516456-A/640: COMPOSITIONS AND METHODS FOR TREATING GLIOBLASTOMA GBM
GCTTCTGGA
>HW263738.1 JP 2013516454-A/643: METHODS FOR USE OF A SPECIFIC ANTI-ANGIOGENIC ADENOVIRAL AGENT
GCTTCTGGA
>HW263735.1 JP 2013516454-A/640: METHODS FOR USE OF A SPECIFIC ANTI-ANGIOGENIC ADENOVIRAL AGENT
GCTTCTGGA
>HW259901.1 JP 2013516481-A/31: Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-6R) Antibodies
GTTGCATCC
>HW259893.1 JP 2013516481-A/23: Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-6R) Antibodies
GCTGCATCC
>HW259885.1 JP 2013516481-A/15: Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-6R) Antibodies
GGTGCATCC
>HW259877.1 JP 2013516481-A/7: Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-6R) Antibodies
GGTGCATCC
>HW259459.1 JP 2013515486-A/223: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
GCTGCATCC
>HW259447.1 JP 2013515486-A/211: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
GCTGCATCC
>HW259435.1 JP 2013515486-A/199: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
GGTGCATCC
>HW259423.1 JP 2013515486-A/187: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
AAGGCGTCT
>HW259411.1 JP 2013515486-A/175: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
GCTGCATTC
>HW259399.1 JP 2013515486-A/163: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
GGTACATCC
>HW259387.1 JP 2013515486-A/151: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
TTTGCATCC
>HW259375.1 JP 2013515486-A/139: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
AAGGCGTCT
>HW259363.1 JP 2013515486-A/127: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
AAGGCGTCT
>HW259351.1 JP 2013515486-A/115: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
AAGGCGTCT
>HW259339.1 JP 2013515486-A/103: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
GCTGCATCC
>HW259327.1 JP 2013515486-A/91: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
AAGGCGTCT
>HW259315.1 JP 2013515486-A/79: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
AAGGCGTCT
>HW259303.1 JP 2013515486-A/67: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
AAGGCGTCT
>HW259291.1 JP 2013515486-A/55: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
GAGGCGTCT
>HW259279.1 JP 2013515486-A/43: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
GCTGCATCC
>HW259267.1 JP 2013515486-A/31: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
AAGGCGTCT
>HW259255.1 JP 2013515486-A/19: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
GCTGCGTCC
>HW259243.1 JP 2013515486-A/7: HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
CAGGCGTCC
>HW251106.1 WO 2013089157-A/19: Oligonucleotide and therapeutic agent for hyperlipidemia containing the same as an active ingredient
TCGCTATTC
>JB334765.1 Sequence 253 from Patent EP2511300
GATGCATCC
>JB334741.1 Sequence 229 from Patent EP2511300
GATGCATCC
>JB334717.1 Sequence 205 from Patent EP2511300
GTTGCATCC
>JB334693.1 Sequence 181 from Patent EP2511300
GCTGCATCC
>JB334669.1 Sequence 157 from Patent EP2511300
TTGGGTTCT
>JB334645.1 Sequence 133 from Patent EP2511300
AGTGCCTCC
>JB334621.1 Sequence 109 from Patent EP2511300
GCTGCATCC
>JB334597.1 Sequence 85 from Patent EP2511300
TTGGGTTCT
>JB334573.1 Sequence 61 from Patent EP2511300
GCTGTATCC
>JB334549.1 Sequence 37 from Patent EP2511300
GCTGCATCC
>JB334525.1 Sequence 13 from Patent EP2511300
GCTGCATCC
>JB326813.1 Sequence 47 from Patent EP2487187
TGGGCATCT
>JB326797.1 Sequence 31 from Patent EP2487187
CAGGATTCC
>JB326791.1 Sequence 25 from Patent EP2487187
GACAATGAT
>JB317599.1 Sequence 7 from Patent EP2538770
TTTGTGTAG
>JB317598.1 Sequence 6 from Patent EP2538770
TTCAAGAGA
>JB308557.1 Sequence 80 from Patent EP2429565
GCTCTAGAG
>JB308550.1 Sequence 73 from Patent EP2429565
GCTCTAGAG
>JB308548.1 Sequence 71 from Patent EP2429565
GCTTTAGAG
>JB292841.1 Sequence 33 from Patent EP2491944
CTTGAAGAC
>JB292840.1 Sequence 32 from Patent EP2491944
CTGGAGGAT
>JB292839.1 Sequence 31 from Patent EP2491944
TTGGCAGAT
>JB292838.1 Sequence 30 from Patent EP2491944
TTGGCTGAT
